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INTRODUCTION 
partly known. Possibly, in HF developing on
the basis of ischemia/infarction, increased
apoptosis in the affected structures plays a
major role, while it is hypertrophy and fibrosis
in HF developing on the basis of increased
afterload42. It is essential to realize that the
before-mentioned processes originate and
evolve in rest, a state where a beginning degra-
dation of cardiac performance will not become
manifest: in an early stage and only exercise
would unmask a limitation in cardiac output.
It appears that chronic sympathoexcitation
plays a pivotal role in the natural history of HF.
Also, HF is associated with a weakened barore-
flex26. Both sympathetic hyperactivity and
lowered baroreflex sensitivity (BRS) are present
in mild stage C HF31 and the therapeutic effect
of beta-blockade in patients with asymptomatic
left ventricular systolic dysfunction (LVSD)
suggests that chronic sympathoexcitation is also
found in stage B heart failure1. As chronic
sympathoexcitation leads to chronic activation
of the renin-angiotensin-aldosteron system
(RAAS) it implicates a generalized neurohu-
moral activation that is crucial for the remod-
eling of the heart as HF progresses35, with
enlargement due to increased filling pressure,
and hypertrophy and fibrosis stimulated by
increased levels of angiotensin and aldosteron42.
What is the initial mechanism that causes
sympathoexcitation in rest in emerging HF?
The postulate of a diminished cardiac output
that increases sympathetic outflow due to a
decrease in baroreceptor firing rate caused by
low blood pressure62 is no longer a tenable
hypothesis. First of all, cardiac output is not
compromised at rest in the initial stage of
emerging HF. Second, blood pressure is not
lowered in asymptomatic patients. Third, if
blood pressure would decrease, baroreflexes
would reset to the prevailing new blood pres-
sure value16. Fourth, in animal experiments
with denervated baroreflex afferents, no signs
of chronic sympathoexcitation were found, e.g.,
total peripheral resistance did not change16.
Most likely, signals from the heart itself cause
the sympathoexcitation.
It is reasonable to assume that in emerging
HF localized areas in the heart come into exis-
tence in which increased mechanical stretch
and/or metabolic stress/ischemia occur.
Cardiac sympathetic afferents are then acti-
vated by mechanical stretch and by metabolites
like potassium, hydrogen ion, adenosine,
bradykinin and prostaglandins63,83, resulting in
elevation of sympathetic tone: the cardiac
sympathetic afferent reflex (CSAR).
In normal hearts, CSAR is not excited at rest,
but, in HF it is. Additionally, CSAR is enhanced
in HF because of an increase in discharge inten-
sity at the receptor level and also because of an
increase in central reflex gain51,86. A schematic
representation of the CSAR pathway is outlined
in Figure 1. CSAR afferents project on the rostro-
ventrolateral medulla (RVLM) and on the
nucleus tractus solitarii (NTS). CSAR afferents
activate sympathetic efferents at the level of the
RLVM. At the level of the NTS, CSAR afferents
activate interneurons71,86. These interneurons
release the neuromodulator gamma-aminobu-
tyric acid (GABA) that inhibits the barosensitive
NTS neurons87. As a result CSAR increases
sympathetic outflow and reduces BRS.
Hence, permanent CSAR activation might
well be the initial cause of the chronic sympa-
thoexcitation in HF. As HF progresses, and due
to changes in blood composition due to the
permanent neurohumoral activation, skeletal
muscle becomes involved. Due to several struc-
tural and functional changes, mataboreceptors,
normally only stimulated during exercise,
become also active at rest. This permanent
stimulation of the peripheral chemoreflex
causes additional sympathoexcitation89.
As patients with the highest sympathetic
activation and patients with the lowest BRS
have the poorest survival4,10, lowering CSAR
activity, sympathoexcitation and plasma cate-
cholamine concentrations, and increasing BRS,
seem logical therapeutic goals in emerging and
overt HF.
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1.1 PREVALENCE AND
PROGNOSIS OF HEART FAILURE
Heart failure (HF) was already described in
antiquity. Around 400 BCE, Hippocrates gave a
detailed description of the symptoms of this
disease. He depicts one of his patients as
follows: ‘[The patient] appears yellow; the
whole body is edematous; the face is red; the
mouth dry; he is thirsty; and when he eats,
respiration quickens. In the same day at some
times he may appear better while at others he
is suffering acutely and seems on the verge of
dying’ (Internal Affections XXI)44.
HF is a growing worldwide health problem.
In the Netherlands, from 1980 to 1999, the
annual hospitalization rate increased by 72%56.
In the European population, the estimated
prevalence of HF ranges from 0.4% up to 2%.
The prevalence of HF increases rapidly with
advancing age. The Framingham study
reported an approximately 10 times higher
occurrence of HF in the age group ≥ 80 years as
in the age group 50-59 (91 versus 8 cases per
1000 persons)36. It is estimated that the world’s
population aged 60 and over will be three
times higher in 2050 than in 2000 (2 billion).
Hence, with a proportionally increasing older
population, longevity partly accounts for this
increasing occurrence of HF. Another factor
that contributes to the rising prevalence of HF
is the increasing post-infarction survival rate54:
the occurrence of a myocardial infarction
increases the risk for CHF 2-3 fold74. Also, it was
found in patients ≥ 65 years in Canada,  that
75% of this cohort developed HF within 5 years
after their first myocardial infarction24.
Furthermore, a high living standard with over-
weight and sedentary life style is also associated
with HF21,58. According to the World Health
Organization, in 2015, 2.3 billion people around
the world will have a body mass index in the
obese or overweight range. Consequently, this
increase in obese people will add to the
increasing prevalence of HF. 
Despite the development of new therapies,
the prognosis of HF remains poor76. Half of the
HF patients dies within 4 years of the diagnosis,
and less than half of the population with severe
HF survives the first year after diagnosis80. This
underscores the importance of the ongoing
quest to improve current therapies and to
develop new therapeutic modalities.
1.2 PATHOPHYSIOLOGY OF
CHRONIC HEART FAILURE 
An unifying definition of HF is lacking.
There are, however, three items that are
emphasized in most definitions, namely short-
ness of breath during rest and/or during exer-
tion, fluid retention, and a functional or struc-
tural abnormality of the heart21. HF can occur
acutely, e.g., in the setting of acute myocardial
infarction, or it can be a chronic condition. A
majority of research, including this thesis,
focuses on chronic heart failure (CHF).
Formerly, the abbreviation CHF stood for
congestive HF; this usage has been abandoned,
because adequate treatment keeps most of the
HF patients out of the decompensated condi-
tion.
In 2001, the American Heart Association
postulated a new approach to the classify HF39.
Four stages were discerned in the pathogenesis
and development of HF:
Stage A; At high risk for HF but without
structural heart disease or symptoms of HF.
Stage B; Structural heart disease but without
signs or symptoms of HF.
Stage C; Structural heart disease with prior or
current symptoms of HF
Stage D; Refractory HF requiring specialized
interventions.
With these stages, the Guidelines emphasize
origin, development and progression of the
disease, where ‘pre’-stages A and B focus on the
risk factors that predispose toward the develop-
ment of actual HF (stages C and D). The mecha-
nisms that cause structural heart disease (stage
B) to develop into actual HF (stage C) are only
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difficult to perceive57, and in symptom-limited
exercise tests, as performed in CHF, the plateau
is often not attained81 (see Figure 2), hence, peak
oxygen uptake (V
.
O2 peak) is assessed instead. By
its nature, V
.
O2 peak is in practice strongly influ-
enced by the motivation of the patient, the
selected exercise protocol and the tester’s
subjective choice of the test endpoint5,79.
Consequently, V
.
O2 peak is more a subjective
parameter. 
More objective measures of exercise capacity
than V
.
O2 peak can be assessed by submaximal
exercise testing (or by the submaximal part of a
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CO2 slope is an exercise testing
parameter with high prognostic value in
CHF
13,18. It can be obtained by linear regression
analysis of the relation between minute ventila-
tion (V
.
E) and carbon dioxide output (V
.
CO2)
during an incremental exercise test (see Figure
3). It reflects the ventilatory response to exer-
cise, i.e., the slope reflects the gain of the
chemoreflex that triggers ventilation in
response to PCO2 changes in the blood. As a





CO2 slope is increased in CHF. Normal




CO2 slope are between 20 and
30; in CHF patients it can reach values as high
as 8067.  
In 1996 Baba et al.7 introduced OUES as an
objective and reproducible measure of exercise
capacity8,37,85 (see Figure 4). The OUES is deter-
mined by regressing oxygen uptake against the
logarithm of total ventilation during an incre-
mental exercise test. It describes the efficiency
by which oxygen can be extracted from the
ambient air. In CHF patients it was shown that







CO2 slope and ventilatory anaer-
obic threshold) OUES had the strongest prog-
nostic value; OUES was also the only exercise
variable with independent prognostic value18.
Another measure of exercise capacity is
∆V
.
O2/∆W, which can be used as a supplemental
index to the other exercise testing variables to
more precisely assess exercise capacity.
∆V
.
O2/∆W describes the amount of oxygen that
is utilized in relation to the amount of external
work performed (see Figure 5); ∆V
.
O2/∆W on




O2/∆W is often reduced in CHF, and
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Figure 2. Peak oxygen uptake
Peak oxygen uptake of a healthy male (, age 48)
and a male chronic heart failure patient (, age 48). 
The oxygen uptake of the healthy male reaches a
plateau, the oxygen uptake of the chronic heart
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CO2 slope = 37.
1.3 FITNESS
Fitness is a broad term. According to the
Dutch Van Dale dictionary, fitness means
being physically in good shape. Oftentimes, the
ability to cope with stress is included in the
definition of the word. In this thesis we focus
on two different aspects of fitness that are
specifically relevant in CHF: exercise capacity
and autonomic functioning. 
1.3.1 Fitness and exercise capacity 
in CHF
In CHF patients exercise capacity is
decreased, frequently to such an extent that
participation in several daily life activities
becomes impossible. The degree of exercise
intolerance in CHF is paralleled by an increased
mortality18, moreover, several studies suggest
that increasing exercise capacity in CHF
improves prognosis68,73,77. Therefore, improving
exercise capacity is one of the major issues in
CHF-related treatment. Part of this thesis
concentrates on the effect of therapeutic inter-
ventions on fitness in the context of exercise
capacity, focusing on changes in fitness-related
cardiopulmonary exercise variables discussed
below.  
Clinically, the maximal oxygen uptake 
(V
.
O2 max) is the most frequently used measure of
exercise capacity. V
.
O2 max is an objective para-
meter, being defined as the point at which
oxygen uptake reaches a plateau despite contin-
uing exercise and increasing workload82 (see
Figure 2). Unfortunately, such a plateau is often
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Figure 1. Neural pathways involved in sympa-
thoexcitation and baroreflex inhibition by cardiac
sympathetic afferents. 
Gademan et al. Am J Physiol 2008.
Panel A: sacral and thoracic spinal, and caudal and
rostral medullar sections; 
panel B: NTS details (based on71). ALS = anterolateral
(spinothalamic) system; CVLM = caudal ventrolateral
medulla; GABA = inhibiting neuromodulator gamma-
aminobutyric acid; Glu = excitatory neurotransmitter 
L-glutamate; NA = nucleus ambiguus; NG = nodose
ganglion; NRM = nucleus raphe magnus; NTS =
nucleus tractus solitarius; PAG = periaquaductal grey;
PG = petrosal ganglion; PRG = posterior (dorsal) root
ganglion; RVLM = rostral ventrolateral medulla; 
SP = excitatory neuromodulator substance P; IX = 9th
cranial (glossopharyngeal) nerve; X = 10th cranial
(vagus) nerve. Dark gray spots: involved areas.
Inhibiting neurons at the level of the brainstem: gray,
dashed; sympathetic efferents: gray, continuous;
parasympathetic efferents: gray, dotted.
Baroreflex vigor is usually characterized in
terms of the extent of bradycardia that occurs
when blood pressure increases, and is indicated
by BRS. BRS is expressed as the increase of the
interval between heart beats (in ms) per mmHg
systolic blood pressure rise and is usually deter-
mined during rest. Lowered BRS in CHF paral-
lels deterioration of clinical and hemodynamic
status and is strongly associated with poor
survival48,55.
1.4 TREATMENT OF 
HEART FAILURE
A broad therapeutic spectrum is used in
CHF. The cornerstone of CHF management is
pharmacological therapy, where each patient is
to be submitted to an individualized combina-
tion of the following medications to achieve an
optimal treatment effect: angiotensin-
converting (ACE) inhibitors, diuretics, beta-
adrenoreceptor antagonists, aldosterone
receptor antagonists, angiotensin receptor
antagonists, cardiac glycosides, vasodilator
agents (nitrates/hydralazine), positive inotropic
agents, anticoagulation and antiarrhytmic
agents. Treatment with this pharmacological
regimen interferes at various levels with the
process of neurohumoral activation, thus
reducing the detrimental influences of this
process to a certain extent21. 
Besides pharmacological therapy, surgical
treatment is an option for part of the CHF
patients. Common surgical interventions are:
coronary revascularization, valvular surgery
and surgical remodeling of the left ventricle.
For patients with end-stage drug refractory
CHF, cardiac transplantation may be the last
option. Supplementary to pharmacological
therapy and/or surgical intervention, device
therapy (implantable cardiovertor defibrillator
and/or biventricular pacemaker, Figure 6) has
been implemented in the last decade as therapy
for patients with both drug refractory CHF and
left ventricular dysfunction.
Another important part of treatment of CHF
is self-care management. Self-care can be
defined as actions by the patient intended at
maintaining physical stability, avoidance of
behavior that can worsen the condition, and
recognition of the early symptoms of deteriora-
tion43. One of the aspects of self-care manage-
ment is being physically active. In practice, a
limited period of exercise training/rehabilita-
tion is often prescribed/advised following a
cardiovascular event, an episode of decompen-
sation or to recover from surgical interventions.
However, exercise training could be a more
beneficial therapy if it is incorporated in daily
life and not only used occasionally in situations
as mentioned above.
In this thesis we focus on the fitness-related
effects of two non-pharmacological treatment
modalities within the scope of the cardiologist,
namely exercise training and biventricular
pacing.
1.5 MECHANISMS AND EFFECTS
OF EXERCISE TRAINING 
In the past, patients with CHF were advised
to avoid exertion, for fear of worsening cardiac
function due to myocardial stress38. In the late
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Figure 6. A biventricular pacing device, the leads
are positioned in the right atrium, the right ventricle
(usually the apex) and a postero-lateral vein (through
the coronary sinus). 
the reduction in ∆V
.
O2/∆W reflects the severity
of CHF40,78. However, patients with mild CHF
may have relatively normal ∆V
.
O2/∆W values78.  
1.3.2 Fitness and autonomic functioning
in CHF
Discussing autonomic functioning in the
context of fitness is less evident than discussing
exercise capacity. However, exercise capacity
and autonomic functioning in CHF are closely
related41,52, as physical training improves both
exercise capacity and autonomic functioning,
the latter manifesting, e.g., as a decrease in
neurohumoral activation and an increase in
BRS
27. Major part of this thesis is concerned
with improvement of autonomic functioning
in CHF, mainly focusing on the arterial barore-
flex.
The arterial baroreflex buffers blood pres-
sure and it prevents wide short-term fluctua-
tions of arterial blood pressure. Baroreceptors
are stretch-sensitive receptors located in the
aortic wall, the wall of the pulmonary artery,
and the carotid sinuses. Every blood pressure
pulsation elicits an afferent baroreceptor burst,
of which the intensity depends on the systolic
blood pressure (SBP) of the given heart beat
relative to the average blood pressure level.
Hence, when the SBP of the given heart beat is
relatively low, the burst intensity of the barore-
ceptor will also be low, and when the SBP of
the given heart beat is relatively high, the burst
intensity of the baroreceptor will also be high.
The afferent baroreceptor burst constitutes
neural information for the vasomotor centre in
the medulla oblongata62. Here, the efferent
reflex output is generated, both in the form of
a vagal burst (more intense with a higher blood
pressure pulsation) and in the form of a brief
episode of sympathoinhibition (the degree of
inhibition increasing with blood pressure). 
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Figure 4. The oxygen uptake efficiency slope 
Panel A:  The relationship between oxygen uptake
and minute ventilation during exercise in a 53-year
old chronic heart failure patient () and in a
healthy male (age 48, ). 
Panel B: The relation plotted on a logarhytmic
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Figure 5. Oxygen uptake kinetics (∆V
.
O2/∆W)
The oxygen uptake – work rate relation of a 48 year
old chronic heart failure patient. This relation
describes how much oxygen is consumed in relation to
the quantity of external work performed. 
Improvement of the mechanical activation
pattern of the left ventricle is the primary
working mechanism of CRT49. CRT induces
early excitation of the region which is else late
activated due to delayed intrinsic conduction,
hence, biventricular pacing synchronizes the
activation of the left ventricular free wall and
the intraventricular septum and improves
mechanical contractility and mitral regurgita-
tion. Moreover, Nelson et al.59 found that CRT
enhanced systolic function with modestly
diminished energy cost, which is probably
explained by lowering of lateral wall stress. 
As CRT enhances systolic function and
improves myocardial efficiency in CHF, it is not
surprising that CRT also improves exercise
capacity, since oxygen uptake depends on
cardiac output67. In the MIRACLE trial it was
shown that CRT improved V
.
O2 peak , as  well as
submaximal exercise capacity, measured by the
six minute walk test2. 
In addition to the beneficial clinical effects
of CRT on fitness in the context of exercise
capacity, CRT also has a positive impact on
autonomic functioning in CHF. CRT has been
proven to reduce sympathetic nerve activity,
BNP, ET-1 and norepinephrine and to increase
heart rate variability after six
months3,11,23,25,32,47,60,75. A plausible and clinically
relevant explanation for these observations
would be that CRT reduces metabolic and
mechanical stress in affected ventricular
muscle, thus reversing CSAR activation and
sympathetic outflow. However, direct proof of
this CRT working mechanism is difficult to
obtain, as CSAR afferent activity cannot be
measured in humans. 
1.7 AIMS AND OUTLINE OF 
THIS THESIS
Aim of this thesis is to study the effects of
exercise training and of biventricular pacing on
fitness-related cardiopulmonary exercise testing
variables and on brs in the setting of CHF. Also,
we address the underlying effect mechanisms.
In Chapter 2 we review the effects of exercise
training on neurohumoral excitation and auto-
nomic derangement at rest.
In Chapter 3 we address, in a modeling study,
a number of issues that are relevant for the
interpretation of BRS. By means of computer
simulations we investigate the link between the
well known phenomena of blood pressure
resonance (the Mayer waves) on one hand, and
blood pressure buffering (possibly the most
essential function of the baroreflex) on the
other hand.
In Chapter 4 we probe the hypothesis that
sole exercise-associated somatosensory input to
the brainstem is a training stimulus for the
autonomic nervous system. We compare in
stable untrained CHF patients the effect of tran-
scutaneous electrical nerve stimulation (TENS)
with the effects of bicycle exercise training. BRS
was used as an outcome measure of autonomic
functioning. To mimic exercise-associated
somatosensory ergoreceptor stimulation by
TENS, we applied periodic (2/s, marching pace)
burst stimulation to both feet. 
Chapters 5 and 6 are devoted to the effect of
exercise training on fitness in the context of
exercise capacity. We studied the effect of exer-
cise training in CHF patients on the OUES
(chapter 5) and on oxygen uptake - work rela-





O2/∆W are independent of the maxi-
mally attained exercise intensity. Therefore
both are very convenient and reliable measures
of exercise capacity in CHF. 
In Chapters 7 and 8 we describe the effect of
biventricular pacing on the arterial baroreflex.
Since CSAR afferent firing is known to decrease
BRS
28,87, CRT-induced CSAR deactivation should
be accompanied by a BRS increase. 
In Chapter 7 we describe the acute effect of
biventricular pacing on the arterial baroreflex.
As no other studies have yet found an acute
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1970s and early 1980s the first studies appeared
reporting that exercise training was safe in
patients with CHF15,50. At present, it is clear that
exercise training is not only safe but also bene-
ficial in CHF. Exercise training lessens dyspnea
and fatigue34,53, improves quality of life,
improves New York Heart Association (NYHA)
class6,9,20,61,65,84, decreases morbidity and, likely,
also mortality19,68,73,77. Currently, European and
American guidelines21,38 recommend exercise
training in addition to pharmacotherapy.
Beneficial effects of exercise training in CHF
have been documented at various functional
and structural levels. Several peripheral
muscular adaptations occur under the influ-
ence of exercise training, for instance, increased
capillary density, blood flow, mitochondrial
volume density, fibre size, slow twitch fibres
and decreased lactic acidosis and vascular resis-
tance22,30,33,34,45,69. Although the ELVD-CHF
trial29 reported a slightly increased left ventric-
ular ejection fraction, most studies report
hardly any change in this variable70. The gener-




73 is presumably mainly to be attrib-
uted to an increase in peak heart rate, an
increase in stroke volume during exercise and
to peripheral muscular adaptations. Other
cardiopulmonary exercise testing variables than
V
.
O2 peak, that are increased by exercise training





anaerobic threshold and workload. The effect
of exercise training in CHF on OUES and
∆V
.
O2/∆W has not been elucidated yet.
In addition to these effects, exercise training
in CHF also reduces autonomic derangement
and neurohumoral excitation at rest27; exercise
training decreases sympathetic outflow and
increases BRS in CHF. However, the mechanism
that mediates the normalization of the neuro-
humoral activation and autonomic derange-
ment by exercise training has not yet been
identified. Pinpointing the key elements of an
exercise program that are responsible to
achieve an autonomic training effect would
allow for the design of training programs
specific for CHF patients, with maximal efficacy
at minimal work loads that meet the limited
exercise tolerance.
Ergoreceptor activity stemming from
working muscle may be a key factor in the
exercise-induced increase in BRS at rest. On
their way to the thalamus, the neural fibres
conveying such ergoreceptor information
project to several structures, such as the NTS17.
During exercise, these projections release
substance P at the NTS72. Substance P enhances
the baroreflex66 by modulating the transmis-
sion of the baroreceptive afferents to the NTS
neurons. We assume that baroreflex enhance-
ment after exercise materializes in the NTS in
the form of an elevated substance P level that
outlasts the actual exercise period88. The
enduring production of substance P by barore-
ceptor afferents71 would make such a sustained
effect even more likely. We suppose that this
effect lasts for more than 24 hours, thus facili-
tating a lasting cumulative training effect that
can be achieved by daily stimulation. Substance
P has long-lasting effects (>24 hours) on the
modulation of neural activity in other systems,
e.g., in the spinal cord64. It is however not
known if substance P has these long-lasting
effects in the NTS. In any case, the consequence
of this scenario would be that baroreflex
training effects could also be attained by exer-
cise-mimicking somatosensory stimulation




Cardiac resynchronization therapy (CRT) is a
relatively new therapy in CHF; the first case
report of a patient who received CRT appeared
in 199412. Currently, it is known that CRT
improves mortality, symptoms, quality of life
and NYHA class2,14. As a result of these
successful outcomes, CRT is nowadays an estab-
lished therapy in CHF.
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effect of CRT on autonomic fitness in the form
of an increase in BRS, this study may reveal a
new indication for the working mechanisms of
biventricular pacing.
In Chapter 8 we investigate if the acute
response in BRS after institution of CRT has
predictive value for mid-term response.
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Moreover, there is a more prominent role of
the ergoreflex in CHF patients compared to
healthy subjects; indirectly, by increased stimu-
lation of the ergoreceptors by lactate accumu-
lation in peripheral muscle, or directly, by
increased reflex gain74. 
Pharmacological approach
Attempts have been made to assist or repair
the heart by mechanical23 and electrical devices
or surgical intervention90. A major component
of CHF pharmacological therapy is, however,
the suppression of the detrimental influences of
neurohumoral activation. Although diuretics,
digoxin, adrenergic receptor agents,
angiotensin-converting enzyme inhibitors,
angiotensin receptor blockers and aldosteron
receptor antagonists have greatly reduced
mortality73,91, even with optimal treatment
mortality rates remain high. Surveys show that
45-65% of CHF patients die within 5 years10,82.
This underscores the importance of the
ongoing quest to improve current therapy and
to develop new therapeutic modalities.
Patients with the highest sympathetic acti-
vation and patients with the lowest BRS have
the poorest survival rate5,9.  Lowering of plasma
catecholamine concentrations and increasing
BRS seem logical therapeutic goals, as, in CHF,
over time lowered plasma neurohormones and
increased BRS are associated with decreased
morbidity and mortality5. Optimal treatment
with adrenergic receptor blockers and
angiotensin-converting enzyme inhibitors
lowers plasma neurohormones but, unfortu-
nately, the levels remain elevated with respect
to normal52,73. Beta-blockade may also increase
BRS
64,86, however, BRS in CHF patients remains
lower than normal. 
Exercise training
European and American guidelines43,90
recommend exercise training in addition to
pharmacotherapy. Exercise training lessens
dyspnea and fatigue39,61, improves quality of
life, improves New York Heart Association
(NYHA) class6,7,24,68,71,92, decreases morbidity and,
likely, also mortality22,75,81,89. The beneficial
effects of exercise training in CHF have been
documented at various functional and struc-
tural levels. Although the ELVD-CHF trial31
reports a slightly increased left ventricular ejec-
tion fraction, most studies report hardly any
change in this parameter78. The generally
observed exercise training induced increase 
in peak oxygen consumption (V
.
O2 peak)81 is
presumably mainly attributable to an increase
in peak heart rate, an increase in stroke volume
during exercise, and peripheral muscular adap-




















Figure 1. Neurohumoral excitation depicted as a
process consisting of primary sympathetic excitation
with neural and humoral feedback at the level of the
brainstem. In heart failure, hormonal compounds like
angiotensin-II, endothelin-I, nitric oxide, atrial
natriuretic peptide and arginine-vasopressin in the
circulation are dysregulated, as are the concentrations
of these modulatory substances at the level of the
brainstem. Obviously, the active function of the
blood-brain barrier and local production at the level of
the brain result in differences in the peripheral and
central concentrations of these compounds. Hence, the
levels measured in blood are not fully representative of
the concentrations in the brain. However, there is good
evidence to support that peripheral and central
concentrations parallel each other, thus making the
peripherally measured concentrations at least indica-
tive for the degree of feed-back inhibition/excitation at
the central level20,21,41. Figure reproduced from Zucker
et al.99, with permission.
ABSTRACT 
Background. In chronic heart failure (CHF),
persistent autonomic derangement and neuro-
humoral activation cause structural end-organ
damage, decrease exercise capacity and reduce
quality of life. Beneficial effects of pharma-
cotherapy and of exercise training in CHF have
been documented at various functional and
structural levels. However, pharmacological
treatment can not yet reduce autonomic
derangement and neurohumoral activation in
CHF to a minimum. Various studies suggest
that exercise training is effective in this respect. 
Results. After reviewing the available
evidence we conclude that exercise training
increases baroreflex sensitivity and heart rate
variability, and reduces sympathetic outflow,
plasma levels of catecholamines, angiotensin II,
vasopressin and brain natriuretic peptides at
rest. 
Conclusions. Exercise training has direct and
reflex sympathoinhibitory beneficial effects in
CHF. The mechanism by which exercise
training normalizes autonomic derangement
and neurohumoral activation is to elucidate for
further development of CHF-related training
programs aimed at maximizing efficacy while
minimizing workload.
INTRODUCTION
Chronic heart failure (CHF) is associated
with autonomic derangement, notably, perma-
nent sympathoexcition and arterial baroreflex
sensitivity (BRS) weakening29. Autonomic
derangement is already present in mild CHF36,
and is likely to be induced by augmented input
from cardiac “sympathetic afferents”30.
The sympathetic nervous system plays a
pivotal role in the natural history of CHF.
When the heart begins to fail a series of neural
and hormonal survival adaptations are activated
to preserve perfusion pressure and conserve
sodium and water. These systems include arte-
rial and cardiopulmonary baroreflexes, natri-
uretic peptides, nitric oxide, the peripheral
chemoreflex, angiotensin II
(A-II), endothelin-1 and arginine-vasopressin
(AVP)99 (Figure 1). There is early activation of
cardiac adrenergic drive, which is, with wors-
ening heart failure, followed by an increasing
magnitude of generalized sympathetic activa-
tion84. Eventually, the adverse consequences of
this neurohumoral activation will dominate
over the short-term compensatory effects
(compensation of a diminished heart function
by increase of cardiac rate and contractility,
vascular tone, venous return and circulatory
filling).  They are mediated through down-
regulation of beta-receptor function and
harmful biological effects on the cardiomy-
ocyte and structural end-organ damage such as
cardiac enlargement, hypertrophy and fibrosis
begin to develop, secondary to permanently
elevated levels of catecholamines, renin,
angiotensin and aldosteron42. Also, neuro-
humoral activation is a possible trigger for the
heart failure related inflammatory response and
its effect on cytokines17,46.
Besides the negative effects of persistent
neurohumoral activation on the heart, periph-
eral musculature undergoes detrimental struc-
tural and functional changes as well35,60, and
the rise in neurohomones is paralleled by an
increase in the degree of exercise intolerance44.
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RESULTS
Baroreflex and heart rate variability
Baroreceptors are stretch-sensitive receptors
located in the aortic wall, the wall of the
pulmonary artery, and the carotid sinuses.
Every blood pressure pulsation elicits an
afferent baroreceptor burst, of which the inten-
sity varies from zero to average to maximum
when the systolic blood pressure of the given
heart beat is very low, equal to, or very high
respectively, relative to the average blood pres-
sure level. The afferent baroreceptor burst
constitute neural information for the vaso-
motor centre in the medulla oblongata70. Here,
the efferent reflex output is generated, both in
the form of a vagal burst (more intense with a
higher blood pressure pulsation) and in the
form of a brief episode of sympathoinhibition
(the degree of inhibition increasing with blood
pressure). Thus, the baroreflex is a negative
feedback loop in the neurohumoral excitation
process in CHF. 
Baroreflex vigor is usually characterized in
terms of the extent of bradycardia that occurs
when blood pressure increases, and is indicated
by the BRS. BRS is expressed as the increase of
the interval between heart beats (in ms) per
mmHg systolic blood pressure rise and is
usually determined during rest. Lowered BRS
sensitivity in CHF parallels deterioration of
clinical and hemodynamic status and is signifi-
cantly associated with poor survival65.
Exercise training increases BRS in healthy
subjects13 and in patients with myocardial
infarction54,63. A significant positive relation
was also found between individual exercise-
induced BRS improvement and survival54.
Only 1 study examined the effect of exercise
training on resting BRS in patients with CHF
(Table 2)77, but unfortunately, this study lacked
a control group. The study comprised of a
small training group (13 patients), but managed
to find a significant training-induced increase
in BRS. Controlled studies should verify this
interesting finding.
Heart rate variability (HRV) is intimately
related to BRS, as it gives a qualitative and
quantitative description of the variations in the
instantaneous heart rate that are mainly the
result of baroreflex-mediated spontaneous
blood pressure fluctuations28,94. Decreased HRV
in CHF patients is likely to be attributed to
decreased vagal involvement in cardiovascular
control37. Reduced HRV (e.g., a reduced stan-
dard deviation of the intervals between normal
beats, SDNN) has a strong prognostic value and
is related to increased mortality in CHF67.
Because SDNN is one of the most commonly
computed HRV parameters, and has the advan-
tage that is not sensitive to algorithmic variants
as seen in spectral HRV analysis1 we have
searched the literature for studies towards the
influence of exercise training on SDNN in rest
in CHF patients. Four such studies2,3,18,88 were
found (Table 2). Three studies2,3,18 reported a
significant increase in SDNN at rest after exer-
cise training. Selig et al.88 did not find any
difference after exercise training; however, in
this study, the training regimen was restricted
to resistance training. In conclusion, aerobic
exercise training increases SDNN at rest in CHF
patients. 
Sympathetic nervous system
Circulating catecholamines originate from
the adrenal medulla, in the form of epineph-
rine and norepinephrine in a ratio of about
80/20%. Catecholamine secretion occurs when
the innervating preganglionic sympathetic
nerves are activated during times of stress.
Circulating catecholamines also originate from
spilled-over norepinephrine produced at
sympathetic nerve endings throughout the
body50. In addition to measuring cate-
cholamines in blood, sympathoexcitation can
also be assessed by measuring MSNA e.g., in the
peroneal nerve; catecholamine levels and MSNA
are well correlated during enhanced sympa-
thetic drive80.
Thirteen studies2,8,18,33,39,40,48,49,51,72,92,93,97,
comprising a total of 481 patients (239/199
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tations like increased capillary density, blood
flow, mitochondrial volume density, fibre size,
slow twitch fibres and decreased lactic acidosis
and vascular resistance27,34,38,39,47,76. 
In addition to these functional and clinical
effects, exercise training in CHF also appears to
reduce autonomic derangement and neurohu-
moral excitation at rest11. The mechanisms by
which these effects are accomplished are
incompletely known; in part, it may be
ascribed to neuronal nitric oxide synthase
formation in the paraventricular nucleus98. By
lowering neurohormone plasma concentrations
and by reinforcing the arterial baroreflex, exer-
cise training acts in concert with pharma-
cotherapy in the treatment of CHF patients.
Unfortunately, the effects of exercise
training on autonomic derangement and
neurohumoral excitation in CHF patients at rest
have not been studied or reviewed to the extent
of the effects of pharmacological therapy. Only
one review55, merely reiterating the one by
Braith and Edwards11, appeared since 2003. A
total of 16 original studies, of which 10 were
published after the review by Braith and
Edwards11, were not included in either review
article (see Table 1). Hence, a recent overview
with the merit to update readers and with
educational potential to readers not familiar
with this topic, is necessary. The recent studies
have confirmed and nuanced earlier findings
and demonstrated new information in the field,
notably the effect of exercise on resting BRS, on
resting muscle sympathetic nerve activity
(MSNA), and on resting plasma renin,
endothelin and brain natriuretic peptide (BNP)
concentrations in heart failure. Of these, BRS
and BNP have a high prognostic value in CHF
and have substantial importance for clinical
evaluation and treatment of CHF patients. 
REVIEWED STUDIES 
We searched MEDLINE and www.scholar.
google.com, using the following terms: chronic
heart failure, exercise, training, rehabilitation,
physical activity, neurhohumoral, neurohor-
mones, catecholamines, epinephrine, norepi-
nephrine, angiotensin, aldosteron, brain natri-
uretic peptide, atrial natriuretic peptide,
baroreflex, endothelin, vasopressin, muscle
sympathetic nerve activity, heart rate vari-
ability. We found 23 original studies addressing
the effects of exercise training on autonomic
derangement and neurohumoral activation in
CHF patients with systolic failure, measured at
rest. The main methodological characteristics
of all 23 studies are listed in Table 1. Seventeen
studies had a control group; 14 of these were
randomised controlled trials, while in the other
2 studies no explicit statement about randomi-
sation was made. Six studies had no control
group, 3 of these were case series and 3 were
crossover trials.
In the 23 reviewed studies, a total of 849
patients (550/299 exercise/control) were
included. Nineteen studies enrolled NYHA class
II-III patients; Hambrecht et al.39, Passino et
al.72 and the European heart failure training
group2 included NYHA class I-III patients, while
Yeh et al.97 included NYHA class I-IV patients.
In the latter study, training was done by Tai
Chi, which is to be classified as exercise with
moderate intensity, requiring energy expendi-
ture of approximately 3 to 5 metabolic equiva-
lent (MET) tasks4. In the publication by Yeh et
al.97 there is no explicit statement about the
training intensity, but it is doubtful whether
the Tai Chi was applied at a 3-5 MET intensity
level, as NYHA class IV patients are already
symptomatic at rest.
Among the reviewed papers, the exercise
training programs varied considerably in inten-
sity, training frequency (2 to 7 sessions/week),
session duration (15 to 60 minutes), program
duration (8 weeks to 6 months) and training
modality. The observed effects of exercise on
autonomic derangement and neurohumoral
excitation, summarized in Tables 2-5, are
discussed in the following sections.
32 FITNESS IN CHRONIC HEART FAILURE: EFFECTS OF EXERCISE TRAINING AND OF BIVENTRICULAR PACING 
CHAPTER 2 | EXERCISE TRAINING IN CHRONIC HEART FAILURE 3534 FITNESS IN CHRONIC HEART FAILURE: EFFECTS OF EXERCISE TRAINING AND OF BIVENTRICULAR PACING 
Table 1. Methodological characteristics of the included studies.
Study RCT N (C/T) M/F EF% EF% NYHA Intensity days/ Duration Duration Exercise Modality
inclusion week per session training program
T C criteria T C
Adamopouos, 1995 No 12 12/0 - - 19 ± 2 - II/III 70-80% max HR 5 ? 8 weeks Cycling
Belardinelli, 1995 No 27 (9/18) 16/2 7/2 30 ± 5% 31 ± 5 29 ± 4 II/III 40% V
.
O2 peak 3 30-40 min 8 weeks Cycling
Braith, 1999 Yes 19 (9/10) ? ? <40% 30 ± 7 30 ± 7 II/III 70%80% V
.
O2 peak ? 30-40 min 16 weeks Walking
Coats, 1992 No 17 17/0 - - 20± 2 - II/III 60-80% max HR 5 20 min 8 weeks Cycling
*Conraads, 2004 No 49 (22/27) 21/6 15/7 <35% 26 ± 1 26 ± 1 II/III 90% of VT/ 3 10 min cycling 4 months Cycling / Resistance
50-60% 1RM 40 min resistance
*European HF No 1341/432/ 126/8 - - 25 ± 9 - I/II/III 70-80% max HR 4-5 25 min cycling 6-16 weeks Cycling/Calisthenics optional
training Group, 1998 113/574 12 min calisthenetics
*Gordon, 1997 No 20 (7/13) 13/0 7/0 - 28 ± 3 27 ± 3 II/III 65-75% V
.
O2 peak 3 20 min 8 weeks Knee extensor
Hambrecht, 1995 Yes 22 (10/12) 12/0 10/0 <40% 26 ± 9 27 ± 10 II/III 70% V
.
O2 peak 6-7 two 20 min sessions a day 6 months Cycling/Walking/Calisthenics/
Ball games
*Hambrecht, 2000 Yes 73 (37/36) 37/0 36/0 <40% 27 ± 9 27 ± 9 I/II/III 70% V
.
O2 peak 7 20 min 6 months Cycling/Walking/Calisthenics/
Ball games
*Jónsdóttir, 2005 Yes 43 (22/21) 16/5 18/4 - 42 ± 14 41 ± 14 II/III 50% V
.
O2 peak/ 2 50 min 5 months Cycling/Thera-bands/
20-40% 1RM Resistance
Keteyian, 1999 Yes 51 (25/26) 25/0 26/0 <35% 22 ± 8 22 ± 7 II/III 50-80% HR-reserve 3 33 min 24 weeks Treadmill/Walking/
Armergometer
Kiilavuori, 1999 Yes 22 (10/12) 12/0 14/1 <40% 24 ± 5 25 ± 7 II/III 50-60% V
.
O2 peak 3 30 min 6 months Cycling
*Kobayashi, 2003 Yes 28 (14/14) 12/2 8/6 <40% 33 ± 2 29 ± 2 II/III VT 2-3 two 15 min sessions a day 3 months Cycling
*Larsen, 2004 No 12 12/0 - - 32 ± 6 - II/III 80% max HR 3 30 min 12 weeks Cycling
*De Mello Franco, Yes 29 (12/17) 13/4 9/3 <40% 29 ± 2 27 ± 3 II/III 10% below VT 3 60 min 4 months supervised, Cycling/Resistance
2006 4 months at home
*Passino, 2006 Yes 85 (41/44) 39/5 35/6 <45% 35 ± 2 32 ± 2 I/II/III 60% V
.
O2 peak 3 30 min 9 months Cycling
*Pietilä, 2002 No 13 12/1 - - 36 ± 5 - II/III 60-85% max HR 6 minimal 30 min 6 months Light anaerobic muscle training,  
walking, aerobic, step board, Cycling
*Roveda, 2003 Yes 16 (9/7) 5/2 6/3 <40% 35 ± 3 35 ± 3 II/III 90% of VT 3 60 min 4 months Cycling/Ground exercise
*Sarullo, 2006 Yes 60 (30/30) 23/7 22/8 <40% 29 ± 5 30 ± 4 II/III 60-70% V
.
O2 peak 3 30 min 3 months Cycling
*Selig, 2004 Yes 39 (20/19) 15/4 18/2 <40% 27 ± 7 28 ± 6 II/III < within 5 beats/ 3 - 3 months Resistance
min of max HR
*Tyni-Lenne, 1999 Yes 24 (8/8+8) T:5/3 4/4 <40% T:29 ± 13 30 ± 11 II/III 50-80% HR-reserve 3 30 min 8 weeks Cycling/Knee extensor
KT:4/4 KT:31 ± 9
*Tyni-Lenne, 2001 Yes 24 (8/16) 8/8 5/3 <40% 30 ± 9 30 ± 10 II/III ? 3 60 min 8 weeks Cycling/Knee extensor
*Yeh, 2004 Yes 30 (15/15) 10/5 9/6 <40% 24 ± 7 22 ± 8 I/II/ Tai Chi 5 35-60 min 12 weeks Tai Chi
III/IV
C: control group; EF: ejection fraction; F: female; KT: knee extension training group; M: male; max HR: heart rate; RCT: randomised
controlled trial; T: exercise training group; VT: ventilatory threshold; 1RM: 1-repetitive maximum; 1: total number of patients; 
2: number of patients with noradrenaline measurement; 3: number of patients with adrenaline, plasma renin activity, aldosteron and atrial
natriuretic peptide measurement; 4: number of patients with heart rate variability measurement ;?: unknown; *: not reviewed before.
formation of renin (mainly produced by the
juxtaglomerular kidney cells), that stimulates
the formation of angiotensin I from angioten-
sinogen (produced in the liver). Then, A-II is
formed from angiotensin I by angiotensin
converting enzyme (produced in the lungs).
Finally, A-II enhances the release of aldosteron
from the adrenal glands53. In addition to acting
on circulating volume and vascular resistance,
A-II and aldosteron are also involved in hyper-
trophy and collagen synthesis in the heart69.
One important effect of A-II with respect to
the process of neurohumoral activation is that
it facilitates the production of norepinephrine,
and, at the level of the central nervous system,
has a sympathoexcitatory action99. In addition,
aldosteron inhibits nitric oxide production16
and the arterial baroreflex87; both would, at the
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NE E MSNA
Study T vs C T C T vs C T C T vs C T C
Belardinelli, 1995 - ↓ 16% ↔ - ↓21% ↔
Coats, 1992 - ↓* 16% -
European HF - ↓* 23% - - ↓* 53% -
training Group 
1998
Gordon, 1997 - ↓ 10% - - ↑25% -
Hambrecht, 1995 ↓52*% ↓* 52% ↔ ↓* ↓* 50% ↔
Hambrecht, 2000 ↓ 31% ↓ 31% ↔ ↓* ↓? ↑?
Keteyian, 1999 ↓18% ↓ 17% ↑1%
Kiilavuori, 1999 - ↓ 19% ↓?
Kobayashi, 2003 ↑ 16% ↑37% ↑ 21% ↔ ↔ ↔
de Mello Franco, 45%S↓* 29%S↓*
2006 33%H↓ 17%H↓ 16%↑
Passino, 2006 ↓44% ↓*26% ↑18%
Roveda, 2003 ↓* 46% ↓* 48% ↓ 2%
Tyni-Lenne, 1999 - ↓knee* -
↔Cycling
Tyni-Lenne, 2001 ↓*32% ↓* 26% ↑ 6%
Yeh, 2004 ↑29% ↑ 46% ↑17%
Table 3. The effect of exercise training in CHF on norepinephrine, epinephrine and muscle sympathetic nerve
activity at rest.
C: relative change (baseline vs placebo) in the control group; E: epinephrine; MSNA: muscle sympathetic nerve activity;
NE: norepinephrine;  T: relative change (baseline vs intervention) in the training group; T vs C: change (baseline vs inter-
vention) in the exercise training group relatively to the change (baseline vs placebo) in control group; ↓: decrease; 
↑: increase; ↔: no changes were found; ?: unknown significance level; *: significant change, P<0,05.
exercise/control), investigated the effect of
exercise on plasma norepinephrine levels or
norepinephrine spill-over levels at rest (Table 3).
Coats et al.18 found a significant decrease in
whole body norepinephrine spill-over in the
exercise group, when compared to the control
group. Likewise, 4 other studies found signifi-
cant reduction of norepinephrine plasma
resting levels40,72,92. Tyni-Lenné et al.93, in a
study with 2 different exercise groups, found a
significant decrease in norepinephrine plasma
resting levels in the knee extensor training
group, but not in the cycling group. None of
the 13 studies found a significant increase of
norepinephrine in rest. Kobayashi et al.51 and
Yeh et al.97 found a trend towards an increase
in plasma norepinephrine at rest in the training
groups51,97, but, as stated before, the Tai Chi
training intensity in the study by Yeh et al.
may have been low, while Kobayashi et al. used
the shortest session duration of all studies.
Possibly, a longer session duration and a higher
training intensity are needed to lower norepi-
nephrine plasma concentrations at rest.
Six studies measured the effect of exercise
on plasma epinephrine at rest (Table 3)2,8,33,39,40,51.
Three studies39,40 showed a significant reduc-
tion of plasma epinephrine in the exercise
group, in 1 controlled study there was a
nonsignificant trend of plasma epinephrine
reduction in the exercise group8. Another
controlled study showed no change at all70.
Gordon et al.33 found in an uncontrolled study
a nonsignificant upward trend in plasma
epinephrine at rest.
Two studies62,83 investigated the effect of
exercise on MSNA at rest and found a substan-
tial decrease in resting MSNA after exercise
training. Roveda et al.83 even found that resting
MSNA levels in trained heart failure patients
were even comparable to MSNA levels in
trained healthy controls (Table 3).
In conclusion, the controlled studies report a
significant decrease in sympathoexcitation at
rest, with the exception of the studies by
Kobayashi et al.51, Yeh et al.97 and Kiilavuori et
al.49. As the latter 2 studies used very brief
training sessions or very low intensity exercise,
respectively, we conclude that exercise training
with reasonable frequency, duration and inten-




(RAAS) is the primary mechanism for volume
control96. Sympathetic stimulation increases the
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BRS HRV
Study T vs C T C T vs C T C
Adamopoulos, 1995 - ↑*18% -
Coats, 1992 - ↑*15% -
European HF training Group, 1998 - ↑*13% -
Pietilä, 2002 - ↑*74% -
Selig, 2004 5%↓ 5%↓ ↔
Table 2. The effect of exercise training in CHF on baroreflex sensitivity and heart rate variability at rest.
BRS: baroreflex sensitivity; C: relative change (baseline vs placebo) in the control group; HRV: heart rate variability; 
T: relative change (baseline vs intervention) in the training group; T vs C: change (baseline vs intervention) in the exercise
training group relatively to the change (baseline vs placebo) in control group; ↓: decrease; ↑: increase; 
↔: no changes were found; ?: unknown significance level; *: significant change, P<0,05.
increased in patients with NYHA class III/IV95.
Endothelin causes arterial vasoconstriction,
myocardial and vascular cell hypertrophy and
aldosteron release; endothelin diminishes
sodium excretion and leads to sympathoexcita-
tion. As such, endothelin closes a positive feed-
back loop in the process of neurohumoral exci-
tation.
Kobayashi et al.51 examined the effect of
exercise on endothelin (Table 5). Resting
endothelin plasma concentrations showed a
nonsignificant decreasing trend (-4%) in the
training group, and a nonsignificant increasing
trend (16%) in the control group, with no
significant difference between the 2 groups.
The number of patients enrolled in this study
was small (N=28), and new studies should verify
the effect of exercise training on resting
endothelin concentrations in patients with CHF. 
Natriuretic peptides
When the compensatory actions of the
sympathetic nervous system-RAAS and hypo-
thalamo-pituitary-adrenal axes lead to a state
of cardiac overload, the humoral emergency
system of the natriuretic peptides is activated.
Release of atrial natriuretic peptide (ANP) and
BNP occurs under influence of increased
preload and afterload, contractility, heart rate,
catecholaminergic stimulation, A-II and
endothelin79,85. Natriuretic peptides have
diuretic and vasodilatory activity and inhibit
aldosteron secretion. Also, ANP attenuates
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Endothelin BNP/NT-proBNP ANP/NT-proANP
Study T vs C T C T vs C T C T vs C T C
Braith, 1999 ↓?33%3 ↓* 27%3 ↑6%3
Conraads, 2004 ↓*21%2 ↓* 23%2 ↓2%2
European HF 
training Group, 1998 - ↓7%3 -
Gordon, 1997 ↓27%3 ↓* 27%3 ↔0%3
Jónsdóttir, 2005 ↓3%1 ↓1%1 ↑2%1 ↑3%3 ↑5%3 ↑2%3
Kiilavuori, 1999 ↔3
Kobayashi, 2003 ↓20% ↓ 4% ↑ 16% ↓ 5%1 ↓ 5%1 ↔0%1
Larsen, 2004 - ↑10%4 -
Passino, 2006 ↓*41%1 ↓*34%1 ↑7%1
↓*38%2 ↓*32%2 ↑6%2
Sarullo, 2006 ↓*49%2 ↓*58%2 ↓9%2
Yeh, 2004 ↓*47%1 ↓15%1 ↑ 32%1
Table 5. The effect of exercise training in CHF on endothelin, brain natriuretic peptide and atrial natriuretic
peptide at rest.
ANP: atrial natriuretic peptide; BNP: brain natriuretic peptide; C: relative change (baseline vs placebo) in the control
group; T: relative change (baseline vs intervention) in the training group; T vs C: change (baseline vs intervention) in the
exercise training group relatively to the change (baseline vs placebo) in control group; ↓: decrease; ↑: increase; 
↔: no changes were found; ?: unknown significance level; *: significant change, P<0,05; 1: BNP; 2: NT-proBNP; 3: ANP; 
4: NT-proANP.
central level, result in additional sympathoexci-
tation99. Hence, the RAAS acts as a positive
feedback loop in the process of neurohumoral
activation.
Three studies2,12,72 examined the effect of
exercise on resting RAAS parameters (Table 4).
Braith et al.12 found a significant decrease in 
A-II and aldosteron plasma levels at rest in the
exercise group, reaching values comparable to
those of sedentary healthy subjects. Although
this study had a randomized controlled setup,
no explicit information about the statistical
comparison between the RAAS parameter
changes in the exercise training group as
compared to the changes in the control group
was presented. Passino et al.72 and the Euro-
pean Heart Failure Training Group2 didn’t find
any significant differences in plasma renin
activity or aldosteron plasma levels.
In conclusion, the available data are contro-
versial and more research is necessary to verify
the effect of exercise on resting RAAS activity 
in CHF
Arginine-vasopressin
Arterial underfilling, low cardiac output,
rising osmolarity and increased A-II levels acti-
vate the hypothalamo-pituitary-adrenal axis
that interacts with the sympathetic nervous
system-RAAS axis to maintain cardiovascular
and metabolic homeostasis57. As a consequence,
AVP is released from the posterior pituitary. AVP
increases water reabsorption by the kidneys,
and, in high concentrations, constricts arterial
blood vessels. CHF patients may have two- to
threefold elevated AVP plasma levels32, causing
the already increased systemic vascular resis-
tance to rise even further. The feedback action
of AVP in neurohumoral activation process is
not completely elucidated. Predominantly
negative feedback effects by AVP have been
described at the central level. Stimulation of
V1b receptors in the medulla causes cate-
cholamine secretion (positive feedback)25, while
AVP produces adrenocorticotropic hormone
and beta-endorphins at the pituitary level15,57
and AVP increases BRS66. Beta-endorphins and
the arterial baroreflex suppress sympathetic
activity (negative feedback)14. 
The study by Braith et al.12 (Table 4) is the
only study that addresses the effect of exercise
on resting AVP levels in CHF. The paper reports
a significant AVP reduction in the exercise
group, whereas levels in the control group
remained unchanged.
Endothelin
Hypoxia, shear stress, catecholamines and 
A-II stimulate endothelial cells to release
endothelin58. Endothelin levels are considerably
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C: relative change (baseline vs placebo) in the control group; T: relative change (baseline vs intervention) in the training
group; T vs C: change (baseline vs intervention) in the exercise training group relatively to the change (baseline vs
placebo) in control group; ↓: decrease; ↑: increase; ?: unknown significance level; *: significant change: P<0,05.
Plasma renin activity Angiotensin II Aldosterone Vasopressin
Study T vs C T C T vs C T C T vs C T C T vs C T C
Braith, 1999 ↓?30% ↓*26% ↑4% ↓?35% ↓* 32% ↑3% ↓?34% ↓* 30% ↑4%
European HF - ↓12% - - ↓1% -
training Group, 
1998
Passino, 2006 ↑1% ↓3% ↓4% ↓17% ↓6% ↑11%
Table 4. The effect of exercise training in CHF on plasma renin activity, angiotensin II, aldosterone,
vasopressin and endothelin at rest.
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norepinephrine release from sympathetic nerve
terminals as well as (by central action) sympa-
thetic outflow. As such, the natriuretic peptides
form a negative feedback loop in the process of
neurohumoral activation in CHF. As an emer-
gency system, elevation of ANP (atrial volume
overload), and certainly elevation of BNP
(ventricular pressure overload) have a strong
predictive value: a 100 pg/ml increase of BNP
plasma levels results in a 35% higher risk of
death26. Some investigators prefer the measure-
ment of NT-pro BNP/NT-pro ANP over the BNP
or ANP plasma levels because of their larger
half-time life. 
The effect of exercise on BNP/NT-pro BNP
resting levels in plasma was investigated in 6 of
all reviewed studies (Table 5)19,45,51,59,72,97. Yeh et
al.97 found a decreasing trend in plasma BNP
resting levels in the training group and an
increasing trend in the control group, resulting
in a significant difference between the 2
groups. Conraads et al.19, Sarullo et al.59 and
Passino et al.72 found a significant decrease of
NT-pro BNP resting levels in the training group
and the difference between the training group
and the control group was also significant,
where Passino et al.72 found the same results
also for BNP resting levels. Finally, Kobayashi et
al.51 and Jónsdóttir et al.45 found no significant
effect of exercise training on resting BNP levels.
These differences might be explained by the
larger half-time life of NT-pro BNP.
In 6 studies, the effect of exercise on resting
ANP/NT-proANP levels in plasma was investi-
gated (Table 5)2,12,33,45,49,56. Two studies12,33 found
in the training group a significant decrease in
resting ANP levels to within the reference
interval (ANP <32 pmol/L). Four studies2,45,49,55
found no significant differences in resting ANP
or NT-pro aNP levels, in two of them45,49 the
training intensity applied in these studies was
lower than that employed in the studies of
Braith et al.12 and Gordon et al.33, respectively
50-60% of  V
.
O2 peak against 65-85% of  V
.
O2 peak. 
A higher training intensity may be needed for
lowering resting ANP levels. 
In conclusion, training had no adverse
effects on resting levels of natriuretic peptides.
The available data on ANP/NT-pro ANP are
controversial and more research is necessary to
verify the effect of exercise on resting RAAS
activity in CHF. Also exercise training decreased
resting NT-pro bNP levels in patients with CHF,
although BNP resting levels did not always
decrease after exercise training. 
CONCLUSION
In conclusion, exercise training has benefi-
cial direct and reflex sympathoinhibitory
effects in CHF. Also, evidence exists for the
normalization of other components of neuro-
humoral excitation as a consequence of exercise
training. Thus, exercise training directly
competes with the pathophysiological afferent
stimuli from the failing heart that tend to
permanently increase sympathetic outflow,
leading to autonomic derangement and neuro-
humoral activation. Therefore exercise training
is an important complementary therapy for
CHF patients on stable medication. 
The mechanism responsible for the normal-
isation of the neurohumoral activation and
autonomic derangement by exercise training is
not yet clarified. Knowledge of the key
elements of an exercise program that are
responsible to achieve a training effect would
allow designing training programs specific for
CHF patients, with maximal efficacy at minimal
work load, to meet their limited exercise toler-
ance. Also, follow-up studies are needed to
determine whether normalization of exercise
induced neurohumoral excitation and auto-
nomic derangement in CHF patients is associ-
ated with improved prognosis.
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and blood pressure fluctuations15,39, BRS
might represent resonance- rather than
buffering baroreflex characteristics.
We addressed these skepticisms by simula-
tions with a hybrid mathematical model of
baroreflex blood pressure and heart rate
control, composed of hemodynamic elements
that are evaluated on a beat to beat basis, linked
to a time-continuous modeled neural control
part. By changing some parameter settings the
model mimics physiological as well as patho-
logical hemodynamic and autonomic condi-
tions.
By simulating with various gain combina-
tion values, we quantified the role of the
sympathetic and parasympathetic gains in the
three baroreflex limbs for blood pressure vari-
ability (BPV) and heart rate variability (HRV)
under physiologic and pathologic conditions.
From the obtained systolic blood pressure and
interbeat interval values, relations between BRS
and blood pressure buffering, and between
blood pressure buffering and resonance were
examined.
METHODS
The simulation model we used for this
study represents short-term human blood pres-
sure control without breathing modulation. It
is tuned for supine posture. This model —
programmed in Matlab Simulink (The Math-
Works, Inc., Natick, MA) — is, apart from some
modifications, similar to the model as earlier
designed and validated by TenVoorde and
Kingma46. 
Model description
A gross overview of the autonomically
controlled model is given in Figure 1 (see Table 1
and Table 2 for abbreviations and model para-
meters). The model represents the systemic
circulation and consists of three sections: a
hemodynamic section, a baroreceptor section
and an autonomic control section. The model
generates output in the form of time depen-
dent systolic blood pressure values (SBP,
mmHg) and interbeat interval values (IBI, ms)
by using a sinusoidal pressure probe (frequency
adjustable, amplitude fixed at 1 mmHg) as an
input signal. This apparently small perturbation
at the input of the baroreflex produces reduced
SBP fluctuations (amplitude <1 mmHg,
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Figure 1. Model of baroreflex arterial blood pressure control. The model variables and model parameters are
described in Table 1 and Table 2. Model sections and parameters are discussed in the Methods section. Note that
variables (i.e., continuous signals and sample and hold signals) are denoted italic. Adjustable parameters
(denoted bold) are placed in white boxes, fixed model divisions are placed in grey boxes.
ABSTRACT
Objectives. The arterial baroreflex buffers
slow (< 0.05 Hz) blood pressure (BP) fluctua-
tions, mainly by controlling peripheral resis-
tance. Baroreflex sensitivity (BRS), an important
characteristic of baroreflex control, is often
noninvasively assessed by relating heart rate
(HR) fluctuations to BP fluctuations; more
specifically, spectral BRS assessment techniques
focus on the BP to HR transfer function around
0.1 Hz. Scepsis about the relevance of BRS to
characterize baroreflex-mediated BP buffering
is based on two considerations: 1) baroreflex
modulated peripheral vasomotor function is
not necessarily related to baroreflex-HR
transfer, and 2) though BP fluctuations around
0.1 Hz (Mayer waves) might be related to
baroreflex blood pressure buffering, they are
merely a not-intended side-effect of a closed
loop control system.
Methods. To further investigate the relation-
ship between BRS and baroreflex-mediated BP
buffering, we set up a computer model of
baroreflex BP control to simulate normal
subjects and heart failure patients. Output vari-
ables for various randomly chosen combina-
tions of feedback gains in the baroreflex arms
were BP resonance, BP buffering capacity and
BRS.
Results. BP buffering and BP resonance are
related expressions of baroreflex BP control and
depend strongly on the gain to the peripheral
resistance. BRS is almost uniquely determined
by the vagal baroreflex gain to the sinus node. 
Conclusions. BP buffering and BRS are unre-
lated unless coupled gains in all baroreflex
limbs are assumed. Hence, the clinical benefit
of a high BRS is most likely to be attributed to
vagal effects on the heart instead of to effective
blood pressure buffering.
INTRODUCTION
In daily life, multiple processes perturb
blood pressure. The duration of these chal-
lenges varies widely. For example, respiration
makes blood pressure fluctuate with every
breath13 while physical or mental stress elevate
blood pressure for minutes or even longer. The
arterial baroreflex is a negative feedback mech-
anism that effectively buffers such incidental
blood pressure fluctuations11,20,21,23. In negative
feedback systems, feedback delay often causes
resonance in a given frequency band; this is 
the price to be paid for effective buffering at
other frequencies. Resonance in blood pres-
sure5,8,12,31,49 manifests in the form of the well
known Mayer22,33 waves (beat-to-beat blood
pressure oscillations with a frequency around
0.1 Hz / periodicity around 10 s). Effective
baroreflex blood pressure buffering occurs
below the Mayer frequency10,16.
Besides a sympathetic limb that modulates
peripheral resistance, the baroreflex has also
sympathetic and parasympathetic (vagal) limbs
that influence cardiac contractility, venous
return and cardiac rhythm. Usually, baroreflex
functioning is characterized by baroreflex
sensitivity (BRS). This index of baroreflex vigor
is defined as the reflex-induced change in
interbeat interval in ms per mmHg blood
pressure change14,34,36,44. The prognostic value
of BRS, and the favorable consequences of
successful interventions with BRS, has amply
been demonstrated27,28.
Little is known, however, about the repre-
sentativeness of this index for the efficacy of
blood pressure buffering. There are two reasons
to be skeptical in this respect: 
1) By definition — interbeat interval change
per unit blood pressure change — BRS is
bound to characterize baroreflex mediated
effects on the heart, while the baroreflex
buffers blood pressure mainly by controlling
peripheral resistance2,30
2) Oftentimes being assessed in the Mayer
frequency range of spontaneous heart rate
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to compute diastolic pressure as the exponen-
tial decay of systolic pressure, we used this
slightly modified formula to obtain more accu-
rate systolic blood pressure values. Finally,
systolic pressure Sn is computed by adding Pn
and Dn. 
Baroreceptor section
The baroreceptors are modeled linearly
within a range of threshold of 90 mmHg and
saturation level of 150 mmHg. At the barore-
ceptors, the systolic blood pressure Sn is
compared with a low-pass filtered systolic
blood pressure reference value. This value
functions as a dynamic blood pressure set
point, mimicking the physiologic process of
baroreceptor resetting47,50,51. The pressure vari-
ability source is added at the input of the
baroreflex, rendering a sample and hold systolic
blood pressure variability signal SBP, the first
model output signal.
Autonomic control section
In the time-continuous autonomic control
section, SBP is converted into an afferent neural
signal NE by factorizing this signal by the
baroreceptor sensitivity coefficient αN. This
signal concerns as input for three effectors: 
- vagal heart rate control (output: vagal signal
n);
- sympathetic heart rate control (output:
sympathetic signal m);
- sympathetic peripheral resistance control
(output Windkessel time constant T);
The vagal signal n represents vagal heart rate
deceleration (0<n<1), while the sympathetic
signal m represents sympathetic heart rate
acceleration (m>1).
The three effectors are modeled in
frequency-dependent functional blocks, with
specific sensitivity coefficients, time constants,
time delays and by autonomic tones (N, MH
and MPR; see Table 1 for actual values). In addi-
tion to these model parameters, extra barore-
flex gain multipliers (SH, V and S ) were added
to strengthen or weaken the role of each
baroreflex effector.
The neural time-continuous part and the
hemodynamic beat-to-beat part are intercon-
nected by an Integral Pulse Frequency Modu-
lator (IPFM), which simulates cardiac pace-
maker function18. Rosenblueth and Simeone40
have demonstrated that combined sympathetic
and vagal influences on the sinus node
contribute to the actual heart rate R according
to the following relationship: R = R0·m·n,
where R0 is the intrinsic heart rate. Integration
of incoming neural activity results in the
generation of the heart interval length In18.
This interbeat interval IBI is the second model
output signal.
Adjustable model parameters
Thus, the model is controlled by seven para-
meters: one (Vref) for stroke volume, three (MH,
N and MPR) for autonomic outflow, and three
(SH, V and SPR) multipliers for the gains in the
three baroreflex limbs.
The first four parameters for stroke volume
and autonomic outflow were set as two fixed
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Symbol Description Unit
Dn Diastolic blood pressure mmHg
δn Left ventricle filling factor -
In, IBI Interbeat interval ms
m(t) Sympathetic heart rate acceleration signal -
n(t) Vagal heart rate deceleration signal -
NE(t) Neural error driving signal nu
Pn Pulse pressure mmHg
Pref (t) Reference systolic blood pressure mmHg
Qn Stroke volume ml
R(t) Heart rate bpm
Sn, SBP Systolic blood pressure mmHg
t Simulation time s
Tn, T(t) Windkessel time constant ms
Vn Venous return ml 
(expressed in blood volume units)
Table 2. Model variables: sample and hold (n) or
time dependent (t). bpm: beats per minute
buffering) but also Mayer waves (amplitude >1
mmHg, resonance), depending on the
frequency of the pressure probe.
Hemodynamic section
In the hemodynamic section, all signals are
sample-and-hold signals: the beat-to-beat
varying cardiovascular signals are modeled in
elementary difference equations. All values are
adapted when a new heartbeat emerges. Stroke
volume Qn is produced by the one-chamber
Starling heart. It depends on interbeat interval
In, venous return volume Vn and a contractility
volume term Cn: 
Qn = δn ·Vn + Cn, 
where δn is a left ventricle filling factor: 
δn = 0.5 + 0.5 In / 1000. 
As this model will only be used to simulate
different autonomic control states, rather than
different hemodynamic states (like standing
posture), changes in cardiac contractility and
venous return appear to generate only very
small fluctuations in stroke volume (<5%).
Therefore, we simplified above relation into:
Qn = δn ·Vref, 
where Starling heart filling parameter Vref indi-
cates the stroke volume when δn = 1.
Stroke volume, Qn, assuming a constant arterial
compliance CA, determines pulse pressure Pn
by: Pn = Qn / CA.
A systemic Windkessel simulates diastolic
blood pressure Dn: 
- _
In
TnDn = (Dn-1 + 1_2Pn-1 )e      .
The Windkessel time constants Tn is
controlled by the baroreflex (see autonomic
control section), and is directly associated with
total peripheral resistance. Although it is usual
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Symbol Description Value
AT Sympathetic peripheral resistance control sensitivity coefficient 11500 ms/nu
αN Baroreceptor sensitivity coefficient 0.004 nu/mmHg
f Pressure probe frequency 0.0033 – 0.3 Hz
MH Sympathetic tone to the heart 1.2 (phys.) / 1.5 (path.)
MPR Sympathetic tone to the peripheral vasculature 1.2 (phys.) / 1.25 (path.)
N Vagal tone to the heart 0.5 (phys.) / 0.6 (path.)
R0 Intrinsic heart rate 100 beats/min 25
SH Sympathetic baroreflex gain to the heart multiplier 0.0 – 3.0
SPR Sympathetic baroreflex gain to the peripheral resistance multiplier 0.0 – 3.0
T0 Sympathetic peripheral resistance control intrinsic value 1800 ms
TSR Sympathetic heart rate control time delay 3000 ms 48
tSR Sympathetic heart rate control time constant 4000 ms 48
TT Sympathetic peripheral resistance control time delay 2000 ms
τT Sympathetic peripheral resistance control time constant 2000 ms
TVR Vagal heart rate control time delay 200 ms 35
τVR Vagal heart rate control time constant 100 ms 4,26
TCE Delay of cardiac event from SA-trigger to pressure rise 250 ms
TCNS Delay in central nervous system processing 100 ms 24
V Vagal baroreflex gain multiplier 0.0 – 3.0
Vref Stroke volume at 1000 ms filling time 80 ml (phys.) / 60 ml (path.)
Table 1. Model parameters and values under physiological (phys.) and pathological (path.) conditions.
When one of these parameter values equals 0,
the corresponding limb of the baroreflex does
not react to changes of SBP with respect to the
reference value and the corresponding effector
output becomes the (fixed) tone. A value of 0.5
corresponds to weak involvement. The
maximum value of these parameters is 3; this
value corresponds to a strong involvement of a
given baroreflex limb, e.g., as found in highly
trained subjects.
Simulations and frequency 
characteristics
For a given combination of the seven model
parameter values, 100 simulation runs were
done. A single simulation run served to deter-
mine one SBP variability (BPV) frequency
component, one IBI variability (HRV) frequency
component and the modulus of the SBP-to-IBI
transfer function (TF, necessary to compute
BRS) frequency component, at a given
frequency of the sinusoid pressure probe. A
single simulation run was executed as follows.
First, the model was run till steady state condi-
tions were met. Then, cubic splines were fitted
through the resulting output signals to obtain
the amplitudes of the SBP- and IBI fluctuations,
caused by the pressure probe. Finally, the
corresponding TF frequency component was
computed by dividing HRV (the amplitude of
the IBI fluctuations) by BPV (the amplitude of
the SBP fluctuations). The 100 simulation runs
were done to construct the complete frequency
characteristics of BPV, HRV and TF by
computing all frequency components between
0.003 Hz and 0.300 Hz (step 0.003 Hz).
A total of 162 frequency characteristics of
HRV, BPV and TF were made for both the physi-
ological as well as for the pathophysiological
conditions. These 162 frequency characteristics
were made to represent 162 different combina-
tions of baroreflex gain multiplier settings.
One-hundred fifty gain multiplier combina-
tions were randomly chosen to simulate
uncoupled baroreflex gains (values between 0
and 3 from uniform distributions for V, SH and
SPR). In addition, 12 other V/SH/SPR combina-
tions were made to simulate coupled baroreflex
gains (0.5/0.5/0.5, 1/1/1, 1.5/1.5/1.5, 2/2/2,
2.5/2.5/2.5, 3/3/3). Besides these multiplier
combinations, an extra set of simulation results
(obtained with V/SH/SPR combinations 0/1/1,
3/1/1, 1/0/1, 1/3/1, 1/1/0, 1/1/3) was made for
the generation of Figure 2.
Main derived simulation variables:
BRS, SBP buffering capacity,
SBP resonance
After having computed a full BPV, HRV and
TF characteristic, we determined the following
variables. BRS was computed as the averaged
magnitude of TF in the low-frequency (LF,
0.05-0.15 Hz)15,37,39. This band incorporates the
Mayer frequencies. SBP buffering capacity was
expressed as the amplitude of the original
perturbation (the 1 mmHg sinusoidal pressure
probe) divided by the BPV amplitude at the
lowest simulated frequency component (0.0033
Hz, which is still well above the baroreceptor
resetting frequency47). E.g., when the BPV at the
lowest frequency component had an amplitude
of 0.25 mmHg, the buffering capacity was 4.
Maximal SBP resonance (in the LF band) was
expressed as the maximal BPV divided by the
amplitude of the original perturbation. To
determine the relative importance of V, SH and
SPR for brs and blood pressure buffering/reso-
nance, multiple linear regressions were done.
For these regressions, only the simulations
made with random generated baroreflex gain
multipliers were used.
RESULTS
The simulation results obtained under phys-
iological and pathological conditions (see Table
1) differ quantitatively (more outspoken char-
acteristics under physiological conditions)
rather than qualitatively: all frequency charac-
teristics are smooth, and buffering occurs at the
lowest frequencies while resonance occurs at
the Mayer frequency around 0.1 Hz. Figure 2
displays examples of some HRV-, BPV- and TF
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combinations (Table 1) to represent either
normal physiological, or abnormal pathological
resting conditions. With an increased sympa-
thetic tone to the heart and to the peripheral
resistance, and decreased parasympathetic tone
and reference stroke volume, the pathological
parameter settings represent a serious patho-
logic condition resembling congestive heart
failure. Compared to the physiological condi-
tions, the resting heart rate is higher (90 bpm
instead of 60 bpm), and the average systolic
blood pressure is slightly lower (114 mmHg
instead of 120 mmHg).
The last three parameters serve as poten-
tiometers (multipliers) on the vagal and sympa-
thetic baroreflex gains to the heart and to the
peripheral resistance; 
V = SH = SPR = 1 is the reference value that is
to represent a normally working baroreflex.
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Figure 2. Examples of simulated heart rate variability (HRV; A1, B1, C1), blood pressure variability (BPV;
A2, B2, C2) and transfer function (TF; A3, B3, C3) frequency characteristics. Note that frequency axes are log
scaled. For these simulations, the model parameters for stroke volume and autonomic outflow, —Vref , MH, MPR
and N—, were kept fixed at physiological values (see Table 1). The baroreflex gain multipliers SH, V and SPR
were varied around SH /V/SPR = 1/1/1 (solid line in all panels) in the following way: 
Panels A: dotted line: SH /V/SPR = 0/1/1 (inactivated SH), dashed line: SH /V/SPR = 3/1/1 (strong SH);
Panels B: dotted line: SH /V/SPR = 1/0/1 (inactivated V), dashed line: SH /V/SPR = 1/3/1 (strong V);
Panels C: dotted line: SH /V/SPR = 1/1/0 (inactivated SPR), dashed line: SH /V/SPR = 1/1/3 (strong SPR).
BPV and HRV amplitudes have to be related to the driving force of the sinusoidal pressure probe (1 mmHg).
BPV = blood pressure variability (amplitude of SBP fluctuations); HRV = heart rate variability (amplitude of
IBI fluctuations); TF = modulus of the SBP-to-IBI transfer function.
vagal heart rate control is weakened or
strengthened (multiplier V assumes the value 0
or 3 respectively, multipliers SH and SPR are
kept at a value of 1). Here, the impression arises
that multiplier V strongly influences HRV and
the brs, while it does not affect the resonance
and buffering behavior (relatively little differ-
ences in resonance and buffering are seen in
panel B2).
Panels C1-C2 show the striking effect of a
strengthened sympathetic peripheral resistance
control (multiplier SPR assumes the value of 3,
multipliers V and SH are kept at a value of 1)
on the HRV and BPV frequency characteristics.
Panel C2 shows that the original sinusoidal
disturbance of SBP by the 1 mmHg pressure
probe (see Figure 1) is strongly weakened
(buffered) for the lowest frequencies, is ampli-
fied (resonance) over nearly the whole LF band,
and returns to about 1 mmHg for higher
frequencies. Larger part of this effect — espe-
cially the resonance phenomenon — disappears
under normal control (multiplier SPR assumes
the value of 1). The frequency characteristic is
almost flat when control is absent (multiplier
SPR assumes the value of 0). The shapes of the
HRV frequency characteristics in panel C1
grossly follow the BPV characteristics. As
expected, the TF frequency characteristics
(panel C3) are very much similar for all three
SPR values 0, 1 and 3. In summary, from
frequency characteristics C1-C3 the impression
arises that sympathetic peripheral resistance
control strongly influences resonance and
buffering while it does not affect the tf or brs.
Figure 3 depicts the strongest relations
between vagal and sympathetic baroreflex
gains, SBP buffering capacity, SBP resonance
and BRS, based on the results of multiple linear
regression analysis. It pointed out that in a
physiological setting 83% of the variance in SBP
buffering was attributable to sympathetic
peripheral resistance control (multiplier SPR);
under pathological conditions this percentage
was 78%. Also, 99% of the variance in BRS was
attributable to vagal heart rate control (multi-
plier V); under pathological conditions this
percentage was also 99%. 
The scatter plot of the SBP buffering
capacity as a function of SPR, together with
linear fits for the physiological and the patho-
logical data (Figure 3, panel A), shows close to
perfect linear relationships. Also, there is little
difference between the linear fits for the physi-
ological and the pathological simulation results.
Obviously, heart rate control, but also the
settings of Vref and MPR were of minor impor-
tance for blood pressure buffering.
The scatter plot of BRS as a function of V,
together with linear fits for the physiological
and the pathological data (Figure 3, panel B),
shows nearly perfect linear relationships. Here,
the physiological fit (slope 6.9 ms·mmHg-1)
and the pathological fit (slope 4.0 ms·mmHg-1)
differ considerably: with equal vagal gain
multipliers, BRS is much larger in physiological
conditions. 
Figure 3 panel C shows that SBP buffering
capacity and SBP resonance have a convex rela-
tionship and that the resonance phenomenon is
much more prominent in physiological
circumstances compared to pathological condi-
tions. The strong link between buffering and
resonance follows directly from regression
analysis: also here, multiplier SPR attributes the
most to variance in SBP resonance (95% under
normal conditions, 91% under pathological
conditions).
Figure 3, panel D, finally, shows that BRS was
almost unrelated to SBP buffering capacity,
unless coupled baroreflex gains (simulation
results represented by the open and solid
squares) are assumed. The squared correlation
coefficients of the linear regressions of SBP
buffering capacity on BRS were as low as 0.037
(physiological conditions) and 0.083 (pathologic
conditions).
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frequency characteristics obtained under physi-
ological conditions. This Figure consists of
three sets of HRV, BPV and TF frequency char-
acteristics, in each of which one of the three
effectors was weakened or strengthened, i.e.,
baroreflex gain multipliers, V, SH, or SPR was
increased to 3 (strong) or reduced to 0 (inacti-
vated) with respect to the default value of 1
(normal), while the other two baroreflex gain
multipliers were kept at their default values of
1 (normal).
Panel A3 shows an unexpected influence of
sympathetic heart rate control on IBI: the
transfer function in the LF band (i.e. BRS) even
decreases when control is strengthened (strong
SH). Obviously, blood pressure buffering and
resonance are completely insensitive for
changes in the sympathetic gain to the heart
(panel A2).
Panels B1-B3 show how the HRV, BPV and
TF frequency characteristics react when the
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Figure 3. Main graphical representations of the simulation results. Panel A: systolic blood pressure (SBP)
buffering capacity increases with increasing sympathetic baroreflex gain to the peripheral resistance.  Panel B:
baroreflex sensitivity (BRS) increases with increasing vagal baroreflex gain to the heart. Panel C: SBP
resonance increases with increasing SBP buffering capacity. Panel D: SBP buffering capacity is only weakly
related to baroreflex sensitivity. Filled circles and squares: physiological conditions; open circles and squares:
pathological conditions. Circles (small): simulations with uncoupled (random generated) baroreflex gain
multiplier combinations; squares (larger): simulations with coupled baroreflex gain multiplier combinations:
SH /V/SPR = 0.5/0.5/0.5, 1/1/1, 1.5/1.5/1.5, 2/2/2, 2.5/2.5/2.5, 3/3/3. Dashed lines: linear regressions in the random
data (hence, scouting simulations with coupled baroflex gain multiplier combinations excluded). See text for
further explanation.
[ms·mmHg-1]. Such arithmetic operations
would change the linear relationships in Figure
3 panel B in curved ones, but leave the conclu-
sions unaffected that BRS increases with
increasing vagal feedback gain and that the
vagal feedback gain almost uniquely deter-
mines BRS.
The predominant role of the vagal feedback
gain on the brs38 can also be formulated in a
slightly different way: due to the differences in
the time constants of the vagal and the sympa-
thetic branches (in our model 0.1 s and 4.0 s,
respectively), greater part of hrv is simply
vagal transmission of blood pressure variability
to the sinus node. This is easily perceived in
panels B and C in Figure 2 and in accordance
with the findings of Cevese et al.9. When vagal
feedback gain is zero (dotted lines in panels B)
there is almost no HRV (panel B1) while there
still is appreciable BPV (panel B2). When there
is appreciable vagal baroreflex feedback gain
(solid and dashed lines in panels B, and all lines
in panels C) the HRV frequency characteristics
in panels B1 and C1 have the same shape as the
BPV frequency characteristics in panels B2 and
C2. In the case of overt (sympathetically medi-
ated) blood pressure resonance, where the BPV
frequency characteristic has a narrow peak
(panel C2), a similar ‘monochrome’ HRV
frequency characteristic is seen in panel C1.
Alternatively, when there is no outspoken reso-
nance (panel B2), there is ‘broad band’ HRV
(panel B1).
Blood pressure buffering capacity and
Mayer waves
Figure 3 panel C illustrates the principle that
a negative feedback control system with feed-
back delay buffers the controlled variable at
certain frequencies at the cost of resonance at
other frequencies. The baroreflex blood pres-
sure control system as simulated in this study
behaves in a way that is very similar to what
was experimentally observed10. Blood pressure
buffering, a major function of the baroreflex,
occurs at frequencies below the Mayer waves
(resonance in the LF band, Figure 2 panel C2).
Typically, the arterial baroreflex could dampen
blood pressure and heart rate responses to
stressors that last several minutes. On one hand,
neural control of blood pressure by sympathet-
ically induced vasoconstriction is relatively fast
(seconds). On the other hand, baroreceptor
resetting47,50,51 limits the maximal duration
during which baroreflex mediated buffering of
a stressor may continue. In our simulations the
BPV frequency characteristics in panels A2, B2
and C2 show that dampening (reduction of the
sinusoidal pressure probe disturbance) is
strongest for the lowest frequencies.
Although there still exist some controversy
about the origin of the observed spontaneous
blood pressure and heart rate variations around
0.1 Hz32, we assume that this phenomenon is
due to the dynamics of the closed-loop vaso-
motor control (arterial peripheral resistance), in
which the time delay of a few seconds plays the
major role. Building a baroreflex model with
negative feedback control, and with parameters
estimated from physiologically known data,
results in a model that simply shows such reso-
nance behavior, without the need to postulate
centrally driven oscillators or (strong) non-
linearities.
Resonance, the price to be paid for
buffering, is likely to be useless in terms of
homeostasis. At the same time it may be an
innocent phenomenon without any negative
impact for the organism22. The fact that Mayer
waves, useless or not, exist, facilitates spectral
BRS assessment in the LF band, by creating an
input signal (bpv) for the baroreflex of which
the output signal (hrv) can easily be measured.
There is no inherent signal analysis problem in
measuring BRS by the transfer function around
the resonance frequency. However, the 180°
phase shift caused by the time lag in the
sympathetic efferent baroreflex limb to the
heart with respect to the phase shift in the
efferent vagal limb, that has a much shorter
time lag, may cause the sympathetic and vagal
limbs to the heart to counteract in the LF band.
This effect will become prominent with
CHAPTER 3 | BLOOD PRESSURE AND BAROREFLEX: BUFFERING AND RESONANCE 57
DISCUSSION
We used a mathematical model to investi-
gate the relation between baroreflex sensitivity
(BRS, an index of baroreflex vigor) and barore-
flex mediated blood pressure buffering
capacity. This relation is not straightforward
since the involved efferent baroreflex limbs
(vagal and sympathetic pathways to the heart,
and sympathetic pathways to the peripheral
vasculature, respectively) differ. Moreover,
baroreflex buffering occurs at lower frequen-
cies than the Mayer frequency band in which
BRS is noninvasively assessed and in which
blood pressure resonates. Whether or not reso-
nance disturbs the transfer function, thus
precluding reliable BRS assessment in the
Mayer frequency band is not known. Also it is
not clear what the relation is between, on one
hand, the 'desired' phenomenon of blood pres-
sure buffering at frequencies lower than the
Mayer frequency and, on the other hand, the
phenomenon of blood pressure resonance in
the Mayer frequency band (nothing more than
a byproduct of baroreflex mediated blood pres-
sure control10).
Simulations with various combinations of
baroreflex gains, under physiologic as well as
under pathologic conditions (increased sympa-
thetic tone, decreased vagal tone, reduced
cardiac stroke volume) yielded frequency char-
acteristics of the transfer function, of hrv and
of bpv, and values of BRS, blood pressure
buffering capacity and baroreflex resonance in
a wide range of conditions that may be met in
real life. All frequency characteristics had a
smooth character, and even with striking reso-
nance the transfer function did not show
discontinuous or deviant behavior when
compared with its value below and above the
frequency band of resonance (see Figure 2). In
the following, the simulation results will be
discussed in the order they have been presented
in Figure 3.
Baroreflex gains and blood pressure
buffering capacity
Our results suggest a predominant role for
the sympathetic limb to the peripheral vascula-
ture for the blood pressure buffering capacity
of the arterial baroreflex (Figure 3, panel A).
There is almost no difference in buffering
capacity between the physiological and the
pathological conditions. This result clearly
illustrates the fact that efficacy of baroreflex
mediated blood pressure control rests on
dynamic control of the peripheral resistance.
Modulation of heart rate by baroreflex medi-
ated modulation of the vagal and sympathetic
tone to the heart is not very relevant for blood
pressure control in the frequency range of
interest for this study (0.05 to 0.3 Hz).
Obviously, the simulation results may not
be interpreted in such a way that baroreflex
mediated blood pressure buffering in patients is
not different from that in healthy subjects. The
sympathetic feedback gain to the peripheral
vasculature is the decisive factor here. We spec-
ulate that this gain will be lower in patients.
Hence, it may have been somewhat unrealistic
to extend the simulations in pathological
conditions to a similar value of SPR than the
simulations in physiological conditions. The
consequence of our speculation would be that
the blood pressure buffering capacity in
patients is smaller than that in healthy subjects.
Baroreflex gains and baroreflex
sensitivity
Brs is linear with, and depends almost
exclusively on the vagal feedback gain to the
heart (Figure 3, panel B). The slopes of the
linear regressions (6.9 and 4.0 ms·mmHg-1
with physiological and pathological conditions,
respectively) are merely to be explained on the
basis of heart rate differences between these
two situations and the way the ipfm18 reacts to
fluctuations in vagal tone. The fact that BRS
depends on heart rate has been recognized
earlier1 and proposals have been done to
normalize BRS on heart rate, or, alternatively, to
express BRS in [bpm·mmHg-1] instead of in
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mediated heart rate control was not effective in
reducing blood pressure variability, that had a
larger amplitude in sinus rhythm compared
with fixed-interval atrial pacing.
Within the operating space — constituted by
the ranges of the parameters as given in Table 1,
in combination with baroreflex gain multiplier
values between 0 and 3 — our model can be
used without any difficulty. For example, as the
baroreflex gain to the peripheral resistance
(SPR) should not have any influence on the
transfer function, Figure 2 panel C3 shows
indeed that only varying SPR produce almost
the same transfer functions. The minimal
differences between those functions can be
explained by nonlinearities in the model.
Further expansion of the operating space may
therefore be not allowed. Furthermore, higher
baroreflex gains would no longer be realistic
and leads to, e.g., unacceptably high bpv values.
Brs can be enhanced by training7 and the
beneficial effects of a thus increased BRS have
convincingly been demonstrated27. How this
effect is accomplished remains uncertain. Inhi-
bition of stressor induced heart rate increases
may be one reason; the vagal feedback gain in
the cardiac efferent limb may predominantly
cause this effect. Inhibition of stressor induced
blood pressure increases may be another
reason; the sympathetic feedback gain in the
baroreflex efferent limb to the peripheral
vasculature may predominantly cause this
effect. Both effects could help to inhibit a
stressor induced raise of myocardial oxygen
consumption, which is proportional to the
product of heart rate and systolic blood pres-
sure3,29. 
A final remark regards the phenomenon as
seen in Figure 2, panel A3. It appears that BRS
(the TF between 0.05 and 0.15 Hz.) may lower
with high sympathetic gain to the heart. This is
caused by the differences in the latencies/time
constants in the sympathetic17,41 and vagal6,48
limbs, bringing the vagal and the sympathetic
effects in counterphase in the BRS frequency
band. Hence, there are situations thinkable in
which cancellation of vagal effects on heart rate
by concurring sympathetic effects on heart rate
in counterphase incorrectly suggest a deficient
baroreflex. For higher frequencies, the influ-
ence of the sympathetic feedback gain weakens
and disappears due to a low pass filtering effect
caused by slow neurotransmitter diffusion at
the synaptic clefts17.
CONCLUSIONS
In conclusion, our simulation study suggests
that, within the limitations of the model, BRS
and baroreflex mediated blood pressure
buffering are unrelated baroreflex features
unless there is a good physiological reason to
assume a fixed relation between the baroreflex
feedback gains in the efferent baroreflex limbs
to the heart and peripheral vasculature.
Also, we conclude that baroreflex mediated
blood pressure buffering capacity is almost
uniquely determined by the sympathetic
baroreflex feedback gain to the peripheral
vasculature, while BRS is almost uniquely
determined by the vagal feedback gain to the
sinus node.
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increased sympathetic gain to the heart (see,
e.g., Figure 2, Panel A1, dashed line). In this
respect, lower TF frequencies would constitute
a more realistic BRS estimate, because here
vagal and sympathetic feedback to the heart is
concordant (Panel A3, dashed line). In general,
TF values in the LF band are not too different
at higher frequencies; TF values increase for
lower frequencies (Figure 2, Panels A3, B3, C3).
Baroreflex sensitivity and blood
pressure buffering capacity
One of the major reasons to perform this
study was the question whether or not there is
a relation between the primary function of the
baroreflex, i.e., blood pressure buffering, and
the generally accepted clinical index for
baroreflex vigor, BRS. Figure 3, panel D shows
that this relation does almost not exist. The
correlation coefficients of the regression lines
of SBP buffering capacity on BRS are very low,
and the data are diffusely distributed.
Indeed, vagal control of heart rate (major
cause of the BPV-to-HRV transfer and, hence,
major determinant of BRS) and sympathetic
modulation of the peripheral vasculature
(major cause of peripheral resistance adapta-
tions and, hence, a major determinant of blood
pressure buffering) become effective via sepa-
rate efferent pathways of the baroreflex. There
should not necessarily be a fixed relationship
between the feedback gains in both reflex
limbs43.
To our knowledge, there are no data
regarding the relative strength of the gains in
the three baroreflex effector limbs. It might
well be that subjects with a low gain in the
vagal limb have also low gains in the sympa-
thetic limbs, amongst others, because part of
the origin of these gains is to be found in the
common afferent pathway of the reflex starting
at the baroreceptors in the arterial wall up to
and including the nucleus tractus solitarii in
the brainstem. Inspection of the simulation
results obtained under coupled gains (closed
and open squares in Figure 3 panel D) reveals
that in such cases there is a seemingly linear
relationship between BRS and blood pressure
buffering capacity in healthy subjects as well as
in patients.
Limitations of the model
Basic to our study is the representativeness
of the mathematical model. The original model
has extensively been validated46, amongst
others by comparing the results of modeled
vagal blockade and of standing with real world
observations. The modified model, however,
has a simplified hemodynamic structure. Since
the simulations addressed blood pressure and
heart rate control in the supine posture only,
the dynamic control capabilities of cardiac
contractility and venous return on cardiac
output and hence, blood pressure, have
completely been removed (obviously, such a
simplification cannot be made in cases where
the average IBI changes due to an altering
circulatory load). Elimination of these feedfor-
ward mechanisms enabled us to concentrate on
the role of the various baroreflex gains, espe-
cially in the LF-band, rather than steady state
phenomena in the lower frequencies. As our
simulation results are still comparable with the
various spectra produced by the original model,
we do believe that our model still produces
relevant spectra. 
The modified model that was used for our
current study generates and explains some situ-
ations that are known from the clinic. It is
obvious that the resonance phenomenon in the
LF band, generally known as Mayer waves33, is
strongly under influence of the baroreflex. The
only situations in which Mayer waves hardly
appear is when the sympathetic baroreflex gain
to the peripheral resistance is small (see Figure 2,
panel C2, dotted line). This simulation result
parallels studies in rats19, and in humans42,45.
The relevance of the model is underscored by
the observation that SBP variability in the LF
band decreases for fixed interval (results not
shown here). This phenomenon was described
by Taylor and Eckberg45 in a study in humans.
The authors demonstrated that baroreflex
58 FITNESS IN CHRONIC HEART FAILURE: EFFECTS OF EXERCISE TRAINING AND OF BIVENTRICULAR PACING 
druckschwankungen. Akad Wiss Math-Nat Kl (Wien)
1876;74:281-307.
34. Parati G, Di Rienzo M, Mancia G. How to measure
baroreflex sensitivity: from the cardiovascular labora-
tory to daily life. J Hypertens 2000;18:7-19.
35. Penáz J, Buriánek P. Zeitverlauf und Dynamik der
durch Atmung ausgelösten Kreislaufänderungen beim
Menschen. Pflügers Arch 1962;267:618-635.
36. Pickering TG, Gribbin B, Sleight P. Comparison of
the reflex heart rate response to rising and falling arte-
rial pressure in man. Circ Res 1972;6:277-283.
37. Pinna GD, Maestri R. Reliability of transfer function
estimates in cardiovascular variability analysis. 
Med Biol Eng Comput 2001;39:338-347.
38. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam
D, Gordon D et al. Assessment of autonomic function
in humans by heart rate spectral analysis. 
Am J Physiol 1985;248:H151-H153.
39. Robbe HWJ, Mulder LJM, Rüddel H, Langewitz
WA, Veldman JBP, Mulder G. Assessment of barore-
ceptor reflex sensitivity by means of spectral analysis.
Hypertension 1987;10:538-543.
40. Rosenblueth A, Simeone FA. The interrelations of
vagal and accelerator effects on the cardiac rate. 
Am J Physiol 1934;110:42-45.
41. Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH,
Cohen RJ. Transfer function analysis of the circula-
tion: unique insights into cardiovascular regulation.
Am J Physiol 1991;261:H1231-H1245.
42. Scheffer GJ, TenVoorde BJ, Karemaker JM, Ros HH.
Effects of epidural analgesia and atropine on heart rate
and blood pressure variability: implications for the
interpretation of beat-to-beat fluctuations. 
Eur J Anaesthesiol 1994;11:75-80.
43. Simms AE, Paton JF, Pickering AE. Disininhibition of
the cardiac limb of the arterial baroreflex in rat: A role
for metabotropic glutamate receptors in the nucleus
tractus solitarii. J Physiol 2006.
44. Smyth HS, Sleight P, Pickering GW. Reflex regulation
of arterial pressure during sleep in man: a quantitative
method of assessing baroreflex sensitivity. 
Circ Res 1969;24:109-121.
45. Taylor JA, Eckberg DL. Fundamental relations
between short-term RR interval and arterial pressure
oscillations in humans. Circulation 1996;93:1527-1532.
46. Ten Voorde BJ, Kingma R. A baroreflex model of
short term blood pressure and heart rate variability.
Stud Health Technol Inform 2000;71:179-200.
47. Thrasher TN. Baroreceptors and the long-term
control of blood pressure. Exp Physiol 2004;89:331-335.
48. Warner HR, Cox A. A mathematical model of heart
rate control by sympathetic and vagus efferent infor-
mation. J Appl Physiol 1962;17:349-355.
49. Wesseling KH, Settels JJ. Baromodulation explains
short-term blood pressure variability. In: Psychophysi-
ology of cardiovascular control. Orlebeke JF, Mulder
G, VanDoornen LJP, eds. 1985. Plenum Press, New York.
50. Xavier-Neto J, Moreira E, Krieger E. Viscoelastic
mechanisms of aortic baroreceptor resetting to
hypotension and hypertension. 
Am J Physiol 1996;271:H1407-H1415.
51. Xie P, McDowell T, Chapleau M, Hajduczok G,
Abboud F. Rapid baroreceptor resetting in chronic
hypertension. Implications for normalization of arterial
pressure. Hypertension 1991;17:72-79.
CHAPTER 3 | BLOOD PRESSURE AND BAROREFLEX: BUFFERING AND RESONANCE 61
REFERENCE LIST
1. Abrahamsson C, Ahlund C, Nordlander M, Lind L. A
method for heart rate-corrected estimation of barore-
flex sensitivity. J Hypertens 2003;21:2133-2140.
2. Aljuri N, Marini R, Cohen RJ. Test of dynamic
closed-loop baroreflex and autoregulatory control of
total peripheral resistance in intact and conscious
sheep. 
Am J Physiol Heart Circ Physiol 2004;287:H2274-H2286.
3. Baller D, Bretschneider HJ, Hellige G. A critical look
at currently used indirect indices of myocardial oxygen
consumption. Basic Res Cardiol 1981;76:163-181.
4. Berger RD, Saul JP, Cohen RJ. Transfer function
analysis of autonomic regulation I. Canine atrial rate
response. Am J Physiol 1989;256:H142-H152.
5. Bertram D, Barres C, Cuisinaud G, Julien C. The arte-
rial baroreceptor reflex of the rat exhibits positive
feedback properties at the frequency of mayer waves. 
J Physiol 1998;513 ( Pt 1):251-261.
6. Borst C, Karemaker JM. Time delays in the human
baroreceptor reflex. J Auton Nerv Syst 1983;9:399-409.
7. Buch AN, Coote JH, Townend JN. Mortality, cardiac
vagal control and physical training - what's the link?
Exp Physiol 2002;87:423-435.
8. Burgess DE, Hundley JC, Li SG, Randall DC, Brown
DR. First-order differential-delay equation for the
baroreflex predicts the 0.4-Hz blood pressure rhythm
in rats. Am J Physiol 1997;273:R1878-R1884.
9. Cevese A, Gulli G, Polati E, Gottin L, Grasso R.
Baroreflex and oscillation of heart period at 0.1 Hz
studied by alpha-blockade and cross-spectral analysis
in healthy humans. J Physiol 2001;531:235-244.
10. Chapuis B, Vidal-Petiot E, Orea V, Barres C, Julien C.
Linear modelling analysis of baroreflex control of arte-
rial pressure variability in rats. 
J Physiol 2004;559:639-649.
11. Christou DD, Jones PP, Seals DR. Baroreflex
buffering in sedentary and endurance exercise-trained
healthy men. Hypertension 2003;41:1219-1222.
12. De Boer RW, Karemaker JM, Strackee J. Hemody-
namic fluctuations and baroreflex sensitivity in
humans: a beat-to-beat model. 
Am J Physiol 1987;253:H680-H689.
13. Eckberg DL. The human respiratory gate. 
J Physiol 2003;548.2:339-352.
14. Eckberg DL, Sleight P. Human baroreflexes in health
and disease. 1992. Clarendon Press, Oxford.
15. Frederiks J, Swenne CA, TenVoorde BJ, Honzíková
N, Levert JV, Maan AC et al. The importance of high-
frequency paced breathing in spectral baroreflex sensi-
tivity assessment. J Hypertens 2000;11:1635-1644.
16. Hammer PE, Saul JP. Resonance in a mathematical
model of baroreflex control: arterial blood pressure
waves accompanying postural stress. Am J Physiol Regul
Integr Comp Physiol 2005;288:R1637-R1648.
17. Hill-Smith I, Purves RD. Synaptic delay in the heart:
an inophoretic study. J Physiol (Lond) 1978;279:31-54.
18. Hyndman BW, Mohn RK. A model of the cardiac
pacemaker and it's use in decoding the information
content of cardiac intervals. Automedica 1973;1:239-252.
19. Japundzic N, Grichois ML, Zitoun P, Laude D,
Elghozi JL. Spectral analysis of blood pressure and
heart rate in conscious rats: effects of autonomic
blockers. J Auton Nerv Syst 1990;30:91-100.
20. Jones PP, Christou DD, Jordan J, Seals DR. Baroreflex
buffering is reduced with age in healthy men. 
Circulation 2003;107:1770-1774.
21. Jordan J, Tank J, Shannon JR, Diedrich A, Lipp A,
Schroder C et al. Baroreflex buffering and suscepti-
bility to vasoactive drugs. Circulation 2002;105:1459-
1464.
22. Julien C. The enigma of Mayer waves: Facts and
models. Cardiovasc Res 2006;70:12-21.
23. Just A, Wittmann U, Nafz B, Wagner CD, Ehmke H,
Kirchheim HR et al. The blood pressure buffering
capacity of nitric oxide by comparison to the barore-
ceptor reflex. Am J Physiol 1994;267:H521-H527.
24. Karemaker JM. Neurophysiology of the baroreceptor
reflex. In: The beat-to-beat investigation of cardiovas-
cular function. Kitney R, Rompelman O, eds. 1987.
Clarendon Press, Oxford.
25. Katona PG, McLean M, Dighton DH, Guz A. Sympa-
thetic and parasympathetic cardiac control in athletes
and nonathletes at rest. J Appl Physiol Respirat Environ
Exercise Physiol 1982;52:1652-1657.
26. Katona PG, Poitras JW, Barnett GO, Terry BS.
Cardiac vagal efferent activity and heart period in the
carotid sinus reflex. Am J Physiol 1970;218:1030-1037.
27. La Rovere MT, Bersano C, Gnemmi M, Specchia G,
Schwartz PJ. Exercise-induced increase in baroreflex
sensitivity predicts improved prognosis after myocar-
dial infarction. Circulation 2002;106:945-949.
28. La Rovere MT, Bigger Jr JT, Marcus FI, Mortara A,
Schwartz PJ. Baroreflex sensitivity and heart-rate vari-
ability in prediction of total cardiac mortality after
myocardial infarction. Lancet 1998;351:478-484.
29. Laurent D, Bolene-Williams C, Williams FL, Katz
LN. Effects of heart rate on coronary flow and cardiac
oxygen consumption. Am J Physiol 1956;185:355-364.
30. Liu HK, Guild SJ, Ringwood JV, Barrett CJ, Leonard
BL, Nguang SK et al. Dynamic baroreflex control of
blood pressure: influence of the heart vs. peripheral
resistance. Am J Physiol Regul Integr Comp Physiol
2002;283:R533-R542.
31. Madwed JB, Albrecht P, Mark RG, Cohen RJ. Low-
frequency oscillations in arterial pressure and heart
rate: a simple computer model. 
Am J Physiol 1989;256:H1573-H1579.
32. Malpas SC. Neural influences on cardiovascular vari-
ability: possibilities and pitfalls. 
Am J Physiol Heart Circ Physiol 2002;282:H6-20.
33. Mayer S. Studien zur Physiologie des Herzens und der
Blutgefässe: V. Über spontane Blut-























E.E. van der Wall1
C.A. Swenne1
1Department of Cardiology, Leiden University 
Medical Center, Leiden
2Department of Cardiopulmonary Rehabilitation, 
Rijnland Rehabilitation Center, Leiden
3Department of Cardiology, Rijnland Hospital, Leiderdorp
4Department of Biomedical Engineering, 
S. Maugeri Foundation - IRCCS, Scientific Institute 
of Montescano, Montescano, Italy
5Department of Cardiology, S. Maugeri Foundation - 
IRCCS, Scientific Institute of Montescano, Montescano, Italy
62 FITNESS IN CHRONIC HEART FAILURE: EFFECTS OF EXERCISE TRAINING AND OF BIVENTRICULAR PACING 
not known if substance P has these long lasting
effects in the NTS. 
The consequence of the latter scenario
would be that training effects in the baroreflex
could be attained by exercise-mimicking
somatosensory stimulation alone, without
actual accompanying exercise. Therefore, we
hypothesized that periodic somatosensory stim-
ulation increases BRS. 
METHODS
The local Medical Ethics Committees
approved the study protocol. Eligible patients
had CHF with systolic dysfunction and left
ventricular ejection fraction (LVEF) <40%, were
on stable medication and did not take part in
any physical training program. All patients gave
written informed consent. In the Leiden
University Medical Center patients received
somatosensory stimulation by means of tran-
scutaneous electrical nerve stimulation (TENS
group). As a control group we studied consecu-
tive patients in Montescano scheduled for
rehabilitation (EXTR group) who matched a
TENS group subjects for age (within 5 years),
heart rate (within 5 beats/min), LVEF (within
5%) and etiology (identical). Patient characteris-
tics are presented in Table 1.
Sessions
Sessions were held on day 0 (baseline
measurements followed by TENS or exercise
training), day 1 (TENS or exercise training) and
day 2 (effect measurements). For each patient
these sessions were held at the same time of the
day.
Measurements
During the measurements the patients were
in supine position. To prevent respiratory
discomfort, the upper part of the bed was
inclined in accordance with individual sleeping
habits. After 30 minutes of rest blood pressure
and heart rate were measured with an auto-
matic arm cuff blood pressure monitor (average
of 5 subsequent readings), Then, the ECG and
the noninvasive continuous arterial blood pres-
sure signal (Finapres, TNO, Amsterdam, NL)
were recorded during 10 minutes for later BRS
calculation while patients performed 0.25 Hz
metronome respiration (preventing the direct
mechanical component of respiration and the
respiratory gating effect to enter the low-





Experimental intervention consisted of one
hour TENS applied to both feet (Figure 1). To
mimic locomotion/exercise-associated
somatosensory ergoreceptor stimulation, we
stimulated (Cefar Tempo TENS device, Cefar
Medical AB, Lund, Sweden) both feet by peri-
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TENS group EXTR group
Sex 15M/8F 16M/4F
Age (years) 62 ± 12  59 ± 10
Heart rate 71 ± 10 69 ± 9
Systolic Blood Pressure (mmHg)
114 ± 17 108 ± 13
NYHA class I/II/III/IV
5/10/8/0 0/12/8/0
MLWHFQ 27 ± 17 27 ± 23
Etiology
Ischemic 13 (57%) 13 (65%)
Non-ischemic 10 (43%) 7 (35%)
BMI (kg/m2) 25.6 ± 4.3 27.2 ± 5.1
LVEF (%) 30.3 ± 9.1 31.6 ± 6.6 
Medication
ACE inhibitor/ 20 (87%) 16 (80%)
AII blocker
Diuretic 17 (74%) 16 (80%)
Spironolactone 8 (35%) 5 (25%)
Beta-blocker 17 (74%) 16 (80%)
Amiodarone    6 (26%) 6 (30%)
Table 1. Patient characteristics.
Legend to Table 1. BMI: body mass index; LVEF: left
ventricular ejection fraction; MLWHFQ: Minnesota Living
with Heart Failure Questionnaire; NYHA: New York
Heart Association.
ABSTRACT
Background. Exercise training induces
major beneficial effects, e.g., in autonomic
nervous system functioning. Arterial baroreflex
sensitivity (BRS), an important prognostic
marker in patients with chronic heart failure
(CHF), is increased by exercise training, and it
was demonstrated that exercise-induced BRS
increase improves prognosis. The mechanism
of this training effect is, however, unknown.
We hypothesized that periodic somatosensory
input to the brainstem is a training stimulus for
the autonomic nervous system.
Methods. We compared in stable CHF
patients the effect of transcutaneous electrical
nerve stimulation (TENS, N=23, age 62 ± 12
years, LVEF 30 ± 9%) with the effects of bicycle
exercise training (EXTR, N=20, age 59 ± 10 years,
LVEF 32 ± 7%). To mimic exercise-associated
somatosensory ergoreceptor stimulation, we
applied periodic (2/s, marching pace) burst
TENS to both feet. TENS and EXTR sessions were
held during two successive days. 
Results. BRS, measured noninvasively prior to
the first intervention session and one day after
the second intervention session, increased by
28% from 3.07 ± 2.06 to 4.24 ± 2.61 ms/mmHg
in the TENS group, but did not change in the
EXTR group (baseline: 3.37 ± 2.53 ms/mmHg;
effect: 3.26 ± 2.54 ms/mmHg) (P(TENS vs EXTR)
=0.02). Heart rate and systolic blood pressure
did not change in either group.
Conclusions. We demonstrated that periodic
somatosensory input alone is sufficient and
efficient in increasing BRS in CHF patients. This
concept constitutes a basis for new studies on
more effective exercise training regimens in the
diseased/impaired, in whom training aimed at
BRS improvement should possibly focus more
on the somatosensory aspect.
INTRODUCTION
Exercise training is effective in primary and
secondary prevention. It induces major benefi-
cial effects, e.g., in autonomic nervous system
functioning. E.g., arterial baroreflex sensitivity
(BRS), an important prognostic marker in
chronic heart failure (CHF) patients12,15, is
increased by exercise training20,25. Patients with
an exercise-induced BRS increase have, indeed,
an improved life expectance11. Sadly, many
patients with low BRS have limited exercise
capacity. As a consequence, they cannot comply
with the efforts that are deemed necessary for
successful rehabilitation. Hence, insight in the
currently unknown mechanism by which the
training effect on BRS is mediated is of utmost
importance. Possible hypothesis are: 
Scenario 1:
CHF is characterized by permanent neuro-
humoral activation, i.e., elevated sympathetic
tone, activation of the renin-angiotensin-aldos-
teron system and decreased BRS. Exercise
training in CHF reduces sympathetic outflow
and increases BRS7. Currently evidence suggests
that these effects of exercise could be mediated
by an NO-dependent GABAergic pathway in
synergy with angiotensin II reduction8,16. 
Scenario 2:
On their way to the thalamus, neural fibres
conveying ergoreceptor information form
working muscle project to several structures,
such as the nucleus tractus solitarii (NTS)5.
During exercise, these projections release
substance P at the NTS22. Substance P enhances
BRS
18 by modulating the transmission of the
baroreceptive afferents to the NTS neurons.
Baroreflex enhancement after exercise may
materialize in the NTS in the form of elevated
substance P level that outlasts the exercise
period21,30. We suppose that this effect lasts
over 24 hours, which facilitates the develop-
ment of a training effect with daily stimulation.
Substance P has long lasting effects (>24 hours)
on the modulation of neural activity in other
systems, e.g., in the spinal cord17. It is however
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Heart rate and systolic blood pressure
SBP values did not change after TENS, 114 ±
17 versus 115 ± 18 mmHg (P=0.45), nor after
exercise training, 108 ± 13 versus 106 ± 10
mmHg (P=0.53). Also, after intervention, there
was no significant change in resting heart rate
in both groups, 70.8 ± 10.1 versus 68.6 ± 9.3 bpm
in the TENS group (P=0.09), and 68.4 ± 9.2
versus 68.2 ± 7.9 bpm in the EXTR group
(P=0.97).
Baroreflex sensitivity
BRS increased significantly with TENS
compared to exercise training (P=0.02): in 18/23
(78%) of the subjects in the TENS group the
effect BRS value was larger than baseline; BRS
increased by 28% from 3.07 ± 2.06 to 4.2 ± 2.61
ms/mmHg (P=0.02). No significant change
occurred in the EXTR group: baseline BRS value
was 3.37 ± 2.53 ms/mmHg and the effect BRS
value was 3.26 ± 2.54 ms/mmHg (P=0.90). Indi-
vidual baseline and effect BRS values intervals
are depicted in Figure 2. 
DISCUSSION
Our study suggests that, in CHF patients,
periodic somatosensory stimulation is sufficient
and efficient in increasing BRS. This finding
bears potential relevance for all patients with
lowered exercise capacity and low BRS, as it
supports the concept that, in such patients,
low-intensity exercise training programs
focusing on periodic somatosensory stimuli
rather than on effort might induce the desired
training effects.
Several studies have demonstrated the clin-
ical value of BRS as a prognostic parameter11,12,15.
Endurance training (and, in our study, TENS)
improves BRS. Prognosis of patients in whom
exercise increased BRS improved11. It is,
however, not known how BRS improvement
could induce the observed clinical effects; BRS
improvement might be only an associated
phenomenon. Recently, Ceroni and colleagues3
addressed this issue with an experiment in
which training effects were compared in sham
operated and sino-aortic denervated rats. They
concluded that the positive training effects,

































TENS group EXTR group
Figure 2. Individual changes in baroreflex sensitivity (brs)
Individual BRS baseline and effect values in the TENS group (left panel) and the exercise training group 
(right panel). EXTR: exercise training; tens: transcutaneous electrical nerve stimulation.
odic (2/s, marching pace) bursts of 8 pulses
(pulse width 180 µs, pulse rate 80 Hz). This
electrical stimulus excites mainly A-δ nerve
fibres1, which carry ergoreceptor information
and mediate cold, touch and sharp pain percep-
tion; A-α,β,γ and C fibers that mediate propri-
oception, motor activity, touch, pressure and
deep pain sensation, and autonomic sympa-
thetic control of the body tissues are less sensi-
tive for this stimulus. To achieve the strongest
possible stimulation without discomfort, the
current was slowly increased until pain or
muscle contractions occurred, and then
reduced by 0.5 or 1.0 mA. To compensate for
neuroadaptation, it was every 10 minutes
attempted to increase the current. To reduce
possible mental stress, all patients became
acquainted with the TENS-induced sensations
one week before session 0. 
Exercise training
Exercise training consisted of the standard
bicycle exercise protocol for cardiovascular
patients. Patients treated with beta-blockers
exercised at 75% of the heart rate reserve
(reduced to 60% in case of limited exercise
tolerance). Patients not treated with beta-
blockers trained at similar levels unless the
anaerobic threshold could be detected. In the
latter case they exercised at the heart rate that
corresponded to the anaerobic threshold
(assessed by the V-slope method). Training
consisted of: a) 2 minutes unloaded cycling; 
b) 3 minutes cycling at 50% of the endurance
load; c) 30 minutes cycling at endurance load;
d) 3 minutes cycling at 50% of the endurance
load. Sessions were terminated if signs of
distress (dizziness, angina, severe dyspnea or
musculoskeletal pain) occurred. 
Baroreflex sensitivity calculation
All signals were blindly analyzed. First, all
arrhythmia free and stationary periods >90
seconds in the metronome respiration episode
were selected. Compliance to the metronome
respiration protocol was visually verified in the
respiration signal. Then, BRS was computed in
each of the selected episodes. The BRS algo-
rithm computes the magnitude of the transfer
function between the systolic blood pressure
(SBP) variability (baroreflex input) and the
interbeat interval variability (output), averaged
over the 0.04-0.15 Hz band. Additionally, it
calculates 95% two-sided BRS confidence inter-
vals (CI)26. Finally, the overall BRS was
composed from all the BRS and CI values in
data segments by the best linear unbiased esti-
mator (BLUE) method27. 
Statistics
Data are expressed as mean ± SD. Baseline
characteristics were evaluated by using
unpaired two-sided t-tests, Mann-Whitney U
tests and chi-square tests with Yates correction.
Comparisons were done by t-tests for paired
and unpaired data when appropriate. 
RESULTS
Study groups
Twenty-three patients were enrolled in the
TENS group and 20 in the EXTR group. The
measured baseline characteristics of the control
and exercise groups matched well (Table 1).
Medication remained the same in all patients
throughout the study.
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Figure 1. Transcutaneous electrical nerve stimula-
tion (tens)
Lateral and medial electrodes (4” foam-oval self-
adhesive, AdvanTeq Development Corp, Thousand
Oaks, ca, usa) cover branches of the peroneal and
tibial nerves innervating the dorsal part and the
heel/sole of the foot, respectively.
training to improve BRS in CHF. We rather
used TENS to provide the proof-of-the-prin-
ciple by fully separating periodic somatosen-
sory stimulation and exercise.  Obviously, in
clinical practice, actual exercise is to be
preferred, as besides increasing BRS, is also
induces other major peripheral beneficial
effects19. It has to be realized that the
somatosensory afferent information during
exercise is more complex than the relatively
simple artificial electrical stimulus used in our
study. Hence, it has still to be proven that the
rhythmic/periodic component in somatosen-
sory nerve traffic during exercise is important
or even crucial to achieve BRS training effects.
A more pragmatic approach would be the
design and validation of novel experimental
exercise programs focusing on rhythmicity/
periodicity rather than on effort. If proven
effective, ‘autonomic fitness’ (a good working
baroreflex) might thus be achievable for large
groups of exercise-deprived or exercise-limited
persons.
Limitations
Several limitations of our study need atten-
tion. First, our study was not randomized,
however, the measured baseline characteristics
of both groups matched well (Table 1).
Second, our study did not directly address
the supposed mechanism of BRS improvement
due to periodic somatosensory stimulation.
Animal studies are needed to reveal what
happens at the level of the brainstem. In
humans, muscle sympathetic nerve activity
recordings could reveal if there is an effect of
periodic somatosensory stimulation on the
sympathetic baroreflex gain9 (BRS measure-
ments cannot discern between parasympathetic
and sympathetic baroreflex gain28).
Third, we did not include a group receiving
“placebo TENS”, which limits the validity of our
results. Placebo TENS would, e.g., involve
subthreshold stimulation. According to the
Convention of Helsinki, research protocols
with humans require complete information of
candidate participants, hence, whatever the
placebo stimulation would be, fully informed
participants would know the difference
between the placebo and the experimental
stimulus. Hence, equal trust/mistrust in the
experimental and placebo treatments, a prereq-
uisite for a good placebo, cannot be attained.
Instead, we decided to contrast TENS with the
conventional intervention of exercise training,
which, admittedly, does not fulfill the method-
ological requirements of a real placebo treat-
ment.  
CONCLUSIONS
In conclusion, periodic somatosensory stim-
ulation to the feet is potentially able to increase
BRS in CHF patients. This finding is an opening
to more comprehensive trials to evaluate exer-
cise modes that focus mainly on rhythmic/
periodic somatosensory stimuli. Also, follow-
up studies are needed to corroborate our find-
ings in larger groups of persons with varying
pathology, to establish the mechanism, and to
assess the associated health benefits.
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such as resting bradycardia and mean arterial
pressure fall were only seen in animals with
intact afferent baroreceptor information. When
extending these results3, we may assume that
BRS improvement by any intervention removes
a limiting factor for the emergence of benefi-
cial training effects. 
TENS increased BRS by 28%. In general, BRS
changes may partly be explained by changes in
resting heart rate and SBP, however, we found
that both heart rate and SBP did not change
after intervention. This makes the concept
tenable that periodic afferent somatosensory
nerve traffic caused the observed BRS increase.
This effect differed significantly from the
negligibly small BRS change in the EXTR group.
To our knowledge, no studies in CHF patients
have been conducted in which BRS changes
after one or a few exercise sessions were
measured. Such a quick effect cannot be
outruled. Convertino and Adams showed that
one bout of exercise was sufficient in inducing
an observable 24 hours BRS increase4. However,
this study was done in healthy men and with
exhaustive exercise, while the maximal exercise
level in CHF patients is much lower and the
exercise intensity in our study was 75% of the
heart rate reserve.
The training effect (28% BRS increase) after
only two days of TENS was about half of the
effect observed in much longer exercise
programs11,20. The quickly achieved effect
could be explained by the much stronger
somatosensory stimulus generated by TENS
than by the low intensity cycling in CHF
training. If strong somatosensory stimuli are
truly that important, the more discrete sensa-
tions that accompany walking might even be
superior to cycling as a baroreflex training
stimulus, even when this occurs at lower exer-
cise intensity. E.g., the value of brisk walking
for the prevention of cardiovascular events in
postmenopausal women has convincingly been
demonstrated13.
When ergoreceptors are chronically firing,
which happens when chemoreceptors are
becoming stimulated due to metabolic
processes in working muscle the projections of
ergoreceptor-associated fibers to the rostral
ventrolateral medulla23 increase sympathetic
outflow24. This is a stressing condition as it
elevates SBP and heart rate10. The experimental
‘training stimulus’ rather mimics the periodic,
intermittent mechanoreceptor stimulation in
active muscle21. It is known that periodic
ergoreceptor-associated stimulation of higher
centers5 activates the hypothalamic endorphin-
ergic system1. The descending serotinergic
projections of this system to the rostral ventro-
lateral medulla limits sympathetic outflow. 
We choose the feet a stimulation site
because of their involvement in most exercise
modalities (hence, a ‘natural’ place to stimulate
when attempting to mimic somatosensory
nerve traffic during exercise), because they are
distant from the heart and therefore safe2, and
because stimulation is relatively easy as the
peroneal and tibial nerve branches in the feet
run very superficially. It is conceivable that
similar electrical stimuli, applied at different
sites and exciting A-δ nerve fibres, will also
increase BRS. Hence, there is no explicit reason
why the NTS would process somatosensory
information from, e.g., the hands, different that
from the feet. Further experimentation is
required to explore this.
To our knowledge, no earlier attempts to
achieve a training effect in BRS by periodic
somatosensory stimulation were done. Wang
and Yao published the first evidence, in rabbits,
that the baroreflex may be altered by electro-
acupuncture or deep peroneal nerve stimula-
tion29. Later, other animal studies confirmed
and explained these effects14,21. However, these
studies all addressed baroreflex functioning
during stimulation rather than with a delay
after intervention, what is needed to demon-
strate a training effect.
With our study, we have not aimed to test
TENS as a therapeutic alternative for exercise
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METHODS
Patients
The Medical Ethics Committees of the
Leiden University Medical Centre and of the
Rijnland Rehabilitation Center approved the
protocol of this study. The investigation
conforms with the principles outlined in the
Declaration of Helsinki20. All participants gave
written informed consent. Eligible patients had
CHF New York Heart Association (NYHA) class
II or III, with systolic dysfunction and a left
ventricular ejection fraction (LVEF) less than
45%. Patients with pulmonary hypertension and
chronic obstructive pulmonary disease were
excluded from the study.
Two groups of patients, a sedentary control
group and an exercise training group, were
defined as follows. Consecutive CHF patients
who had one regular baseline symptom-limited
exercise test before commencing their actual
rehabilitation program, and in whom a final
evaluative symptom-limited exercise test was
performed 1 day after completing the last
training session, constituted the training group.
After inclusion of the exercise training group,
we started inclusion of the control group. For
this group, consecutive patients eligible for
rehabilitation were selected who matched one
of the participants of the training group for age
(within 5 years), NYHA class (identical), LVEF
(within 5%) and etiology (identical). The
patients in the control group had 2 baseline
symptom-limited exercise tests, 4 weeks apart,
before starting their actual rehabilitation
program. Table 1 summarizes the main patient
characteristics of the training and control
groups.
Symptom-limited exercise testing
Symptom-limited exercise tests at baseline
and after 4 weeks (control group) or after
completion of the rehabilitation program
(training group) were done with respiratory gas
exchange analysis (Oxycon Pro, Jaeger-Viasys
Healthcare, Hoechberg, Germany). Exercise
intensity started at 5 Watts and was increased
by 5 Watts every 30 seconds. Participants exer-
cised to their self-determined maximal capacity
or until the supervising physician stopped the
test because of significant symptoms, such as
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Training group Control group P-value
Sex 19M / 1F 13M / 1F NS
Age (years) 60 ± 9 63 ± 10 NS
LVEF (%) 34 ± 5 34 ± 7 NS
BMI (kg/m2) 27.3 ± 3.5 28.7 ± 3.0 NS
NYHA class 2.6 ± 0.5 2.3 ± 0.4 NS
Etiology
Ischemic 11 (55%) 6 (43%) NS
Non-ischemic 9 (45%) 7 (57%) NS
Medication
Antithrombotic therapy 16 (80%) 11 (79%) NS
ACE inhibitor/AII blocker 18 (90%) 14 (100%) NS
Diuretic 12 (60%) 10 (71%) NS
Spironolactone 3 (15%) 4 (29%) NS
Beta-blocker 17 (85%) 12 (86%) NS
Statin 14 (70%) 10 (71%) NS
Digoxin 0 (0%) 0 (0%) NS
Amiodarone 4 (20%) 1 (7%) NS
Table 1. Patient characteristics.
Legend to Table 1. BMI: body mass index (kg·m-2); F: female; LVEF: left ventricular ejection fraction; M: male; 
NS: not significant (P>0.05); NYHA: New York Heart Association functional class.
ABSTRACT
Background and Aim. The oxygen uptake
efficiency slope (OUES) is a novel measure of
cardiopulmonary reserve. OUES is measured
during an exercise test, but it is independent of
the maximally achieved exercise intensity. It
has a higher prognostic value in chronic heart
failure (CHF) than other exercise-test derived
variables like V
.





cise training improves V
.





CHF patients. We hypothesized that exercise
training also improves OUES.
Methods and Results. We studied 34 New
York Heart Association (NYHA) class II-III CHF
patients who constituted an exercise training
group T (N= 20; 19 men/1 woman; age 60 ± 9
years; left ventricular ejection fraction 34 ± 5%)
and a control group C (N=14;  13 men /1
woman; age 63 ± 10 years; left ventricular ejec-
tion fraction 34 ± 7%). A symptom-limited
exercise test was done at baseline and repeated
after four weeks (C) or after completion of the
training program (T). Exercise training
increased NYHA class from 2.6 to 2.0 (P<0.05),
V
.
O2 peak by 14% (P(TvsC)<0.01), and OUES by





CO2 by 14% (P(TvsC)<0.05).







CO2 and also OUES.
This finding is of great potential interest as
OUES is insensitive for peak load. Follow-up
studies are needed to demonstrate wether OUES
improvements induced by exercise training are
associated with improved prognosis.
INTRODUCTION 
Cardiopulmonary performance is often





O2 max is an objective parameter, that
is defined as the point at which oxygen uptake
reaches a plateau despite continuing exercise
and increasing workload25. Unfortunately, such
a plateau is often difficult to perceive14, and in
symptom-limited exercise tests, as performed
in chronic heart failure (CHF), the plateau is
often not attained24. Hence, in practice, peak
oxygen uptake (V
.
O2 peak) is assessed in CHF






is strongly influenced by the motivation of the
patient, the selected exercise protocol and the
tester’s subjective choice of the test end
point1,22. 
As a result of these drawbacks, Baba et al.2
have introduced the oxygen uptake efficiency
slope (OUES), an objective and reproducible
measure of cardiopulmonary function reserve
that can also be measured with submaximal
exercise4,12,27. In CHF patients it was shown that
among other exercise-test derived parameters
(V
.





CO2–; ventilatory anaerobic threshold
–VAT–) OUES had the strongest prognostic
value; OUES was also the only parameter with
independent prognostic value6. It is known that
exercise training improves V
.





in CHF patients919,21, however convincing proof
that exercise training also increases OUES in
CHF patients has not been published yet. There
certainly are positive indicators that this might
be the case: exercise training improves OUES in
other patient groups (coronary artery disease,
haemodialysis7,26) and Van Laethem et al.13
recently published, in an uncontrolled study,
suggestive evidence that exercise training also
increases OUES in CHF patients.  Our current
study aims to complete this evidence by using a
controlled protocol.




O2 peak values of the training and
the control groups did not differ significantly;
exercise training increased V
.
O2 peak by 14%, this
was significantly different (P<0.01) from the










CO2 slope was elevated,
both groups exceed the upper normal limit of




CO2 slope values of
the training and the control groups did not





CO2 slope by 14%. This difference was
significantly different (P<0.01) compared with
the insignificant change in the control group
(Table 2). 
Oxygen uptake efficiency
Baseline OUES and OUES/kg values of the
training and the control groups did not differ
significantly; exercise training increased OUES
by 19% and OUES/kg by 17% (Table 2). This
increase differed significantly (P<0.001) from
the change in the control group (Table 2).
As expected, OUES75 and OUES90 did not
differ relevantly from OUES (Fig 1), OUES75
underestimated OUES by 1.4% and OUES90 over-
estimated OUES by 0.5%. As there was no signif-
icant difference in the beginning in the analysis
of variance repeated measures (Greenhouse-
Geisser P value was 0.09), there was no need to
correct for multiple comparisons. Exercise
training increased OUES75 significantly by 21%
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Group Baseline Remeasurement Change (%) PBvsR
OUES/kg Control 20.2 ± 4.7 21.2 ± 5.7 5 NS
[(ml O2/min)/(L VE/min)] Training 19.8 ± 5.1 23.2 ± 4.8 17 <0.001
PCvsT NS <0.001*
OUES Control 1763 ± 362 1854 ± 451 5 NS
[(ml O2/min)/(L VE/min)] Training 1690 ± 447 2017 ± 462 19 <0.001
PCvsT NS <0.001*
OUES90 Control 1792 ± 335 1903 ± 443 6 NS
[(ml O2/min)/(L VE/min)] Training 1660 ± 470 2030 ± 436 22 <0.001
PCvsT NS <0.001*
OUES75 Control 1797 ± 324 1923 ± 440 7 NS
[(ml O2/min)/(L VE/min)] Training 1609 ± 388 2010 ± 406 21 <0.001
PCvsT NS <0.001*
VE/VCO2slope
Control 35.5 ± 3.6 35.8 ± 3.9 0 NS




O2 peak Control 17.1 ± 3.5 16.9 ± 3.9 -1 NS
(ml O2/kg/min) Training 16.9 ± 4.4 19.4 ± 4.9 14 <0.01
PCvsT NS <0.05*
Table 2. Changes in V
.
O2 peak and OUES.
Legend toTable 2. CvsT: control group vs. training group; BvsR: baseline vs. remeasurement; NA: not applicable; 
NS: not significant; OUES: oxygen uptake efficiency slope (constant a in equation V
.
O2 = a · log V
.
E + b); 
OUES75: OUES calculated from data derived form the first 90% of the symptom limited exercise test; 
OUES90: OUES calculated from data derived form the first 90% of the symptom limited exercise test; 
V
.
O2 peak: peak oxygen uptake [ml O2/kg/min]; *: P-values for the difference between the change in parameters.
chest pain, dizziness, potentially dangerous
arrhythmias or ST-segment deviations, or
marked systolic hypotension or hypertension.
Breath-by-breath respiratory gas analyses were
performed throughout the entire test. V
.
O2
values were determined over every 30 second
period, and over the terminating measurement
period at peak exercise when this was more
than 15 seconds long. The last valid V
.
O2 value












CO2 slope was obtained by linear





CO2 during the entire symptom-limited
exercise test. 
OUES was computed by a linear least
squares regression from the oxygen uptake on
the logarithm of the minute ventilation (V
.
E)





E + b. Constant a is called the
oxygen uptake efficiency slope (OUES), as it
represents the rate of increase in oxygen uptake
in response to a change in minute ventilation2.
In order to assess the validity of OUES during
a submaximal exercise test, OUES was also
calculated from data derived form the first 75%
(OUES75) and 90% (OUES90) of the entire exer-
cise duration. 
To compare the OUES results from our study
group with reference values, we computed the
predicted OUES for age, body surface area (BSA)
and sex-matched normal participants according
to the equations published by Hollenberg et
al.12: for women, OUES = 1175 – 15.8·age +
841·BSA; for men, OUES = 1320 – 26.7·age +
1,394·BSA. 
Exercise training
Patients in the training group attended 30
exercise training sessions. Training sessions
were conducted 2 to 3 times a week, lasted
about 75 minutes and consisted of 20 minutes
cycling, starting at 50% of the maximal load
attained during the baseline symptom-limited
exercise test, preceded/followed by warming
up/cooling down. Per session, this load was
increased, until the attained heart rate was
equal to the heart rate at the anearobic
threshold as estimated during the baseline test.
Further endurance exercise during 15 minutes
was ad libitum and consisted of rowing or
walking. Additionally, all patients in the
training group conducted light resistance
training, consisting of 1 series of 25 repetitions
of each of the following exercises; flies, rowing,
chest press, shoulder press, leg extension, leg
curl, leg press and pull down. Intensity was
chosen and, in the course of the training
program, adjusted in such a way that the
patient experienced nearly complete exhaustion
of the involved muscle group after 25 repeti-
tions.
Statistics
The statistical data are expressed as mean 
± SD. Baseline characteristics were evaluated by
using Mann-Whitney U-test and chi-square
tests, Yates correction was used. A Mann-
Whitney U-test were used to compare,
between the training and the control group,







CO2, OUES/kg, OUES, OUES90 and
OUES75. A paired Student’s t-test was used to
compare the measured OUES with the reference
OUES. NYHA functional class within the
training group changes were evaluated with a
Wilcoxon signed-rank test. Differences in
OUES75, OUES90 and OUES of the entire
maximal exercise duration were assessed by a
repeated-measures analysis of variance. 
RESULTS
Patient characteristics
No significant differences were found for
sex, age, LVEF, body mass index, NYHA func-
tional class, etiology and medication of the
training and the control group (Table 1).
Throughout the study, the type and dose of
medications remained the same for all patients.
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cates decreased lactic acidosis and a better
ventilation/perfusion match in the lungs.
Limitations
Although our study was not randomized,
the baseline characteristics of the control and
exercise groups matched reasonably well (Table
1). Moreover, although the duration between
the two exercise tests in the control group is
probably not of great importance, it is a limita-
tion that there was a discrepancy in the time
between the initial and the second exercise test
between the two groups. 
Whether similar results (more specifically, a
significant increase of OUES in the training
group) would have been obtained with other
exercise training modalities (e.g., walking/
running instead of endurance cycling) or with
other exercise testing modalities (e.g., treadmill
vs. cycle ergometry) cannot be answered with
our current data. So far, standard exercise
testing protocol has been defined for OUES
assessment, and OUES is currently being
measured with treadmill as well as with cycle
ergometry2,4,6,7,27. Baba et al.3 have shown that
there was excellent intra-individual agreement
between OUES values measured with two
different treadmill protocols. Hence, OUES
seems to be relatively insensitive to the testing
protocol, and it is not very likely that the
results of our study would have differed very
much when treadmill instead of cycle ergom-
etry had been used.
CONCLUSIONS
In conclusion, our study demonstrates that
exercise training in CHF patients increases
OUES, a robust parameter for cardiorespiratory
reserve with a strong independent prognostic
value in heart failure. This positive training
effect is associated with an improvement in the
NYHA functional class and other cardiorespira-
tory parameters. Follow-up studies are needed
to determine whether an increase of OUES in a
heart failure patient is associated with
improved prognosis.
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Figure 1. Effect of shortened exercise duration on
OUES. OUES: oxygen uptake efficiency slope; 
OUES75: OUES calculated from data derived form the
first 75% of the symptom limited exercise test;
OUES90: OUES calculated from data derived form the
first 90% of the symptom limited exercise test.
and OUES90 by 22%. Again there was no signifi-
cant change in the control group (Table 2). 
OUES assessed in the control group and in
the training group were significantly lower
(71% and 67% respectively) than reference OUES
values for matched normal subjects (Table 3). 
New York Heart Association functional
class
Baseline NYHA functional class of the
training and the control groups did not differ
significantly. After the exercise training
program, 10 patients improved one NYHA func-
tional class and 1 patient improved two NYHA
functional classes (P<0.01).
DISCUSSION
As compared to normal values, baseline 
V
.





CO2 slope was increased. According to
expectation19, exercise training increased 
V
.





control group showed an increasing trend of
OUES, probably caused by a familiarization
effect. Nevertheless, the increase of OUES in the
exercise group differed significantly from the
change in the control group. Therefore, our
study confirmed our hypothesis that exercise
training increases OUES in CHF patients. To our
knowledge, this is the first controlled study
that reports a beneficial effect of exercise
training on OUES in CHF. This finding is of
great potential interest. Multiple factors affect
the maximal load attained during a symptom-
limited maximal exercise test1,22. As a conse-
quence, individual V
.
O2 peak values are relatively
unreliable. Contrastingly, we found, in line
with the findings by Hollenberg et al.12 and van
Laethem et al.27, that OUES is a more consistent
parameter. Hence, OUES75 and OUES90 also
increased significantly in the exercise training
group. 
Physiological background of the oxygen
uptake efficiency slope
OUES was significantly lower than the
computed OUES reference values. Factors
affecting OUES are the arterial carbon dioxide
set point (PaCO2), the metabolic carbon dioxide
production (V
.
CO2) and the ratio of pulmonary
dead space to tidal volume (Vd/Vt)2. During
exercise, the arterial carbon dioxide set point in
CHF patients does not differ from normal23.
Metabolic acidosis in CHF patients, however,
occurs at lower workloads than in healthy
persons as a consequence of reduced muscle
perfusion and structural muscular changes17.
This causes increased ventilation18. Moreover,
the reduced lung perfusion in CHF patients
results in an increase in the physiologic
pulmonary dead space2. Hence, a depressed
OUES in CHF patients is likely resulting from
underperfusion of skeletal muscle and under-
perfusion of the lungs. The observed exercise
training-induced increase in OUES is therefore
presumably attributable to both peripheral
muscular adaptations, such as increased capil-
lary density, blood flow, mitochondrial volume
density, fibre size, slow twitch fibres and
decreased lactic acidosis and vascular resis-
tance8,10,11,16, and pulmonary adaptations like
increased alveolar capillary membrane perfu-
sion and capillary blood flow9. In accordance
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Group Assessed OUES Predicted OUES % predicted OUES Passessed vs predicted
[(ml O2/min)/(L VE/min)] [(ml O2/min)/(L VE/min)] [(ml O2/min)/(L VE/min)]
Training group 1690 ± 447 2542 ± 355 67 <0.001
Control group 1763 ± 362 2497 ± 396 71 <0.001
Table 3. Assessed versus predicted OUES.
Legend to Table 3. OUES: oxygen uptake efficiency slope (constant a in equation V
.
O2 = a · log V
.
E + b).
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METHODS
Patients
Our institutional Medical Ethics Commit-
tees approved the protocol of this study. All
participants gave written informed consent.
Eligible patients (NYHA class II or III CHF with
systolic dysfunction and left ventricular ejec-
tion fraction < 45%) were scheduled for
cardiopulmonary rehabilitation. Patients with
pulmonary hypertension and/or chronic
obstructive pulmonary disease were excluded
from the study.
Patients were randomized to a control (C)
and an exercise training group (T). T patients
performed exercise tests before commencing
their exercise training program and within one
week after their final training session. C
patients performed two exercise tests, four
weeks apart, before starting their actual
training program.
Exercise testing
The symptom-limited exercise tests were
done with respiratory gas exchange analysis
(Oxycon Pro, Jaeger). Exercise intensity started
at 5 Watts and was increased by 5 Watts every
30 seconds. Maximal work rate (Wmax) was
defined as the highest obtained workload mini-
mally maintained for 30 seconds. Subjects exer-
cised to their self-determined maximal capacity
or until the supervising physician stopped the
test because of adverse symptoms, e.g., chest
pain, dizziness, potentially dangerous arrhyth-
mias or ST-segment deviations, or marked
systolic hypotension or hypertension.  Breath-
by-breath respiratory gas analysis was done




O2) values were deter-
mined over every 30 second period and over
the final measurement period at peak exercise
when this was more than 15 seconds long. The
last valid V
.







O2/∆W was calculated by linear
regression of V
.
O2 on work rate, from 1 minute





CO2 slope was obtained by
linear regression of minute ventilation (V
.
E) on
carbon dioxide output (V
.
CO2) over the entire
exercise test.  OUES was computed by a linear
least squares regression from V
.
O2 on the loga-
rithm of the minute ventilation (V
.
E) over the
entire exercise test3. 
Exercise training
T-patients performed 30 exercise training
sessions, which were held 2 to 3 times a week.
The initial 20 minutes of a training session
consisted of cycling. Exercise intensity during
the first session was 50% of the maximal load
attained during the baseline exercise test,
preceded by warming up and followed by
cooling down. Per session, this load was
increased, until the attained heart rate was
equal to the heart rate at the anearobic
threshold as estimated during the baseline test.
Subsequent rowing or walking during 15
minutes was optional. Additionally, light resis-
tance training was performed, consisting of 1
series of 25 repetitions of each of: flies, rowing,
chest press, shoulder press, leg extension, leg
curl, leg press and pull down. Resistance
training intensity was adjusted in such a way
that the patient experienced nearly-complete
exhaustion of the involved muscle group after
25 repetitions.
Statistics
Data are expressed as mean ± standard devi-
ation. Baseline characteristics were evaluated
by using Mann-Whitney U test or chi-square
tests with Yates correction. An unpaired
Student’s t-test was used to compare baseline
values between the training and the control









CO2 slope, OUES and maximal
workload (Wmax). Changes in NYHA class within
group T were evaluated with a Wilcoxon
signed rank test. Linear regression analyses
were performed to evaluate the relationship
between ∆V
.
O2/∆W and the baseline values of
the other cardiopulmonary oxygen uptake vari-
ables (V
.
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ABSTRACT
Background. The oxygen uptake-work rela-
tion (∆V
.
O2/∆W) has predictive value in chronic
heart failure (CHF) and the reduction in
∆V
.
O2/∆W reflects the severity of this disease.
Exercise training improves prognosis in CHF
patients. Exercise training also improves several
cardiopulmonary exercise testing variables in
these patients. It is, however, unknown if exer-
cise training improves ∆V
.
O2/∆W in CHF. We
hypothesized that exercise training improves
∆V
.




Methods. We studied 36 New York Heart
Association (NYHA) class II-III CHF patients,
randomized into an exercise training group T
(N=18; 15M/3F; age 60 ± 11 yrs; LVEF 32 ± 7%)
and a control group C (N=18; 17M/1F; age 63 ± 9
yrs; LVEF 33 ± 7%). A progressive workload
exercise test was done at baseline and repeated
after four weeks (group C) or after completion
of the training program (group T).
Results. Exercise training improved V. O2 peak
by 23% (P(TvsC)<0.0001), OUES by 18%





CO2 slope by 10% (P(TvsC)<0.02).
Exercise training did not improve ∆V
.
O2/∆W
(P(TvsC)= 0.86). However, 33% of T and 50% 
of C had a relatively normal ∆V
.
O2/∆W (>10
(ml/min)/Watt) at baseline. ∆V
.
O2/∆W
improved in the population with subnormal
baseline ∆V
.
O2/∆W values from 8.71 ± 0.90 to
9.14 ± 0.78 (ml/min)/Watt (P(TvsC)= 0.04).













O2/∆W. Further research has to





The oxygen uptake-work rate relation
(∆V
.
O2/∆W) describes the amount of oxygen
that is utilized in relation to the amount of
external work performed. ∆V
.
O2/∆W has impor-
tant prognostic power in chronic heart failure
(CHF)20. While patients with mild CHF have





O2/∆W is often subnormal in CHF,
and the amount of depression reflects the
severity of CHF. The mechanisms that lower
∆V
.
O2/∆W in CHF are not fully understood,
most likely this is to be attributed to the atten-
uated cardiac output response to exercise31 and
to other components of oxygen delivery and
utilization systems, e.g., pulmonary, vascular
and skeletal muscle systems1,15. 
Exercise training therapy is effective in CHF:
it lessens dyspnea and fatigue12,21, improves
quality of life, improves New York Heart
Association (NYHA) class2,4,22, decreases
morbidity, and may even decrease
mortality24,26. Also, several cardiopulmonary







slope and OUES increase with exercise




Exercise training may well improve factors
that caused a decrease in ∆V
.
O2/∆W, such as
cardiac output and pulmonary, vascular and
skeletal muscle systems. Studies report an
improvement in intrinsic skeletal muscle prop-
erties11,13,25, a decrease in tissue inflammation10,
a decrease in the concentration of vasoconstric-
tive agents5,6,12 and an improvement of
endothelial function23,28. Hence, we hypothe-
sized that in CHF patients with subnormal
∆V
.
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Exercise capacity







CO2 slope, but it did not
improve ∆V
.
O2/∆W (P=0.99, Table 2). However,






(ml/min)/Watt). We divided group T and
group C in a population with ∆V
.
O2/∆W>10
(normal) and a population with ∆V
.
O2/∆W<10
(subnormal). Exercise training improved
∆V
.
O2/∆W in the population with ∆V
.
O2/∆W <10
(N=12) from 8.71± 0.90 to 9.14 ± 0.78
(ml/min)/Watt (Table 3). In this population all
other exercise testing variables also improved
(Table 3). Furthermore, baseline ∆V
.
O2/∆W was
related with the exercise-induced change in
∆V
.
O2/∆W, r2=0.60 (Figure 1).  
There was only a weak correlation in base-





(r2=0.12, P=0.02), and between ∆V
.
O2/∆W and
OUES (r2=0.15, P=0.01, Figure 1). No correlation







slope (r2=0.02, P=0.41, Figure 1). There was no
significant difference between the ∆V
.
O2/∆W
baseline values of CHF patients with NYHA class
II and of patients with NYHA class III (9.74 ±
0.93 versus 9.28 ± 1.41 (ml/min)/Watt, P=0.25).
DISCUSSION







CO2, OUES and Wmax. In 42% of our study
population, ∆V
.
O2/∆W baseline values were
normal. In patients with subnormal ∆V
.
O2/∆W
baseline values, exercise training improved
∆V
.
O2/∆W. The amount of exercise-induced
change in ∆V
.




To our knowledge, this is the first study
demonstrating the effect of exercise training on
the oxygen uptake-work relation in CHF.
∆V
.





O2/∆W determines the amplitude
of the oxygen response on exercise in a
constant workload test1,32. It is, however, not
identical to the V
.
O2 time constants measured
during a constant workload test36. Only one
previous study has reported on the effect of
exercise training on the V
.
O2 time constants36.
In contrast with our study, they found that
exercise training improved V
.
O2 kinetics in CHF
irrespective of their baseline values. This
discrepancy can be explained by the fact that
∆V
.
O2/∆W measures another aspect of the V
.
O2
kinetics than the V
.
O2 time constants. 
Subnormal ∆V
.
O2/∆W in CHF can be attrib-
uted to components of both oxygen delivery
and oxygen utilization systems1. Recently
Kemps and colleagues18, suggested that in CHF
the delay in V
.
O2 kinetics is primarily due to
limitations in oxygen delivery systems. In
healthy persons cardiac output time constants
are larger than V
.
O2 time constants, indicating
that, during exercise onset, oxygen delivery to
skeletal muscles is in excess of the metabolic
demand. Kemps and colleagues18 demonstrated
that in CHF patients no clear difference
between the  V
.
O2 and cardiac output time
constants existed. This would imply that
oxygen delivery is the limiting factor for V
.
O2
kinetics, hence, limitation in oxygen delivery
systems could also be the limiting factor of
∆V
.
O2/∆W in CHF. 
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N = 12 Baseline Remeasurement
V
.









1448 ± 352 1707 ± 361*




8.71 ± 0.90 9.14 ± 0.78+
Table 3. Changes in exercise testing variables in the





O2/∆W< 10 ((ml/min)/Watt). 
Legend to Table 1. OUES: oxygen uptake efficiency slope;
∆V
.
O2/∆W: oxygen uptake-work relation; V
.
O2 peak: peak
oxygen uptake; Workloadmax: maximal workload; *:
change in the training group versus change in the control
group with subnormal ∆V
.
O2/∆W P<0.01; +: change in the




regression was also performed to asses the rela-
tionship between ∆V
.
O2/∆W baseline values and
∆V
.
O2/∆W changes.  
RESULTS
Patient characteristics
Characteristics of the patients in group T
(N=18) and group C (N=18) groups are summa-
rized in Table 1. No significant differences were
found between any of the characteristics of the
patients in the T and C group. There were also
no significant differences in baseline exercise
testing variables (Table 2). Throughout the
study, medication remained the same for all
patients.
New York Heart Association
classification
NYHA class improved after exercise training
(P<0.01): 8 patients improved one NYHA class,
while 8 patients remained in their NYHA class.
NYHA class values after exercise training were
missing for 2 patients.
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Exercise group Control group P-value
Sex 15M/3F 17M/1F 0.60
Age (years) 60 ± 11   63 ± 9 0.41
NYHA class I/II/III/IV 0/11/7/0 0/10/8/0 0.74
Etiology 0.18
Ischemic 8 (44%) 6 (34%)
Non-ischemic 10 (56%) 13 (66%)
BMI (kg/m2) 27.9 ± 5.9 28.1 ± 2.9 0.92
LVEF (%) 32 ± 7 33 ± 7 0.75
Medication NS
ACE inhibitor/ 
AII blocker 14 (78%) 16 (89%)
Diuretic 11 (61%) 12 (67%)
Spironolactone 4 (22%) 3 (17%)
Beta-blocker 13 (72%) 14 (78%)
Amiodarone   2 (11%) 2 (11%)
Table 1. Patient characteristics.
Legend to Table 1. BMI: body mass index (kg·m-2); F: female; M: male; LVEF: left ventricular ejection fraction; 
NS: not significant (P>0.05); NYHA: New York Heart Association functional class.
Training Group Control Group
Baseline Remeasurement Baseline Remeasurement
V
.





CO2slope 34.2 ± 9.4 30.9 ± 6.5*° 35.7 ± 5.8 36.2 ± 6.8
OUES [(mlO2/min)/(L V
.
E/min)] 1558 ± 438 1845 ± 424*° 1786 ± 518 1768 ± 477
Workloadmax (Watt) 94.8 ± 31.4 110.9 ± 37.5*° 105.7 ± 27.4 101.8 ± 31.6
∆V
.
O2/∆W ((mlO2/min)/Watt) 9.42 ± 1.27 9.41 ± 0.80 9.69 ± 1.06 9.57 ± 1.19
Table 2. Changes in exercise testing variables. 
Legend to Table 2. OUES: oxygen uptake efficiency slope; ∆V
.
O2/∆W: oxygen uptake-work relation;  
V
.
O2 peak: peak oxygen uptake; Workloadmax: maximal workload; *: baseline versus remeasurement P<0.01; 
°: change in training group versus change in control group P<0.01.
testing protocol does not allow for differentia-
tion between cardiac and peripheral training
effects. Several studies showed that exercise
training improves the cardiac output response
to exercise8,13,30. Also, Roditis and colleagues
showed that exercise training increases V
.
O2
kinetics particularly in phase I (the exercise
phase in which cardiac output increases consid-
erably) and speculated that this might imply
cardiac function improvement27. However, it is
known that exercise training also reduces vaso-
constriction, improves endothelial dysfunction,
decreases tissue inflammation and improves
intrinsic skeletal muscle properties5,6,10-13,23,25,28.
Likely, training effects will also occur within
these systems. Also, these systems all influence
each other. E.g., an increased cardiac output
response may improve pulmonary gas
exchange. Further research has to reveal to
which extent each of the codeterminants of
∆V
.




O2/∆W values are around 10
(ml/min)/Watt 34,35. Different from the other







Wmax, and OUES, 42% of our study population
had normal baseline ∆V
.
O2/∆W values. Cohen-
Solal and colleagues29 reported that ∆V
.
O2/∆W
values were significantly reduced in severely
impaired  (V
.
O2 peak <16 ml/kg/min) CHF
patients29. According to this definition, greater
part of our population, 61%, was severely




there was no significant difference in ∆V
.
O2/∆W
in patients with NYHA II and NYHA III classi-
fication, and there existed only a weak corre-





O2 peak and OUES (Figure 1). Therefore,
different from the study by Cohen-Solal and
colleagues29, we found no strong association
between the severity of CHF and ∆V
.
O2/∆W.
However, our study population was relatively
small (N=36). Also, the used exercise testing
protocol influences on the ∆V
.
O2/∆W. Hansen
and colleagues14 showed that ∆V
.
O2/∆W
changed when different slopes of the work rate
increment were used (the slower the increment
in work rate, the higher ∆V
.
O2/∆W). However,
the slope of the work rate increment in our
exercise testing protocol was identical to that of
the one used by Cohen-Solal and colleagues29,
there was only a difference in initial workload
(20 watts in the study of Cohen-Solal and
colleagues versus 5 watts in our study). 
A limitation of the ∆V
.
O2/∆W measure is,
that it is not uniquely determined by aerobic
metabolism during exercise; it is codetermined
by external work efficiency. If external work
efficiency in a subject is low and oxygen
utilization and delivery systems are not limited,
∆V
.
O2/∆W will be higher34. For instance if a
person is performing an exercise test for the
first time, he/she may be pulling the cycle
handlebars which will lead to an increase in
V
.
O2 that is not becoming evident in the
amount of external work performed at the
pedals of the ergometer. Therefore, in subjects





decrease a little bit with training because of
improved external work efficiency (concentra-
tion of all work at the pedals of the ergometer.
This may also have happened in our study
participants: panel D in Figure 1 indicates that,





O2/∆W decreases after exercise
training. If the influence of an improved work
efficiency is apparent in the group with normal
∆V
.
O2/∆W values, one may assume that patients
with subnormal ∆V
.
O2/∆W baseline values also
improved in work efficiency, therefore, the
actual improvement in aerobic metabolism






O2/∆W is likely not sensitive enough
to asses changes in exercise capacity in mild
CHF patients and as ∆V
.
O2/∆W is influenced by
external work efficiency, evaluation of the
severity of the disease or the effectiveness of an
exercise training program in CHF patients
cannot be performed properly by only assessing
∆V
.
O2/∆W. However, as all exercise testing
parameters reflect different aspects of the
CHAPTER 6 | THE EFFECT OF EXERCISE TRAINING ON THE OXYGEN UPTAKE-WORK RELATION IN CHF 89
In line with these findings, Itoh and
colleagues showed that by administration of
the phosphodiesterase inhibitor Enoximone,
which increases vasodilatation and myocardial
inotropy in CHF patients, ∆V
.
O2/∆W increased
acutely16. Also, they found a close association
between ∆V
.
O2/∆W and the rise in norepineph-
rine concentrations during exercise15. They




thoexcitation during exercise causes vasocon-
striction that is overruled by metabolically
induced vasodilatation in the working muscle,
hereby causing blood flow redistribution at the
sacrifice of other organs). Hence, work effi-
ciency is increased, a mechanism that compen-
sates for the limited oxygen supply in CHF
patients.
Cardiac output is an important variable in
oxygen delivery. CHF patients have an attenu-
ated cardiac output response to exercise, which
also can be seen as a major cause of a decreased
∆V
.
O2/∆W19,31. Unfortunately, our exercise
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Figure 1. Relation between V
.




CO2 slope, change in ∆V
.






O2 peak: peak oxygen uptake; OUES: oxygen uptake efficiency slope; ∆V
.
O2/∆W: oxygen uptake-work relation.
Panel A: Relation between V
.
O2 peak and ∆V
.
O2/∆W.
Panel B: Relation between V
.
O2 peak and ∆V
.
O2/∆W.




CO2 slope and ∆V
.
O2/∆W.
Panel D: Relation between baseline ∆V
.
O2/∆W and change in ∆V
.
O2/∆W after exercise training (P = 0.001).
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cardiopulmonary system during exercise, we
think it is still of importance to assess
∆V
.
O2/∆W in combination with other







CO2 slope and OUES. We are
of opinion that assessing all exercise testing
variables together for each individual will make
it possible to establish a more reliable represen-
tation of the patient’s individual capabilities
and drawbacks. Also, exercise testing variables
have all individually important prognostic
value7,20 and, combining these variables might
lead to a powerful prognostic tool. Further




associated with improved prognosis, is needed.
Limitations
Although the time interval between the
initial and second symptom-limited exercise
tests is probably not of utmost importance, it is
a limitation that there is a discrepancy in time
between the performance of the first and
second symptom limited exercise test between
the C and T groups.  This difference was a
result caused by our principle that the start of
the rehabilitation program of the control
patients should not be delayed by our study.
Also, as mentioned in the discussion, it is a
limitation that ∆V
.
O2/∆W is not uniquely deter-
mined by the aerobic metabolism, as it is also
codetermined by the external work efficiency. 
CONCLUSIONS







CO2, Wmax, and OUES. In half of our popu-
lation ∆V
.
O2/∆W baseline values were normal.






studies are needed to demonstrate if exercise-
induced ∆V
.
O2/∆W improvements are associated
with improved prognosis. 
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decrease arterial baroreflex sensitivity (BRS)13,38,
CRT-induced CSAR deactivation should be
accompanied by a BRS increase. Therefore, we
hypothesized that biventricular pacing acutely
facilitates the arterial baroreflex.
Although a CRT-induced BRS increase is not
sufficient to prove that CRT deactivates CSAR, it
is a necessary condition. Hence, in addition to a
possible improved prognosis, the significance of
finding a CRT-induced BRS increase is that it
comports suggestive evidence for CSAR deacti-
vation as one possible working mechanism of




The protocol was approved by the local
Medical Ethics Committee. Thirty-two
consecutive CHF patients eligible for CRT
implantation were included in this study.
Patients with atrial fibrillation, atrioventricular
conduction defects or frequent supraventricular
or vertricular ectopy were not included, as
noninvasive baroreflex sensitivity measurement
requires sinus rhythm.
Protocol
Baseline echocardiography was performed
on the day of implantation preceding the
implantation procedure. One day after implan-
tation of a CRT device, echocardiography was
repeated and a BRS and heart rate variability
(HRV) evaluation was performed. BRS and HRV
were measured in each patient in two condi-
tions: CRT device switched on and switched off
(on/off order randomized). After the first BRS
and HRV evaluation, CRT modality was changed
conform the randomization protocol. After this
change in CRT modality 10 minutes of rest
followed prior to the second BRS and HRV eval-
uation. 
Instrumentation
During baroreflex and HRV evaluation the
patients were in the supine position. To
prevent respiratory discomfort, the upper part
of the bed was inclined in accordance with the
individual’s sleeping habits. The fingercuff of a
continuous noninvasive arterial blood pressure
measurement device (Finometer, Finapres
Medical Systems, Amsterdam, NL) was attached
around the second phalanx of the left middle
finger. The armcuff of an automatic sphyg-
mometer (Accutorr 3, Datascope Corp., Mont-
vale, NJ, USA) was attached around the right
upper arm. A standard 12-lead ECG was derived.
Two electrodes were applied to the lateral sides
of the lower part of the thorax to monitor
respiration (impedance method). Blood pres-
sure, respiration and ECG were recorded with
an ST-surveyor monitoring system (Mortara
Rangoni Europe, Casalechio di Reno, BO,
Italy) with a 500 Hz sampling rate. 
Measurements
First, blood pressure and heart rate (Accu-
torr, average of 5 subsequent readings) were
measured after a 15-minute resting period.
These measurements were used to establish a
reliable systolic blood pressure (SBP) measure-
ment with the noninvasive arterial blood pres-
sure measurement device. Then, after the
patient had been lying for 30 minutes, the ECG,
the noninvasive continuous arterial blood pres-
sure signal and the respiration signal were
recorded during 10 minutes for later BRS and
HRV calculation. During this period, patients
performed 0.25-Hz metronome respiration
(preventing the direct mechanical component
of respiration and the respiratory gating effect
to enter the low-frequency band (0.04-0.15 Hz),
in which we compute BRS)12. After switching
the CRT device on or off and an additional 10
minutes of rest, this measurement was
repeated.
BRS and HRV calculation
To characterize arterial baroreflex function
we computed BRS, the reflex-induced
increase/decrease of the interval between heart
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ABSTRACT
Background. Metabolic and mechanical
stress in the failing heart activates the cardiac
sympathetic afferent reflex (CSAR). It has been
demonstrated that cardiac resynchronization
therapy (CRT) acutely reduces muscle sympa-
thetic nerve activity in clinical responders.
Mechanistically, this beneficial effect might be
explained by acute deactivation of the CSAR. In
addition to sympathoexcitation, CSAR inhibits
the arterial baroreflex at the level of the
nucleus tractus solitarii. Hence, in responders,
CRT is likely to remove/reduce this inhibition.
Therefore, we hypothesized that CRT acutely
facilitates the arterial baroreflex.
Methods and Results. One day after
implantation of a CRT device in 32 patients with
chronic heart failure (left ventricular ejection
fraction (LVEF), 27 ± 6%) we measured noninva-
sive baroreflex sensitivity (BRS) and heart rate
variability (HRV) in two conditions: CRT device
switched on and switched off (on/off order
randomized). BRS changes were correlated with
the difference in unpaced/paced LVEF, a
measure of acute mechanical response to CRT.
CRT increased BRS by 28% from 2.96 to 3.79
ms/mmHg (P<0.02) and increased HRV (stan-
dard deviation of the intervals between normal
beats) from 18.5 to 24.0 ms (P<0.01). The CRT
induced relative change in BRS correlated with
the change in LVEF (r=0.44, P<0.01). 
Conclusion. CRT acutely increases BRS and
HRV. This favourable response of the auto-
nomic nervous system might be caused by CRT-
induced CSAR deactivation. Follow-up studies
should verify the mechanism of the acute
response and the possible predictive value of an
acute positive BRS response.
INTRODUCTION 
Chronic heart failure (CHF) is characterized
by permanent neurohumoral activation, i.e.,
elevated sympathetic tone, depressed parasym-
pathetic tone and activation of the renin-
angiotensin-aldosteron system. This neurohu-
moral activation is accompanied by an
increased peripheral chemoreflex and a
decreased arterial baroreflex. Baroreflex sensi-
tivity (BRS) has independent prognostic value in
CHF
20
Several mechanisms play a role in the
blunting of the arterial baroreflex in CHF, e.g.
an increased sympathetic outflow, an increase
in circulating and central angiotensin II, an
increased chemoreflex and an increased cardiac
sympathetic afferent reflex. (CSAR)13,19. CSAR, a
reflex that is not excited in the normal heart at
rest, is activated by mechanical stretch and by
metabolites like potassium, hydrogen ion,
adenosine, bradykinin and prostaglandins,
which are elevated during myocardial ischemia
and with cardiac stretch25,34. In CHF, CSAR is not
only enhanced because of an increase in
discharge intensity at the receptor level but also
because of an increase in central reflex gain18,38. 
Cardiac resynchronization therapy (CRT), a
relatively new therapy in CHF, is known to
acutely decrease left ventricular (LV) dyssyn-
chrony, to lower left LV filling pressure and to
increase myocardial efficiency32,37. Besides these
acute effects on cardiac functioning, CRT also
induces acute effects in autonomic functioning.
Najem et al.21 showed that muscle sympathetic
nerve activity (MSNA) acutely increased in
responders of CRT when biventricular pacing
was switched off. A plausible and clinically
relevant explanation for this observation would
be that CRT reduces metabolic and mechanical
stress in affected ventricular muscle, thus
reversing CSAR activation and sympathetic
outflow. However, direct proof of this CRT
working mechanism is difficult to obtain, as
CSAR afferent activity cannot be measured in
humans. Since CSAR afferent firing is known to
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MN, USA; Lumax (n= 1), Biotronic, MI, USA).
The atrioventricular delay (AV-delay) was opti-
mized by two-dimensional echocardiography
so that it provided the longest filling time for
completion of the end-diastolic filling flow
before LV contraction, AV-delay was set at 
120 ± 10 ms. No adjustments were made to the
interventricular pacing delay (V-V interval; set
at 0 ms).
BRS, HRV, SBP and IBI 
BRS was significantly larger with biventric-
ular pacing than without: 3.79 ± 4.04
ms/mmHg and 2.96 ± 3.19 ms/mmHg, respec-
tively (average individual change 28%, P<0.05).
SDNN was also larger with biventricular pacing
than without: 24.0 ± 14.3 ms and 18.5 ± 9.5 ms,
respectively (average individual change 30%,
P<0.05). SBP and IBI did not change signifi-
cantly (Table 2). 
LV dyssynchrony, LVEF, LVEDV, LVESV
and E/E’ ratio
In one person it was not possible to asses
LVEF due to poor quality of the acoustic
window. With biventricular pacing, LV dyssyn-
chrony, LVEDV, LVESV and E/E’ ratio decreased
from 62 ± 43 ms to 35 ± 38 ms (P<0.001), from 
227 ± 79 ml to 216 ± 77 ml (P<0.001), from 
168 ± 63 ml to150 ± 63 ml (P<0.001) and from
19.0 ± 9.3 to 15.6 ± 8.1 (P<0.005), respectively.
LVEF increased from 27 ± 6% to 32 ± 7%
(P<0.001) (Table 2). 
Correlations between changes in BRS
and in LVEF.
The relative change in BRS correlated with
the relative change in LVEF (r= 0.44, P<0.01)
(Figure 1).
Ischemic versus nonischemic etiology
There were 15 patients with nonischemic
etiology and 17 patients with ischemic etiology.
In both groups BRS tended to be larger with
biventricular pacing than without: in the
nonischemic group BRS increased by 30% from
3.15 ± 4.5 ms/mmHg to 4.10 ± 5.5 ms/mmHg
(P=0.08) and in the ischemic group BRS
increased by 28% from 2.79 ± 1.4 ms/mmHg to
3.51 ± 2.37.1 ms/mmHg (P=0.10). No significant
difference in increase in BRS was found
between the two groups (P=0.85).
DISCUSSION AND CONCLUSION
Our data demonstrate that CRT acutely
increases BRS and HRV irrespective of etiology;
the relative change in BRS correlates with the
change in LVEF. 
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CRT device off CRT device on P
BRS (ms/mmHg) 2.96 ± 3.19 3.79 ± 4.04 < 0.02
SDNN (ms) 18.5 ± 9.5 24.0 ± 14.3 < 0.01
SBP (mmHg) 109.6 ± 19.2 110.5 ± 19.1 0.54
IBI (ms) 857 ± 165 864 ± 164 0.11
LVdyssynchrony (ms) 62 ± 43 35 ± 38 < 0.001
LVEF (%) 27 ± 6 32 ± 7 < 0.001
LVEDV (ml) 227 ± 79 216 ± 77 < 0.001
LVESV (ml) 168 ± 63 150 ± 63 < 0.001
Table 2. Outcome variables with and without biventricular pacing.
Legend to Table 2. BRS: baroreflex sensitivity; CRT: cardiac resynchronization therapy; IBI: inter beat interval; 
LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic
volume; SBP: systolic blood pressure; SDNN: standard deviation of the intervals between normal heart beats.
beats, in milliseconds, per unit rise/fall of SBP.
First, the arrhythmia free and stationary
periods longer than 60 seconds in the
metronome respiration episode were selected
(stationary sinus rhythm and blood pressure are
prerequisites for a reliable BRS value). Compli-
ance to the metronome respiration protocol
was visually verified in the respiration signal.
Then, BRS was computed in each of the
selected episodes. The BRS algorithm computes
the magnitude of the transfer function between
the systolic blood pressure variability (barore-
flex input) and the interbeat interval (IBI) vari-
ability (output), averaged over the 0.04-0.15 Hz
band. Additionally, it calculates 95% two-sided
BRS confidence intervals33. Finally, the overall
BRS was composed from all data segments by
the best linear unbiased estimator (BLUE)
method36. Mean SBP and mean IBI were
computed from the selected episodes. HRV was
expressed as the standard deviation of the
intervals between normal beats (SDNN). 
Echocardiography
Echocardiographic images were obtained in
the left lateral decubitus position using a
commercially available system (Vivid 7,
General Electric – Vingmed, Milwaukee, WI,
USA). A minimum of 2 consecutive heart beats
was recorded from each view and the images
were digitally stored for off-line analysis
(EchoPac, General Electric Vingmed Ultra-
sound, Milwaukee, USA). LV end-systolic
(LVESV) and end-diastolic (LVEDV) volumes and
LV ejection fraction (LVEF) were calculated
from the apical 2- and 4-chamber images,
using the modified biplane Simpson’s rule30.
LV dyssynchrony was assessed by tissue
Doppler imaging on the apical 2- and 4-
chamber view and calculated as the maximum
time delay between the peak systolic velocities
of 4 opposing basal walls4. 
The sample volume was placed between the
tips of the mitral leaflets to assess Doppler
pulsed-wave mitral inflow. The mitral inflow
peak early velocity (E) to mitral annular peak
early velocity (E’), or E/E’ ratio was assessed by
dividing E by E’ at the basal septal segment22. 
Statistics
Results are presented as mean ± SD. A
paired Student’s t-test was used to evaluate the
changes in BRS, HRV, LV dyssynchrony, LVEF,
LVEDV, LVESV, E/E’ ratio, SBP and IBI between
the different CRT modes. Linear regression
analyses was performed to evaluate the rela-
tionship between CRT-associated LVEF change
and BRS change. 
RESULTS
Study group
Baseline characteristics of the study group
are listed in Table 1. A total of 32 patients were
included. All CRT devices were successfully
implanted (Contak Renewal (n=16), Guidant,
MN, USA; InSync Sentry (n= 14), Medtronic
Inc., MN, USA; Concerto (n= 1), Medtronic Inc.,
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Sex 26M/6F
Age (years) 66 ± 9  




QRS duration (ms) 154 ± 30
LVEF (%) 27 ± 6
LVEDV (ml) 227 ± 79
LVESV (ml) 168 ± 63
LV dyssynchrony (ms) 62 ± 43
Medication




Amiodarone    6  (19%)
Table 1. Patient characteristics before pacemaker
implantation.
Legend to Table 1. LVEDV: left ventricular end-diastolic
volume; LVEF: left ventricular ejection fraction; 
LVESV: left ventricular end-systolic volume; 
NYHA: New York Heart Association.
stretching of the receptors due to a sustained
increase in left ventricular end-diastolic pres-
sure (LVEDP)7. Like others37,we found that CRT
acutely decreased LVEDP (expressed as E/E’
ratio; see Table 2). Hence, in addition to
reducing CSAR afferent firing, CRT may posi-
tively influence vagal afferent mechanoreceptor
functioning, by decreasing LVEDP. It is known
that, at the NTS, cardiac vagal afferents interact
occlusively with cardiac sympathetic afferents34.
Hence, a weakened input at the NTS due to the
CRT-mediated decrease in sympathetic afferent
firing may have been further weakened by
simultaneously occurring increased vagal
afferent firing. It is difficult to draw conclu-
sions about the likeliness of such an extra
contribution to a BRS increase by CRT induced
changes in vagal afferent activity. Paradoxically
in healthy animals, stimulation of cardiac vagal
mechanoreceptors results in an attenuated
BRS
40 and no research has been conducted to
establish the effect of cardiac vagal afferent
stimulation on BRS in CHF.
CRT also acutely increases the maximal rate
of LV pressure change (dP/dtmax)3. An increase
in dP/dtmax may cause more intense firing of
the arterial baroreceptors which could increase
BRS
10. However, Eckberg10 showed that varia-
tions of dP/dtmax within 550 to 3300 mmHg/sec
did not influence BRS. As CHF patients have
dP/dtmax values within this range31, it is
unlikely that the CRT induced increase in
dP/dtmax will have influenced BRS. 
Changes in SBP might also explain BRS
improvement due to biventricular pacing since
a change in SBP influences the logistic curve of
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Figure 2. Neural pathways involved in sympa-
thoexcitation and baroreflex inhibition by cardiac
sympathetic afferents.
Panel A: sacral and thoracic spinal, and caudal and
rostral medullar sections; 
panel B: NTS details (based on28). ALS = anterolateral
(spinothalamic) system; CVLM = caudal ventrolateral
medulla; GABA = inhibiting neuromodulator gamma-
aminobutyric acid; Glu = excitatory neurotransmitter 
L-glutamate; NA = nucleus ambiguus; NG = nodose
ganglion; NRM = nucleus raphe magnus; NTS =
nucleus tractus solitarius; PAG = periaquaductal grey;
PG = petrosal ganglion; PRG = posterior (dorsal) root
ganglion; RVLM = rostral ventrolateral medulla; 
SP = excitatory neuromodulator substance P; IX = 9th
cranial (glossopharyngeal) nerve; X = 10th cranial
(vagus) nerve. Dark gray spots: involved areas.
Inhibiting neurons at the level of the brainstem: gray,
dashed; sympathetic efferents: gray, continuous;
parasympathetic efferents: gray, dotted.
LV dyssynchrony is associated with a decline
in systolic performance, an increase in end-
systolic volume and wall stress, a delayed relax-
ation and a decline in myocardial efficiency14,26.
LV dyssynchrony is probably one of the factors
causing CSAR activation, as CSAR is activated
under influence of metabolic and mechanical
stress in the failing heart38. Optimization of the
mechanical activation pattern of the left
ventricle is the primary working mechanism of
CRT
17. CRT induces early excitation of the
region which is otherwise late activated due to
delayed intrinsic conduction. In concordance
with other studies8 we found that CRT acutely
decreased LV dyssynchrony as well LV filling
pressures, expressed as E/E’ ratio (Table 2).
Previous studies have also shown that CRT
acutely lowers LV filling pressures37 and
enhances myocardial efficiency32. Moreover,
Nelson et al.23 found that CRT enhanced systolic
function with modestly diminished energy
cost, which is probably explained by lowering
of lateral wall stress. Hence resynchronization
might well reduce CSAR activation.
A schematic representation of the CSAR
pathway is outlined in Figure 2. CSAR afferents
project on the rostroventral lateral medulla
(RVLM) and on the nucleus tractus solitarii
(NTS). CSAR afferents activate sympathetic
efferents at the level of the RLVM. At the level
of the NTS, CSAR afferents activate inter-
neurons28,39. These interneurons release the
neuromodulator gamma-aminobutyric acid
(GABA) that inhibits the barosensitive NTS
neurons39. Thus, a decrease in CSAR afferent
firing will lead to a stronger baroreflex. Several
studies in normal animals and in animals with
heart failure have shown that electrical or
mechanical stimulation of CSAR decreases
BRS
13,38. We found that BRS was larger with the
CRT device switched on. Logically, the CRT
induced increase in BRS as well as less excita-
tion of the sympathetic efferents in the RVLM
will contribute to a decreased sympathetic
outflow, which was found by Najem et al.21,
who showed that stopping of CRT instantly
increased MSNA. 
Other factors than a decrease in CSAR
afferent firing might also explain the improve-
ment of BRS with biventricular pacing. In addi-
tion to cardiac sympathetic afferents, the NTS
also receives projections of cardiac vagal affer-
ents5. In heart failure, vagal mechanoreceptors
are desensitized, possibly caused by continuous
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y = 0.9308x + 14.556
r = 0.44
n = 31



















Figure 1. Correlation between % change in BRS and LVEF (CRT switched off versus CRT switched on). 
BRS: baroreflex sensitivity; CRT: cardiac resynchronization therapy; LVEF: left ventricular ejection fraction.
BRS response is here less important, as long as
the BRS increase with CRT remains demon-
strable. Theoretically, we could have measured
a larger contrast between the CRT-on and CRT-
off BRS if we had chosen for longer periods
during which CRT was on or off. In the current
protocol this period was 10 minutes. By inclu-
sion of a BRS measurement before implantation
of the CRT device, we could have verified
wether BRS, after switching of the pacemaker,
returned to preimplantation values. This, and
related questions, address another interesting
research topic, namely what influence CRT has
on BRS in terms of a prognostic factor16 and if
the acute effect as we measured it has predic-
tive value for the long-term effect. This issue
was not addressed by our protocol, however.
BRS changes correlated significantly, but
weakly (r=0.44), with the changes in LVEF,
which we used as a measure of acute mechan-
ical response to CRT. As the acute change in BRS
correlated with acute mechanical response to
CRT, we would also expect a correlation
between acute BRS and late mechanical
response. Long-term follow-up studies are
needed to verify if acute BRS increase facilitated
by CRT predicts clinical outcome.
CONCLUSIONS
CRT acutely facilitates the baroreflex.
Further studies should verify wether this posi-
tive effect is caused by CRT-induced CSAR deac-
tivation. Also, the predictive value of the
limited acute BRS increase as we found for a
possible further BRS increase with time16 and
for a positive clinical response to CRT should be
investigated. 
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the BRS15. Blanc et al. showed with an invasive
arterial blood pressure measurement at the
level of the heart that CRT may acutely increase
blood pressure6. We, however, did not find
such an increase in SBP with CRT. This discrep-
ancy might be caused by the different SBP
measurement methods, since we did not
measure SBP invasively but rather using a
noninvasive device that measures arterial blood
pressure more distally (at the finger). Whatever
the cause of the difference in the observations
by Blanc et al.6 or the current study, our data
do not support a possible influence of SBP on
the logistic function curve of the BRS15. This
leaves us with the plausible explanation of the
observed CRT-induced BRS increase, i.e., facilita-
tion of the baroreflex due to CRT-induced CSAR
deactivation. However, as recording of CSAR
afferent activity is currently not possible in
humans in vivo, new animal studies are needed
to determine whether the CRT-induced BRS
increase is indeed caused by CSAR deactivita-
tion. 
Seminal to our study was the publication by
Sarzi et al.29, who described in a case report
that BRS normalized after 3 months of CRT.
This finding is of high importance, therefore
we tested this hypothesis on group level. Obvi-
ously, this case report could also not separate
between the direct and indirect effect of CRT,
i.e., the direct effect of CRT in terms of a
pacing-related reduction in CSAR afferent nerve
traffic as described above, or the indirect effect
of a BRS increase that might be due to on the
long term remodelling and associated increase
in dP/dt31, and to the training effect of
enhanced physical activity27 that is to be
expected in a patient in whom cardiac function
is improved. In our current study, we noted
that CRT acutely increased BRS; this proves the
existence of a direct effect of CRT 1 day after
implantation. It is however, not known wether
this acute increase in BRS will be followed by a
further gradual increase over time, and what
could be the possible mechanism underlying
such a further gradual increase. These issues
demand clarification as lowered BRS in CHF
parallels deterioration of clinical and hemody-
namic status and is significantly associated with
poor survival20. 
Also HRV has a strong prognostic value in
CHF
24. We used SDNN as a measure of HRV
because SDNN is one of the most commonly
computed HRV parameters. Furthermore, SDNN
has the advantage that is not sensitive to algo-
rithmic variants as seen in spectral HRV
analysis1, and can also be determined in short
recordings like the standard diagnostic 12-lead
ECG
9. Several studies have already shown that
CRT increases HRV2,11, but to our knowledge,
this is the first study to show that HRV increases
acutely after initiation of biventricular pacing.
The average individual increase in HRV (30%)
was in line with the increase in BRS (28%). This
is according to expectation: an increase in BRS
will result in an increase in HRV because greater
part of HRV is caused by baroreflex mediated
vagal and sympathetic transmission of blood
pressure variability to the sinus node35.
When placed in a wider time perspective,
the on-off experiments in our study could have
been done earlier (immediately after CRT
implantation) or later (e.g., 3 or 6 months after
CRT implantation). The earlier these measure-
ments, the purer the on-off BRS difference
reflects the acute effect of CRT institution.
When measured later, the on-off BRS differ-
ence gives rather an impression of the acute
effect of CRT withdrawal than of CRT institu-
tion, as therapeutic effects like inverse remod-
elling might have occurred. Therefore, we have
chosen for the most early evaluation moment
possible; earlier than 1 day after implantation
would have confounded the measurements
with the implantation procedure-related effects
of stress and anaesthetics on BRS.
Our protocol was designed to study differ-
ences in BRS and thereby to probe the mecha-
nism by which CRT might exert its beneficial
influence. We interpret an acute BRS increase
with CRT as suggestive evidence for inactivation
of CSAR by CRT. Basically, the magnitude of the
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As BRS is an important independent prog-
nostic parameter in CHF16, we hypothesized
that patients showing an acute CRT-induced
BRS increase one day after implantation, will
respond positively to CRT. 
METHODS
Patients
The protocol was approved by the local
Medical Ethics Committee. Consecutive CHF
patients eligible for CRT implantation were
included in this study. Patients with atrial
fibrillation, AV-conduction defects or frequent
supraventricular or ventricular ectopy were not
included, as sinus rhythm is a prerequisite for
reliable noninvasive BRS measurement. 
Protocol
One day after implantation, a BRS and heart
rate variability (HRV) evaluation was performed.
BRS and HRV were measured in each patient in
two conditions: CRT device switched on and
switched off (on/off order randomized). After
the first BRS and HRV evaluation the CRT
modality was changed according to the
randomization protocol. After changing CRT
modality, 10 minutes of rest followed, here-
after, the second BRS and HRV evaluation took
place. Echocardiography was performed prior
to the implantation procedure on the day of
implantation, and was repeated 6 months after
implantation.
BRS and HRV evaluation
Instrumentation
During BRS and HRV evaluation the patients
were in the supine position. The upper part of
the bed was inclined in accordance with the
individual sleeping habit, to prevent respiratory
discomfort. Around the second phalanx of the
left middle finger, the fingercuff of a contin-
uous noninvasive arterial blood pressure
measurement device (Finometer, Finapres
Medical Systems, Amsterdam, NL) was
attached. Around the right upper arm, the
armcuff of an automatic sphygmometer (Accu-
torr 3, Datascope Corp., Montvale, NJ, USA) was
attached. A standard 12-lead ECG was continu-
ously recorded during the measurement proce-
dure. To the lateral sides of the lower part of
the thorax, two electrodes were applied in
order to monitor respiration (impedance
method). Blood pressure, ECG and respiration
were recorded with an ST-surveyor monitoring
system (Mortara Rangoni Europe, Casalechio
di Reno, BO, Italy) with a 500 Hz sampling
rate.
Measurements
First, blood pressure and heart rate (Accu-
torr, average of 5 subsequent readings) were
measured after a 15-minute resting period.
These blood pressure measurements were used
as a gold standard and were compared with the
noninvasive arterial blood pressure measure-
ment device. In this way, a reliable noninvasive
arterial blood pressure measurement could be
established. When the patient had been lying
for 30 minutes, the noninvasive continuous
arterial blood pressure signal, the ECG and the
respiration signal were recorded during 10
minutes for later HRV and BRS calculation.
During this period, patients performed 0.25 Hz
metronome respiration (preventing the direct
mechanical component of respiration and the
respiratory gating effect to enter the low-
frequency band (0.04-0.15 Hz), in which we
compute BRS)10. This measurement was
repeated, after switching the CRT device on or
off and an additional 10 minutes of rest.
Analysis
To characterize arterial baroreflex function
we computed BRS, the reflex-induced
increase/decrease of the interval between heart
beats, in milliseconds, per unit rise/fall of
systolic blood pressure. All signals were blindly
analyzed.  First, the arrhythmia free and
stationary periods longer than 60 seconds in
the metronome respiration episode were
selected (stationary sinus rhythm and blood
pressure are prerequisites for a reliable BRS
value). Compliance to the metronome respira-
tion protocol was visually verified in the respi-
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ABSTRACT
Background. In a previous study we demon-
strated that institution of biventricular pacing
in chronic heart failure (CHF) acutely facilitates
the arterial baroreflex. The arterial baroreflex
has important prognostic value in CHF. We
hypothesized that the acute response in barore-
flex sensitivity (BRS) after institution of cardiac
resynchronization therapy (CRT) has predictive
value for mid-term response.
Methods. One day after implantation of a
CRT device in 33 CHF patients (27 male / 6
female, age 66.5 ± 9.5 years, left ventricular
ejection fraction 28 ± 7%) we measured nonin-
vasive BRS and heart rate variability (HRV) in
two conditions: CRT device switched-on and
switched-off (on/off order randomized).
Echocardiography was performed prior to
implantation (baseline) and 6 months after
implantation (follow-up). CRT responders were
defined as patients in whom left ventricular
end systolic volume (LVESV) at follow-up had
decreased by ≥ 15%.
Results. Responders (69.7%) and non-respon-
ders (30.3%) had similar baseline characteristics.
In responders, CRT increased BRS by 30%
(P=0.03); this differed significantly (P=0.02)
from the average BRS change (-2%) in the non-
responders. Also, CRT increased HRV by 30% in
responders (P=0.02), but there was no signifi-
cant difference found compared to the increase
in HRV (8%) in the non-responders. Receiver-
operating characteristic (ROC) curve analysis
revealed that the percetage BRS increase had
predictive value for the discrimination of
responders and non-responders (area-under-
the-curve 0.69; 95% confidence interval 0.51-
0.87; maximal accuracy 0.70). 
Conclusions. Our study demonstrates that a
CRT-induced acute BRS increase has predictive
value for the anatomical response to CRT. This
finding suggests that the autonomic nervous
system is actively involved in CRT-related
reverse remodelling.
INTRODUCTION
Cardiac resynchronization therapy (CRT) is a
relatively new and effective therapy in drug-
refractory chronic heart failure (CHF). Studies
have demonstrated that CRT decreases mortality
and symptoms, and improves quality of life and
New York Heart Association (NYHA) class1,9.
Unfortunately, not all CHF patients experience
positive effects of biventricular pacing: about
30% of the patients with an implanted device
do not respond to CRT3,4,22.  Therefore, several
studies have been and are being conducted to
identify measures that predict a positive
response to CRT.
Permanent neurohumoral activation, i.e.,
elevated sympathetic tone, depressed parasym-
pathetic tone and activation of the renin-
angiotensin-aldosterone system, is a hallmark
of CHF. Simultaneously with neurohumoral
activation, CHF patients have an increased
peripheral chemoreflex and a decreased arterial
baroreflex. Most therapies in CHF aim to
diminish the detrimental influences of this
neurohumoral activation and autonomic
derangement by pharmacological interruption
of the formation of the involved neurohor-
mones or by blocking their effect at the
receptor level.
CRT seems to have an acute beneficial effect
on the permanent neurohumoral activation
and autonomic derangement in CHF. Hamdan
et al. found that biventricular pacing acutely
reduced muscle sympathetic nerve activity
(MSNA) when compared to right ventricular
pacing13. Also, Najem et al.17 showed that MSNA
acutely increased in responders of CRT when
biventricular pacing was switched off, this was
not the case in non-responders of CRT. 
Furthermore, as we recently demonstrated, the
arterial baroreflex sensitivity (BRS) is acutely
improved with CRT11. It is, however, currently
unknown if such acute CRT-induced auto-
nomic responses are associated with clinical
outcome. 
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positive (1-sensitivity) rates that correspond to
each possible discrimination level of the test or
variable under consideration: each cut-off level
generates a point on the graph. The closer the
curve follows the left-hand border and then
the top-border of the ROC space, the more
accurate the test. The closer the curve comes to
the 45 degree diagonal of the ROC space, the
less accurate the test. For all tests, a P-value 
< 0.05 was considered significant. 
RESULTS
Study group
Thirty-five CHF patients were included.
Two patients were excluded from follow-up 
(1 patient because of suspected lung cancer, the
other because of poor quality of the acoustic
window during echocardiography that
prevented reliable LVEF assessment), thus
leaving 33 subjects in our study group. Thirty
of them attended in our previous study11. Base-
line characteristics of the study group are listed
in Table 1.
All CRT devices were successfully implanted
(Contak Renewal (n=18), Guidant, MN, USA;
InSync Sentry (n= 13), Medtronic Inc., MN, USA;
Concerto (n= 1), Medtronic Inc., MN, USA;
Lumax (n= 1), Biotronic, MI, USA). The atri-
oventricular delay (AV-delay) was optimized by
2D echocardiography so that it provided the
longest filling time for completion of the end-
diastolic filling flow before LV contraction (the
mean AV-delay was 120 ± 10 ms). No individual
adjustments were made to the interventricular
delay; the V-V interval was set at 0 ms in all
subjects. 
Responders and non-responders
After 6 months of CRT, 23 patients (70%)
were classified as responders and 10 patients as
non-responders (30%), according to the crite-
rion of a decrease of ≥ 15% in LVESV. No deaths
occurred during follow-up. There were no
significant differences between responders and
non-responders in baseline variables (Table 2).
In responders, substantial reverse remodelling
was present, LVEF increased by 34%, left
ventricular end diastolic volume (LVEDV)
decreased by 16% and LVESV decreased by 28%
(P<0.003, Table 2). In non-responders reverse
remodelling did not occur; changes over time
in LVEF, LVEDV and LVESV were limited and
not statistically significant (Table 2). Responders
and non-responders both significantly
improved in NYHA class and 6-minute walk
test, after 6 months of CRT (Table 2). In neither
of the groups there was a significant change in
MLWHFQ.
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Responders Non-responders
Baseline Follow-up Baseline Follow-up
LVEF (%) 27.6 ± 5.6 37.1 ± 7.8* 28.5 ± 10.0 29.3 ± 9.6
LVEDV (ml) 209.3 ± 70.9 175.4 ± 57.4* 239.1 ± 70.6 233.1 ± 69.8
LVESV (ml) 154.5 ± 60.2 112.4 ± 46.3* 178.3 ± 57.2 169.2 ± 66.6
NYHA class 2.5 ± 0.7 1.9 ± 0.7* 2.4 ± 0.7 1.8 ± 0.6 *
MLWHFQ 29.2 ± 18.2 21.9 ± 18.7 25.8 ± 18.0 20.4 ± 14.9
6-min walk test 339.7 ± 113.4 392.8 ±111.8* 306.4 ± 62.6 391.3 ± 62.0*
Table 2. Clinical and echocardiographic outcome measures in responders and non-responders.
Legend to Table 2. MLWHFQ: Minnesota Living With Heart Failure Questionnaire; NYHA: New York Heart Association;
LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic
volume; 6-min walk test: 6-minute walk test; *: P< 0.01 within group.
ration signal. Then, BRS was computed in each
of the selected episodes. The BRS algorithm
computes the magnitude of the transfer func-
tion between the systolic blood pressure vari-
ability (baroreflex input) and the interbeat
interval variability (output), averaged over the
0.04-0.l5 Hz band. Additionally, it calculates
95% two-sided BRS confidence intervals (CI)27.
Finally, the overall BRS was composed from all
data segments by the best linear unbiased esti-
mator (BLUE) method30. Mean systolic blood
pressure (SBP) and mean inter beat interval (IBI)
were computed by taking the average of all SBP
and IBI values from the selected episodes. HRV
was also computed from the selected episodes
and expressed as the standard deviation of the
intervals between normal beats (SDNN). 
Echocardiography
Echocardiographic images were obtained in
the left lateral decubitus position using a
commercially available system (Vivid Seven,
General Electric – Vingmed, Milwaukee, WI,
USA). A minimum of two consecutive heart
beats was recorded from each view and the
images were digitally stored for off-line
analysis (EchoPac 7.0.0, General Electric
Vingmed Ultrasound, Milwaukee, USA). Left
ventricular (lv) end-systolic and end-diastolic
volumes and LV ejection fraction (LVEF) were
calculated from the apical 2- and 4-chamber
images, using the modified biplane Simpson’s
rule23.
LV dyssynchrony was assessed by tissue
Doppler imaging on the apical 2- and 4-
chamber views and calculated as the maximum
time delay between the peak systolic velocities
of 4 basal walls2. The sample volume was
placed between the tips of the mitral leaflets to
assess Doppler pulsed-wave mitral inflow. 
Clinical evaluation
Prior to implantation and after 6 months of
CRT, clinical evaluation took place consisting of
NYHA class assessment, the Minnesota Living
with Heart Failure Questionnaire (MLWHFQ)
and the 6-minute walk test. MLWHFQ was used
to assess quality of life20. The 6-minute walk
test was used to assess exercise tolerance14.
Evaluation of heart failure symptoms was
coded as NYHA functional class. 
Response to CRT
Patients were classified as responder when
patients showed a decrease of ≥ 15% in left
ventricular end systolic volume (LVESV) after 6
months of CRT5. Patients not fulfilling this
criterion were classified as non-responders. 
Statistics
Results are presented as mean ± SD. Paired
or unpaired Student’s t-test were used to
compare data, when appropriate. A Wilcoxon
signed rank test was used to evaluate changes
in NYHA class within groups. To determine if
BRS has predictive value for the echocardio-
graphic responses to CRT, receiver-operating
characteristic (ROC) curve analysis was applied.
The ROC curve is a graphical display of trade-
offs of the true-positive (sensitivity) and false-
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Sex 27M/6F
Age (years) 66.5 ± 9.5    




QRS duration (ms) 157 ± 30
LVEF (%) 157 ± 30
LVEDV (ml) 218 ± 76
LVESV (ml) 159 ± 62
LV dyssynchrony (ms) 57 ± 44
Medication




Amiodarone    6  (18%)
Table 1. Baseline patient characteristics.
Legend to Table 1. LVEDV: left ventricular end-diastolic
volume; LVEF: left ventricular ejection fraction; 
LVESV: left ventricular end-systolic volume; 
NYHA: New York Heart Association.
an acute BRS increase after CRT institution and
reverse remodelling at mid-term follow-up.
The positive association between acute CRT-
induced baroreflex improvement and reverse
remodelling suggests that the autonomic
nervous system is actively involved in reverse
remodelling. Possibly, CRT decreases the
permanent neurohumoral activation (a hall-
mark of CHF) by decreasing the involvement of
the cardiac sympathetic afferent reflex
(CSAR)8,11. CSAR is activated by mechanical
stretch and by various metabolites which are
elevated during myocardial ischemia and with
cardiac stretch18,29. Improvement of the
mechanical activation pattern by CRT may have
lowered mechanical stretch26,31 in part of our
patients, and may thus have deactivated CSAR.
The arterial baroreflex is known to be
suppressed by CSAR12,32, and the observed
baroreflex improvement in part of our study
population might well be caused by CRT-
induced deactivation of CSAR.     
Although sympathoexcitation, possibly
induced by cardiac sympathetic afferents, is
generally observed in heart failure, cardiac
vagal afferents might also play a role in the
effects observed in our study. No experiments
have been conducted to establish the effect of
cardiac vagal afferent stimulation on BRS in the
setting of heart failure. In healthy animals,
stimulation of cardiac vagal receptors resulted
in BRS attenuation35. Hence, cardiac vagal
afferent firing, like cardiac sympathetic afferent
firing, may well inhibit the effect of barore-
ceptor firing at the level of the nucleus tractus
solitarii (nts). As a consequence, possible CRT-
induced decrease of cardiac vagal afferent firing
would, like possible CRT-induced decrease of
cardiac sympathetic afferent firing, lead to
facilitation of the baroreflex. This reasoning
would become more complicated when both
sympathetic and vagal afferents are involved,
because it was reported that major part of these
fibers have an occlusive interaction at the NTS28.
In addition to baroreflex improvement, one
would also expect improvement (decrease) in
the neurohormone levels. Unfortunately, little
research has been conducted about the effects
of CRT on neurohormone levels, and the results
reported in the literature are inconsistent6,7,15,24.
We have not systematically measured neuro-
hormone plasma levels in our study popula-
tion, hence, a positive association between a
positive BRS response to CRT and normalization
of the neurohormone levels remains hypothet-
ical.
An echocardiographic outcome for evalua-
tion of the response to CRT was chosen, since it
is a robust measure and less subject to both the
patient’s and clinician’s interpretation then
clinical outcome variables1,5. A limitation of
this outcome variable is that there are clinical
responders that exhibit a decrease of >15% in
LVESV, these patients were not indicated as
responder in our study. However, Yu et al.34
showed that clinical outcome variables did not
predict mortality, more over, LVESV was the
only independent predictor of all cause
mortality. Also Ypenburg et al.33 found that
long-term prognosis after CRT is related to the
extend of left ventricular reverse remodeling at
6 months of follow-up. 
Obviously, the predictive value of the CRT-
induced acute BRS change can not be used to
reduce the number of CRT implantations in
those who appear to become non-responders.
The clinical use of our findings would rather
lie in additional attempts to adjust the pace-
maker settings in expected non-responders to
CRT (subjects not showing an acute BRS
increase). 
Currently A-V optimization is recom-
mended over V-V optimization25. If an acute
positive BRS change is predictive for a positive
response to CRT, it could be considered to
attempt V-V optimization in cases where an
acute BRS increase does not occur. To maxi-
mize the beneficial effect of CRT by means of
V-V optimization, aiming for the largest BRS
might prove as valuable as the assessment of
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Baroreflex sensitivity and heart rate
variability 
No significant differences in BRS (P= 0.59)
and HRV (P= 0.89) between responders and
non-responders existed at baseline (Table 3). In
responders, CRT increased BRS considerably
(30%) as compared to the non-responders
(P=0.02, Table 3). CRT also improved HRV in
responders (30%, P=0.02), but there was no
significant difference with the change in the
non-responders (P=0.24, Table 3). In non-
responders, CRT did not acutely change BRS or
HRV (Table 3). ROC analysis revealed that the
percentual BRS increase had predictive value for
the discrimination of responders and non-
responders (area-under-the-curve 0.69; 95% CI
0.51-0.87, maximal accuracy 0.70, see Figure 1). 
DISCUSSION
Response to CRT was defined as echocardio-
graphic reverse remodeling. According to this
criterion 70% of our patients were classified as
responders and 30% as non-responders. We
observed that CRT acutely increased BRS in
responders but not in non-responders. ROC
curve analysis showed that the CRT-induced
acute BRS change at baseline had predictive
value for the echocardiographic response to
CRT.
A positive effect of CRT on autonomic
derangement is not a novel finding per se. In
2006 Sarzi et al.21 described in a case report that
BRS normalized after three months of CRT.
Recently, we described an acute positive effect
of CRT on BRS11, while Piepoli et al.19 demon-
strated that BRS and HRV improved with respect
to baseline after 12 months of CRT. Also, Burri
et al.8 observed a decrease in sympathetic nerve
activity in CRT responders as evidenced by a
lowered 123I-MIBG washout. In addition, Najem
et al.17 showed, in clinical responders, that
temporarily switching of CRT increased MSNA.
These findings suggest that one of the effects of
CRT is the reduction of the autonomic derange-
ment associated with CHF. Our current study
adds a new element to this, namely the predic-
tive value of a positive autonomic response to
CRT for an echocardiographic response, since
we demonstrated a positive association between
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Responders Non-responders
CRT off CRT on CRT off CRT on
BRS (mmHg/ms) 2.74 ± 3.7 3.55 ± 4.5*# 3.39 ± 1.6 3.34 ± 1.6
HRV (ms) 18.2 ± 11.0 23.6 ± 15.9* 17.7 ± 3.6 19.2 ± 6.7
Table 3. Baseline baroreflex sensitivity and heart rate variability with and without biventricular pacing.
Legend toTable 3. BRS: baroreflex sensitivity; CRT: cardiac resynchronization therapy; HRV: heart rate variability 
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Figure 1. ROC curve analysis of the predictive value
of CRT-induced acute BRS change for the echocardio-
graphic response to CRT. The area-under-the-curve
equals 0.69, 95% with a confidence interval of 
0.51-0.87. BRS: baroreflex sensitivity; CRT: cardiac
resynchronization therapy.
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LV outflow tract. Of course, the usefulness of
such a procedure has to be demonstrated in a
prospective study.
Obviously, the limited size of our study
group opposes a limitation to the statistical
armament suitable for analysis of the data. For
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CONCLUSIONS
The current results demonstrated that the
CRT-induced acute BRS increase has predictive
value for the anatomical response (reverse
remodelling) to CRT. The present findings
underscore the relevance of the autonomic
nervous system as an effect pathway/mecha-
nism of CRT in CHF.
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O2/∆W are independent of the maxi-
mally attained exercise intensity. In both
studies we compared a non-exercising control
group with an exercise training group; both
groups consisted of CHF patients eligible for
rehabilitation. OUES and ∆V
.
O2/∆W were
measured during a symptom limited exercise
test, which was performed at baseline and
repeated after four weeks (in the control group)
or after completion of a training program (in
the exercise training group). We found that
exercise training increased OUES. In 58% of our
population ∆V
.
O2/∆W baseline values were
normal.  In patients with decreased ∆V
.
O2/∆W,
exercise training improved ∆V
.
O2/∆W.
However, as all exercise testing parameters
reflect different aspects of the cardiopulmonary
system during exercise, we think it is of impor-
tance to assess ∆V
.
O2/∆W in combination with







CO2 slope and OUES, as a
measure of CHF severity, or as an evaluation
tool for exercise training programs. 
In Chapter 7 and Chapter 8 we studied the
effect of biventricular pacing on the arterial
baroreflex. Metabolic and mechanical stress in
the failing heart activates the cardiac sympa-
thetic afferent reflex (CSAR) even at rest. It has
been demonstrated that in clinical responders
muscle sympathetic nerve activity (MSNA)
acutely increases after switching of the cardiac
resynchronization therapy (CRT) device. There-
fore it seems that CRT decreases MSNA.  Mecha-
nistically, this beneficial effect might be
explained by acute deactivation of the CSAR.
Since CSAR afferent firing decreases arterial
BRS
7,13, CRT-induced CSAR deactivation is likely
accompanied by a BRS increase. In Chapter 7 we
studied the acute effect of biventricular pacing
on the arterial baroreflex. One day after
implantation of a CRT device in CHF patients
we measured BRS and HRV under two condi-
tions: CRT device switched-on and switched-off
(on/off order randomized). CRT acutely
increased BRS and HRV. This favorable response
of the autonomic nervous system may be
caused by CRT induced CSAR deactivation. 
In Chapter 8 we hypothesized that the acute
response in BRS after institution of CRT has
predictive value for mid-term anatomical
response (reverse remodeling). Echocardiog-
raphy was performed prior to implantation
(baseline) and 6 months after implantation
(follow-up). CRT responders were defined as
patients in whom left ventricular end systolic
volume had decreased by ≥ 15% at follow-
up2,14. In responders, but not in non-respon-
ders, CRT increased BRS and HRV at baseline.
Receiver operating characteristic (ROC) curve
analysis revealed that the percentual BRS
increase had predictive value for the discrimi-
nation of responders and non-responders (area-
under-the-curve 0.69; 95% confidence interval
0.51-0.87; maximal accuracy 0.70). Hence, we
demonstrated that a CRT-induced acute BRS
increase at baseline has predictive value for the
echocardiographic response to CRT. This
finding suggests that the autonomic nervous
system is actively involved in CRT-related
reverse remodeling.
CHAPTER 9 | SUMMARY, CONCLUSIONS AND FUTURE PERSPECTIVES 121
SUMMARY
Aim of the research described in this thesis
was to investigate the effects of exercise
training and of biventricular pacing on fitness-
related variables in the setting of chronic heart
failure (CHF). The studied variables were results
of cardiopulmonary exercise testing analysis
and baroreflex sensitivity (BRS). Also, we
addressed the underlying mechanisms.
In Chapter 2 we reviewed the effects of exer-
cise training on neurohumoral excitation and
autonomic derangement at rest. We concluded
that exercise training increases BRS and heart
rate variability (HRV) and reduces sympathetic
outflow, plasma levels of catecholamines,
angiotensin II, vasopressin and brain natriuretic
peptides at rest. Data on the effect of exercise
training on endothelin and aldosteron levels at
rest were not conclusive. 
In Chapter 3 we addressed, in a modeling study,
a number of issues that are relevant for the
interpretation of BRS. By means of computer
simulations we investigated the link between
the well known phenomenon of blood pressure
resonance (the Mayer waves) on one hand, and
blood pressure buffering (the essential function
of the baroreflex) on the other hand. Simula-
tions were done with various randomly chosen
combinations of feedback gains in the
parasympathetic and sympathetic baroreflex
arms to the heart and to the peripheral vascula-
ture. Output variables were: blood pressure
resonance amplitude, blood pressure buffering
capacity, and BRS. We found that high blood
pressure resonance amplitude was associated
with better blood pressure buffering capacity.
BRS is almost uniquely determined by the vagal
baroreflex gain to the sinus node. In conclu-
sion, blood pressure buffering and BRS are
unrelated unless coupled gains in all baroreflex
limbs are assumed. 
As CHF patients have low exercise capacity
and, hence, the assessment of efficient and
effective rehabilitation programs is difficult,
insight in the currently unknown mechanism
by which the training effect of exercise on BRS
is mediated is of utmost importance. Therefore,
in Chapter 4, we investigated if an increase in
BRS could also be achieved by an alternative
protocol. We compared, in stable untrained
CHF patients, the effect of transcutaneous elec-
trical nerve stimulation (TENS) with the effects
of bicycle exercise training.  By applying TENS
in the form of periodic (2/s, marching pace)
burst stimulation to the feet, we attempted to
mimic an exercise-associated somatosensory
ergoreceptor stimulation pattern. TENS and
exercise training sessions were held during two
successive days. BRS, measured noninvasively
prior to the first intervention session (baseline)
and one day after the second intervention
session (training effect), increased significantly
in the TENS group, but did not change in the
exercise training group. Hence, we demon-
strated that periodic somatosensory input
alone, i.e., without actual exercise, is sufficient
and efficient in improving the arterial barore-
flex in CHF patients. Two sessions of TENS were
even more effective than two boots of exercise;
this observation is likely due to the inability of
CHF patients to exercise at a level at which
there is sufficiently intense afferent somatosen-
soric nerve traffic. This concept may therefore,
constitute a basis for more effective exercise
training regimens in the diseased/impaired, in
whom training should focus more on the
somatosensory component of exercise than on
the intensity of exercise.
In addition to improve autonomic nervous
system functioning, it is also important to
improve exercise capacity, as the degree of
exercise intolerance in CHF is paralleled by an
increased mortality, and several studies suggest
that increasing exercise capacity in CHF
improves prognosis. In Chapters 5 and 6 we
investigated whether exercise training, besides







CO2slope, also improved the oxygen




contrast to the maximal oxygen uptake, OUES
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testing variables and autonomic functioning in
CHF is not clear. This association is of utmost
importance, as currently exercise training
programs focus primarily on increasing exercise
capacity and not on improving autonomic
functioning. Furthermore, to develop efficient
training programs in CHF, the mechanism by
which exercise training normalizes autonomic
derangement and neurohumoral activation
needs further elucidation. As an increase in BRS
improves prognosis, measurement of BRS at
baseline and after completion the rehabilitation
program would also provide an objective and
meaningful rehabilitation effect. 
In this thesis we found indications that
somatosensory information is one of the mech-
anisms through which exercise training
normalizes autonomic functioning. If true, we
would also expect that such somatosensory
information decreases neurohumoral activa-
tion. Currently, we are completing a random-
ized controlled trial (the ALLEGRO study) to
confirm our findings. In the ALLEGRO study we
compare the effects of exercise training and
periodic somatosensory stimulation by TENS to
a control group during an intervention period
of two weeks. In addition to BRS, outcome
measures are cardiopulmonary exercise testing
variables, six minute walk test, Minnesota
Living With Heart Failure Questionnaire and
several blood parameters that reflect the
amount of neurohumoral activation (norepi-
nephrine, epinephrine, NT-proBNP, plasma
renin activity and aldosteron). The ALLEGRO
study has both practical and theoretical impor-
tance. If the hypothesis is true that periodic
somatosensory stimulation decreases neurohu-
moral activation, patients with any form of
exercise intolerance could gain benefit from
light but rhythmic activity. 
Biventricular pacing
In this thesis we provided suggestive
evidence that the acute CRT-induced BRS
response is caused by CSAR deactivation. If true,
this would be an important finding as chronic
CSAR firing is one of the causes of the perma-
nent sympathoexcitation in CHF. Moreover, it
seems that CSAR, in addition to a generalized
sympathoexcitatory effect, also has a preferen-
tial sympathoexcitatory effect on the heart
itself 11. Excessive sympathoexcitation in the
heart increases electrical instability, and high
catecholamine concentrations may be toxic to
cardiomyocytes3. As recording of CSAR afferent
activity is currently not possible in humans in
vivo, new animal studies are needed to deter-
mine whether the CRT-induced BRS increase is
indeed caused by CSAR deactivitation. 
In this thesis we have shown that both exer-
cise training and biventricular pacing increase
fitness in CHF patients. The mechanisms
causing this effect are still unknown, hence
studies are needed to elucidate these mecha-
nisms. Also, studies that address the potential
prevention capabilities of exercise training and
of biventricular pacing are needed, as once
heart failure has developed the underlying
process cannot be reversed. With regard to CRT,
‘early’ application is still a dilemma (high risk
and costs), but for exercise training is this not
the case as physical training is accepted as
primary prevention of cardiovascular disease.
The question is if exercise training in popula-
tions with a high risk of heart failure, for
instance patients with a history of myocardial
infarction, should be implemented in the ther-
apeutic regimen, next to standard pharmaco-
logical therapy, to prevent or to delay the
development of heart failure. 
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CONCLUSIONS
• Exercise training increases baroreflex sensi-
tivity and reduces sympathetic outflow,
plasma levels of catecholamines, angiotensin
II, aldosteron, vasopressin and atrial natri-
uretic peptides at rest 
• Baroreflex mediated blood pressure
buffering and baroreflex sensitivity are
unrelated unless coupled gains in all barore-
flex limbs are assumed
• Periodic somatosensory stimulation
increases arterial baroreflex sensitivity in
chronic heart failure patients
• Exercise training in CHF patients increases
the oxygen uptake efficiency slope
• In CHF patients with decreased ∆V. O2/∆W
exercise training improves ∆V
.
O2/∆W
• Cardiac resynchronization therapy acutely
increases baroreflex sensitivity
• An acute increase of baroreflex sensitivity
upon institution of biventricular pacing has
predictive value for the anatomical response
to cardiac resynchronization therapy
FUTURE PERSPECTIVES
Exercise training
In daily practice, V
.
O2 peak is the most
frequently used variable for the evaluation of
exercise capacity of heart failure patients.
However, the interpretation of V
.
O2 peak is diffi-
cult because it depends on the motivation of
patient and test leader, and on the selected
exercise testing protocol1,12. Therefore, in CHF,
exercise testing variables are to be preferred
that can be obtained from submaximal exercise




CO2 slope and  ∆V
.
O2/∆W
can easily be computed from respiratory gas
exchange results obtained during the test, and
have important prognostic value4,5. Meaningful
results can already be derived from the data
generated during the lower 75% of the covered
exercise intensity range6,8,9. Also, in this thesis
we showed that these exercise testing variables
are sensitive enough to measure exercise
training-induced changes. We are of the
opinion that assessing all mentioned exercise
testing variables together for each individual
will make it possible to establish a more reli-
able representation of the patient’s individual
capabilities and drawbacks. Also, exercise
testing variables have all important prognostic
value5,10 and, combining these variables may
constitute an important powerful prognostic
tool. Hence, it would be a step forward if all
mentioned exercise testing variables would
routinely be computed before starting and after
completion of a rehabilitation program as
objective measurements of the achieved reha-
bilitation effect. 
We demonstrated that exercise training
improves OUES and ∆V
.
O2/∆W. In addition, in a
literature study, we found that exercise training
improves autonomic functioning in CHF.
However, the prognostic value of these find-
ings remain unknown. Therefore, follow-up
studies are needed to demonstrate if improve-
ments of these variables induced by exercise
training are associated with improved prog-
nosis. Also the association between the
improvement in cardiopulmonary exercise
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aties in de bloeddruk dempt, en 3) de mate
waarin de baroreflex door resonantie juist fluc-
tuaties in de bloeddruk opwekt. De baroreflex
gaat veranderingen in de bloeddruk tegen,
maar het duurt enige seconden voor (bijvoor-
beeld) een bloeddrukstijging ook daadwerkelijk
door de baroreflex is gedempt. Veel regelsys-
temen hebben een looptijd tussen afwijking en
regeleffect, en het is een gegeven uit de cyber-
netica dat dit bij bepaalde frequenties van de
verstoring juist resonantie kan veroorzaken,
waardoor de oorspronkelijke verstoring
versterkt wordt in plaats van verzwakt. De
resonantiefrequentie van de baroreflex gere-
gelde bloeddruk bevindt zich in de buurt de 0.1
Hz, het bekende ‘10-seconden ritme’ in de
bloeddruk, ofwel de Mayer waves. Onze
computersimulaties geven aan dat er een
verband is tussen de grootte van de Mayer
waves en de mate waarin een veel langzamere
verandering in de bloeddruk door de baroreflex
gedempt wordt. Daarnaast laten onze simula-
ties zien dat het mogelijk is om betrouwbaar de
BRS te meten in het frequentiegebied van de
bloeddrukresonantie. Ook geven onze simula-
ties aan dat een grote BRS geen aanleiding geeft
tot veel resonantie in de bloeddruk. Eerder
hangt een hoge waarde van de BRS samen met
het hebben van veel hrv, die geassocieerd is
met een sterke, parasympathisch bepaalde, via
de vagus zenuw binnenkomende beïnvloeding
van het hart. Deze bevinding suggereert dat een
belangrijk deel van de gunstige prognose die
met een hoge BRS samenhangt verklaard zou
kunnen worden door een sterkere vagale feed-
back naar het hart op momenten van fysieke of
mentale belasting.
Het is belangrijk om inzicht te verkrijgen in
het achterliggende mechanisme van het fysieke
trainingseffect op de baroreflex aangezien de
lage inspanningscapaciteit van hartfalenpa-
tiënten een belemmering is om intensieve reva-
lidatie programma’s aan te kunnen. In hoofdstuk
4 hebben we onderzocht of een verbetering in
de BRS ook bereikt kon worden door middel
van periodieke somatosensorische stimulatie.
De gedachte hierachter is dat er nu eenmaal
voor de hersenstam een aanleiding moet zijn
om de gain van de baroreflex bij te stellen. De
vraag is dan hoe de hersenstam ‘weet’ dat er
lichamelijke activiteit gaande is. Hoogstwaar-
schijnlijk komt deze informatie in de hersen-
stam door zenuwverkeer afkomstig uit de
spieren waarmee arbeid verricht wordt. Omdat
activiteiten, zoals lopen en fietsen, een ritme
hebben, valt te verwachten dat de hersenstam
periodieke somatosensorische informatie als
zodanig herkent en overeenkomstig zal
reageren. We hebben bij hartfalenpatiënten het
effect van TENS (transcutane elektrische neuro
stimulatie) vergeleken met het effect van fiets-
training. We hebben TENS in de vorm van
periodieke stimulatie (2 bursts per seconde,
loop ritme) op de voeten aangebracht. Op deze
manier hebben we geprobeerd om het ergore-
ceptor zenuwverkeer dat gedurende inspanning
bestaat na te bootsen. Zowel de TENS- als de
fietstraining sessies werden op twee opeenvol-
gende dagen gehouden. De BRS, gemeten voor
de eerste interventie sessie (uitgangssituatie) en
een dag na de tweede interventie sessie (trai-
ningseffect), verbeterde significant in de TENS
groep, maar veranderde niet in de fietstraining
groep. We hebben hiermee aangetoond dat
periodieke somatosensorische input in staat is
om de arteriële baroreflex in hartfalenpatiënten
te verbeteren. TENS leek zelfs effectiever dan
fietstraining, dit kan worden verklaard door het
feit dat hartfalenpatiënten zich niet kunnen
inspannen op het niveau waarbij afferent soma-
tosensorisch zenuwverkeer met voldoende
intensiteit ontstaat. In de vorm van TENS kon
dat zenuwverkeer wel met voldoende intensi-
teit worden gerealiseerd (en verdragen). De
gedachte dat periodieke somatosensorische
informatie een belangrijke component in het
verbeteren van de BRS is, kan een basis vormen
voor meer effectieve trainingsvormen bij
zieken/gehandicapten. In deze patiëntenpopu-
latie zal het accent van fysieke training meer
moeten liggen op de somatosensorische
component van inspanning dan op de inspan-
ningsintensiteit, met andere woorden: de
aandacht zou dan moeten verschuiven van de
vraag hoe de belastbaarheid van de patiënt kan
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SAMENVATTING
Bij een hartfalenpatiënt in rust vertoont het
bloed, paradoxalerwijs, een beeld van voortdu-
rende excitatie van zowel het autonome
zenuwstelsel als van de regelsystemen, die
vocht en zout in het lichaam vasthouden en
samentrekking van de bloedvaten veroorzaken.
Dit wordt samengevat met de term ‘neurohu-
morale activatie’. Deze regelsystemen komen
bij gezonde personen slechts in actie om stres-
soren te kunnen weerstaan en de vochtbalans te
handhaven. Permanente activatie van deze
regelsystemen bij hartfalenpatiënten heeft op
termijn zeer nadelige effecten op het hart. De
huidige therapie is er bij hartfalenpatiënten
voornamelijk op gericht om de invloed van de
neurohumorale activatie medicamenteus te
blokkeren, maar niet om de neurohumorale
activatie weg te nemen.
De neurohumorale activatie bij hartfalenpa-
tiënten gaat samen met een verslechtering van
de arteriële baroreflex. De arteriële baroreflex
dempt schommelingen in de bloeddruk en is
derhalve een beschermende reflex. De barore-
flex compenseert bijvoorbeeld voor bloeddruk-
verhoging bij een stressor door middel van een
toename van de parasympathische outflow en
afname van sympathische outflow naar het
hart, samen met een afname van de sympathi-
sche outflow naar de bloedvaten in het hele
lichaam. Hierdoor zullen de hartfrequentie, de
contractiliteit van het hart en de perifere weer-
stand dalen en als gevolg hiervan zal de bloed-
druk dalen. De sterkte van deze reflex wordt
vaak uitgedrukt in de baroreflex sensitiviteit
(BRS). De hoogte van de BRS heeft een sterke
voorspellende waarde in hartfalenpatiënten.
Hartfalenpatiënten hebben tevens een
verlaagde inspanningscapaciteit. Ook dit is een
gevolg van de neurohumorale activatie. De
bloedvaten zullen bijvoorbeeld door deze
neurohumorale activatie samentrekken waar-
door er minder zuurstof naar de werkende
spieren vervoerd kan worden. De verlaagde
inspanningscapaciteit beperkt hartfalenpa-
tiënten in hun dagelijkse activiteiten. De mate
waarin de inspanningscapaciteit verlaagd is
heeft voorspellende waarde voor de mortaliteit.
Verschillende onderzoeken geven aan dat een
verbetering van de inspanningscapaciteit de
prognose van hartfalenpatiënten ook verbetert.
Het is dus belangrijk om naast het terug-
dringen van de neurohumorale activatie en het
verbeteren van de BRS ook de inspanningscapa-
citeit bij hartfalenpatiënten te verbeteren.
Het doel van dit proefschrift was om de
effecten van lichamelijke inspanning en van
biventriculair pacen op fitness gerelateerde
variabelen in de setting van hartfalen te bestu-
deren. In dit proefschrift hebben we ons op
twee verschillende aspecten van fitness gericht
die voor hartfalenpatiënten relevant zijn: de
fysieke fitness (inspanningscapaciteit) en de
fitness van het autonome zenuwstelsel (de
neurohumorale activatie en de BRS). Wanneer
een hartfalenpatiënt een hoge autonome fitness
heeft wil dit dus zeggen dat de BRS hoog is en
er weinig neurohumorale excitatie in rust
aanwezig is. Daarnaast hebben we ook de
onderliggende effectmechanismen van de
gunstige veranderingen die teweeggebracht
worden door lichamelijke inspanning en door
biventriculair pacen aan de orde gesteld.
In hoofdstuk 2 beschrijven we, in een over-
zichtsartikel, de effecten van lichamelijke
inspanning op de neurohumorale excitatie en
autonome ontregeling in rust. Wij concluderen
dat fysieke training de BRS en de hartritme
variabiliteit (HRV) verbetert. Daarnaast vermin-
dert fysieke training de sympathische outflow
en de bloedplasma concentraties van catechola-
minen, angiotensine II, vasopressine en BNP.
Wij kunnen geen conclusies trekken over de
effecten van lichamelijke inspanning op de
endotheline en aldosteron concentraties in het
bloedplasma. 
In hoofdstuk 3 hebben we met behulp van
computersimulaties bestudeerd wat de relatie is
tussen 1) de BRS als index voor de baroreflex
functie, 2) de mate waarin de baroreflex fluctu-
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Derhalve zal een CRT geïnduceerde vermin-
derde CSAR activiteit waarschijnlijk gepaard
gaan met een verbetering in BRS. 
In hoofdstuk 7 hebben we het acute effect van
CRT op de arteriële baroreflex bestudeerd. Een
dag na de implantatie van een CRT-device werd
bij hartfalenpatiënten de BRS en HRV in twee
verschillende modaliteiten gemeten: CRT-
device aan en CRT-device uit (de aan/uit volg-
orde was gerandomiseerd). BRS en HRV verbe-
terden acuut bij het aanzetten van de CRT. We
hebben geen andere verklaring voor deze
gunstige respons van het autonome zenuw-
stelsel dan dat deze wordt veroorzaakt door
CRT-geïnduceerde CSAR deactivatie. 
In hoofdstuk 8 hebben we onderzocht of de
acute verandering in BRS bij baseline, na het
aanzetten van het CRT-device, voorspellende
waarde had voor de anatomische respons
(‘reverse remodeling’) op CRT na de zes
maanden. Voorafgaande aan de implantatie en
6 maanden na de implantatie werd een echo-
cardiogram gemaakt. Een vermindering van
het linker ventrikel eind-systolisch volume van
≥ 15% na 6 maanden CRT therapie werd
beschouwd als een positieve anatomische
respons2,14. Bij anatomische responders was bij
baseline de BRS groter met de biventriculaire
pacemaker aan dan met de biventriculaire
pacemaker uit. Dit was niet het geval bij
patiënten waarbij CRT na 6 maanden geen
anatomische respons was opgetreden.
‘Receiver-operating curve’ (ROC) analyse liet
zien dat de door CRT veroorzaakte procentuele
BRS verbetering bij baseline voorspellende
waarde had voor de anatomische respons op
CRT (oppervlakte onder de curve 0.69; 95%
betrouwbaarheidsinterval 0.51-0.87; maximale
nauwkeurigheid 0.70). We hebben dus aange-
toond dat een door CRT geïnduceerde acute
verbetering van de BRS bij baseline voorspel-
lende waarde heeft voor de anatomische
respons na 6 maanden CRT. Deze bevinding
suggereert dat het autonome zenuwstelsel
actief betrokken is bij de ‘reverse remodeling’
die als gevolg van CRT plaatsvindt.
CONCLUSIES
• Lichamelijke inspanning vergroot de
baroreflex sensitiviteit en vermindert de
sympathische excitatie en de bloedplasma
concentraties van catecholaminen, angioten-
sine II, aldosteron, vasopressine en ANP in
rust
• De bloeddruk buffering capaciteit en de BRS
zijn alleen aan elkaar gerelateerd als
aangenomen wordt dat de gains in alle
efferente baroreflex armen gekoppeld zijn
• Periodieke somatosensorische stimulatie bij
hartfalenpatiënten verbetert de arteriële
baroreflex
• Lichamelijke inspanning verbetert de
‘oxygen uptake efficiency slope’ bij hart-
falenpatiënten
• Bij hartfalenpatiënten met een verminderde
∆V
.




• Cardiale resynchronisatie therapie verbetert
acuut de baroreflex sensitiviteit
• Een acute door biventriculaire pacing
veroorzaakte verbetering in baroreflex sensi-
tiviteit heeft voorspellende waarde voor de
anatomische respons op cardiale resynchro-
nisatie therapie 
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worden opgevoerd naar de vraag hoe de patiënt
het beste periodieke somatosensorische stimuli
van voldoende intensiteit kan verkrijgen, of,
anders geformuleerd, welke bewegingsvorm
rijk is aan somatosensorische stimulatie, terwijl
dit verhoudingsgewijs weinig inspanning kost.
Aangezien bij patiënten met hartfalen een
verminderde inspanningstolerantie samengaat
met een verhoogde mortaliteit is het, naast het
verbeteren van de autonome fitness, ook van
belang de inspanningscapaciteit te verbeteren.
Verschillende onderzoeken geven namelijk aan
dat het verbeteren van de inspanningscapaciteit,
of afgeleiden hiervan, de prognose van hartfa-
lenpatiënten verbetert. In hoofdstuk 5 en 6
hebben we onderzocht of fysieke training naast
de piek zuurstofopname (V
.





CO2helling, ook de ‘oxygen uptake effi-
ciency slope’ (OUES) en de zuurstof opname-
arbeid relatie (∆V
.
O2/∆W) verbetert. Bij hartfa-
lenpatiënten was dit nog niet bekend. De nu
meest gebruikte maat voor de inspanningscapa-
citeit bij hartfalenpatiënten is de V
.
O2 piek, deze is
echter lastig te interpreteren, aangezien deze
afhankelijk is van de motivatie van patiënt en
testleider, en ook van het gekozen inspannings-
test protocol. In tegenstelling tot de V
.
O2 piek,
kunnen de OUES en de ∆V
.
O2/∆W uit submaxi-
male inspanningsdata berekend worden en zijn
dus onafhankelijk van de maximaal behaalde
inspanningsintensiteit. Daardoor kunnen deze
maten betrouwbaarder in hartfalenpatiënten
gemeten worden. 
In beide onderzoeken hebben we een niet-
actieve controlegroep met een trainingsgroep
vergeleken. Beide groepen bestonden uit
stabiele hartfalenpatiënten die op het punt
stonden om met een revalidatieprogramma te
beginnen. De trainingssessies bestonden uit een
duurtraining-gedeelte, waarin gefietst werd en
een krachttraining-gedeelte, waarin lichte
krachtoefeningen plaatsvonden. OUES en 
∆V
.
O2/∆W werden gemeten door middel van
een fietsergometrie-test. Deze werd uitgevoerd
voor de aanvang van het revalidatieprogramma
en herhaald na vier weken (in de controle-
groep) of na het afsluiten van het trainingspro-
gramma (in de fysieke trainingsgroep). Het
trainingsprogramma verbeterde de OUES. De
helft van onze onderzoekspopulatie had
normale ∆V
.
O2/∆W waarden bij aanvang, het
trainingsprogramma had bij deze patiënten
begrijpelijkerwijs geen effect op de ∆V
.
O2/∆W.
Bij patiënten met een verminderde ∆V
.
O2/∆W
verbeterde de training deze waarde. Aangezien
niet alle patiënten een verminderde ∆V
.
O2/∆W
hebben, zou men zich kunnen afvragen of het
wel zinvol is om deze variabele te bepalen. De 
∆V
.
O2/∆W is echter gerelateerd aan de ernst van
het hartfalen. Ook behelzen de verschillende
inspanningscapaciteit variabelen verschillende
aspecten van de bij inspanning betrokken
systemen, zoals het hart, de longen, de bloed-
vaten en de skeletspieren. We zijn dan ook van
mening dat het belangrijk is om de ∆V
.
O2/∆W
in combinatie met andere cardiopulmonale







CO2 slope en OUES te meten om de effecti-
viteit van trainingsprogramma’s bij patiënten
met hartfalen beter te kunnen beoordelen. Op
deze wijze ontstaat er per patiënt een indivi-
dueel beeld van de door training teweegge-
brachte veranderingen.
In de hoofdstukken 7 en 8 hebben we het
effect van cardiale resynchronisatie therapie
(CRT) op de arteriële baroreflex bestudeerd. In
het falende hart wordt de cardiale sympathi-
sche afferente reflex (CSAR) permanent (dus ook
in rust) door zowel metabole als mechanische
stress geactiveerd. Hier uit volgt dat CSAR acti-
vatie een van de oorzaken van de permanente
sympathische outflow in hartfalenpatiënten.
Uit een eerder onderzoek is gebleken dat bij
tijdelijk uitschakelen van het CRT-device
(biventriculaire pacemaker) bij patiënten, die
positief op deze behandeling reageerden (klini-
sche responders), de ‘muscle sympathetic nerve
activity’ direct toenam. Mechanistisch zou dit
effect verklaard kunnen worden doordat CRT
direct de CSAR beïnvloedt. CRT vermindert de
mechanische stress in de hartwand waardoor de
CSAR activiteit zou kunnen dalen. Het is
bekend dat CSAR activatie de BRS verlaagt7,13.
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praktisch als theoretisch belang. Als de hypo-
these, dat periodieke somatosensorische stimu-
latie de neurohumorale activatie vermindert en
de BRS verbetert klopt, dan zouden patiënten
met een lage inspanningstolerantie immers
kunnen profiteren van lichte, maar wel ritmi-
sche activiteit. 
Cardiale resynchronisatie therapie
In dit proefschrift hebben we gepostuleerd
dat de acute door CRT geïnduceerde verande-
ring in BRS veroorzaakt wordt door CSAR deac-
tivatie. Als dit waar blijkt te zijn, is dat een
belangrijke bevinding, omdat chronische CSAR
activatie een van de oorzaken van de perma-
nente neurohumorale excitatie in hartfalen is.
Bovendien lijkt het er op dat CSAR, naast gege-
neraliseerde sympathicus excitatie, ook nog
preferentiële sympathische excitatie van het
hart veroorzaakt11. Buitensporige sympathische
excitatie van het hart veroorzaakt elektrische
instabiliteit (ritmestoornissen), ook zijn hoge
catecholamineconcentraties toxisch voor
cardiomyocyten3. Aangezien het nog niet
mogelijk is om in mensen de activiteit van
cardiale afferenten te meten, is proefdieronder-
zoek nodig om te bepalen of CSAR deactivitatie
een van de oorzaken is voor de door CRT
veroorzaakte acute BRS verbetering. 
In dit proefschrift hebben we laten zien dat
zowel fysieke training als CRT in staat zijn om
de autonome fitness (het goed werken van het
autonome zenuwstelsel/de arteriële baroreflex)
van hartfalenpatiënten te verbeteren. De
mechanismen die deze effecten veroorzaken,
zijn nog niet bekend. Er is dan ook onderzoek
nodig om de onderliggende mechanismen te
achterhalen die de positieve effecten van
fysieke training en ook van CRT veroorzaken.
Als deze mechanismen bekend zijn, kunnen er
betere behandelmodaliteiten voor beide thera-
peutische interventies ontwikkeld worden. Ook
dient er onderzoek gedaan te worden naar de
vraag of en hoe zowel CRT als fysieke training
kunnen worden ingezet in de preventie van
hartfalen (helaas kan hartfalen niet meer
genezen worden wanneer het zich eenmaal
ontwikkeld heeft). Wat betreft CRT is de
‘vroege’ toepassing in zekere zin een dilemma
(qua risico en kosten), maar voor fysieke trai-
ning is dit niet zo (geregelde lichamelijke
inspanning wordt aanbevolen als primaire
preventie van hart- en vaatziekten). Het is de
vraag of fysieke training in populaties met een
verhoogd risico op hartfalen, zoals patiënten
met een myocardinfarct in de voorgeschiedenis,
niet als standaardtherapie, naast de standaard
farmacologische behandeling, ingezet moet
worden om het ontstaan van hartfalen te voor-
komen of althans uit te stellen.
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TOEKOMSTPERSPECTIEVEN
Fysieke training
In de dagelijkse praktijk is de V
.
O2 piek de
meest gebruikte maat bij de evaluatie van de
inspanningscapaciteit van hartfalenpatiënten.
Echter, de behaalde V
.
O2 piek is lastig te interpre-
teren, omdat deze afhankelijk is van de moti-
vatie van patiënt en testleider, alsmede van het
gekozen inspanningstest protocol1,12. Derhalve
verdienen inspanningstestvariabelen die ver-
kregen worden uit de data van een submaxi-
male inspanningstest, die dus niet afhankelijk
zijn van bovengenoemde factoren, de voorkeur.




CO2 helling en ∆V
.
O2/∆W, die
belangrijke prognostische waarde hebben,
kunnen gemakkelijk berekend worden uit de
respiratoire gasanalyse data die gedurende een
fietstest verkregen worden4,5. Resultaten
hiervan kunnen al worden afgeleid uit de gege-
vens afkomstig van de onderste 75% van de
totaal doorlopen inspanningsintensiteit
range6,8,9. In dit proefschrift hebben we laten
zien dat deze inspanningstestvariabelen
gevoelig genoeg zijn om veranderingen na een
trainingsprogramma aan te tonen. Wanneer
alle hiervoor genoemde inspanningstestvaria-
belen per individu bepaald zouden worden,
wordt het mogelijk om een meer betrouwbare
representatie van de individuele capaciteiten en
tekortkomingen per patiënt te verkrijgen. Het
is een stap voorwaarts zijn als alle genoemde
inspanningstestvariabelen zouden worden bere-
kend als objectieve meting van het behaalde
revalidatie effect. Daarnaast hebben deze
inspanningstestvariabelen een aangetoonde
prognostische waarde5,10 en een combinatie van
deze variabelen zal wellicht in de toekomst als
belangrijk prognostisch instrument kunnen
dienen.
We hebben aangetoond dat fysieke training
zowel de inspanningscapaciteit (OUES en 
∆V
.
O2/∆W) als de autonome fitness in hartfalen-
patiënten verbetert. De prognostische waarde
van deze bevindingen is echter onbekend.
Vervolgonderzoek is nodig om te bepalen of de
door fysieke training geïnduceerde verbete-
ringen ook leiden tot een verbeterde prognose.
Tevens is de associatie tussen de verbetering in
cardiopulmonale inspanningstestvariabelen en
het functioneren van het autonome zenuw-
stelsel bij hartfalenpatiënten onduidelijk. Deze
associatie is zeer belangrijk, daar fysieke trai-
ningsprogramma’s zich voornamelijk richten
op het verbeteren van de inspanningscapaciteit
en niet zozeer op het verbeteren van het
autonoom functioneren. Bovendien moet, om
voor hartfalenpatiënten efficiënte trainingspro-
gramma’s te kunnen ontwikkelen, het mecha-
nisme achterhaald worden waardoor training
de autonome verstoring en de neurohumorale
activatie terugdringt. Aangezien een verhoging
van de BRS de prognose verbetert, zou de
meting van de BRS aan het begin en na het
beëindigen van een revalidatieprogramma een
objectief en belangrijk revalidatie effect ten
aanzien van de werking van het autonome
zenuwstelsel kunnen weergeven.
Het in dit proefschrift beschreven onder-
zoek heeft aanwijzingen opgeleverd dat soma-
tosensorische informatie een van de onderlig-
gende stimuli is door middel waarvan fysieke
training het functioneren van het autonome
zenuwstelsel normaliseert. Als dit werkelijk zo
is, dan kan ook humorale normalisatie (norma-
listatie van de catecholamine, aldosteron,
renine, en NT-proBNP concentraties in het
bloed) als respons op deze stimulus verwacht
worden. Op dit moment sluiten we een geran-
domiseerd gecontroleerd onderzoek (de
ALLEGRO studie) af dat opgezet was om deze
hypothese te onderzoeken. In de ALLEGRO
studie vergelijken we effecten van behandeling
door fysieke training en door middel van TENS
toegediende somatosensorische stimuli met een
niet actieve controle groep gedurende een
interventieperiode van twee weken. In de
ALLEGRO studie worden de volgende uitkomst-
variabelen onderzocht: de BRS, diverse bloed
parameters (norepinephrine, epinephrine, NT-
proBNP, plasma renine activiteit and aldos-
teron), de zes-minuten wandeltest, cardiopul-
monale inspanningstestvariabelen en kwaliteit
van leven. De ALLEGRO studie is van zowel
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O2/∆W, oxygen uptake-work rate relation 
A-II, angiotensin II
ANP, atrial natriuretic peptide
AVP, arginine-vasopressin
BNP, brain natriuretic peptide
BP, blood pressure
BPV, blood pressure variability
BRS, baroreflex sensitivity
CHF, chronic heart failure
CI, confidence interval
CRT, cardiac resynchronization therapy
CSAR, cardiac sympathetic afferent reflex
GABA, gamma-aminobutyric acid 
HF, heart failure
HR, heart rate
HRV, heart rate variability
IBI, inter beat interval
LF, low frequency
LVEF, left venticular ejection fraction
LVEDV, left ventricular end diastolic volume
LVESV, left ventricular end systolic volume
MLWHFQ, Minnesota Living with Heart Failure
Questionnaire
MSNA, muscle sympathetic nerve activity
NTS, nucleus tractus solitarii
NYHA, New York Heart Association
classification
OUES, oxygen uptake efficiency slope
RAAS, renin-angiotensin-aldosteron-system
ROC, receiving-operating characteristic
RVLM, rostro ventrolateral medulla 
SBP, systolic blood pressure
SDNN, standard deviation of the intervals
between normal heart beats
TF, transfer function
VAT, ventilatory anaerobic threshold
V
.






O2 kinetics, oxygen uptake kinetics
V
.
O2 max, maximal oxygen uptake
V
.
O2 peak, peak oxygen uptake
Wmax, maximal workload  
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te maken van het door hen verschafte onder-
zoeksmateriaal was dit onderzoek simpelweg
niet mogelijk geweest. Allen wil ik bedanken
voor hun deelname aan mijn onderzoek, hun
mooie verhalen en het in mij gestelde
vertrouwen.
Ook het publiek heeft een inspirerende rol,
met het publiek achter je kan je immers de
hele wereld aan. Hoewel het publiek vaak niet
weet wat je bezield om met een stok over een
lat te willen springen, staan ze daar toch maar.
Ditzelfde geldt voor het promotietraject,
probeer namelijk maar eens aan je familie en
vrienden uit te leggen waarom je in hemels-
naam vier jaar lang op een onderwerp aan het
studeren bent en daarbij mensen onder stroom
zet . . . Ondanks dat, waren mijn vrienden en
familie er altijd! Lief publiek, ik wil jullie dan
ook bedanken voor jullie onvoorwaardelijke
aanwezigheid. Zonder jullie zou mijn wereld
een stuk minder mooi zijn. 
Om nu werkelijk tot de ultieme sprong of
een proefschrift te komen zijn er naast alle tot
nu toe genoemde voorwaarden nog twee zeer
belangrijke vereisten te noemen. Het is alom
bekend dat het echte trainingseffect niet tijdens
de training maar in de daarop volgende rust
bereikt wordt. Na al dat trainen/werken voor
die ultieme prestatie is het dus van groot
belang om een fijn thuis te hebben. Dat thuis
vind ik bij mijn vriend. Iedereen die hem voor
het eerst ziet heeft als opmerking: ‘Wat is hij
groot.’ In mijn ogen is hij echter niet alleen
groot maar zeker ook groots! 
Als laatste vereiste heeft iedere sporter/
promovenda een beschermengel nodig. Mijn
dappere kleine mannetje, als ik naar de wolken
kijk zie ik jou.
NAWOORD 139
NAWOORD
Ruim 4 jaar geleden begon ik aan mijn
promotietraject. Mijn grote passie was op dat
moment polsstokhoogspringen. Helaas heb ik
door een aanhoudende blessure het polsstok-
hoogspringen niet door kunnen zetten. Ik heb
echter ondervonden dat het komen tot een
proefschrift veel overeenkomsten heeft met het
komen tot de ultieme sprong bij het polsstok-
hoogspringen. Zo moeten er voor beiden aan
een aantal vereisten voldaan zijn.
Een goede sprong valt of staat met de juiste
techniek. Om deze techniek zo goed en zo snel
mogelijk aan te leren is het van groot belang
om een goede polsstokcoach te hebben die op
de juiste momenten de juiste aanwijzingen
geeft. Dit is bij het maken van een proefschrift
niet anders. Gelukkig heb ik de afgelopen vier
jaar samen kunnen werken met een bevlogen
coach. Deze coach had altijd aanwijzingen, zat
nooit om woorden verlegen en ik kon altijd bij
hem terecht. Bedankt voor de prettige samen-
werking! 
Hoewel de polsstokcoach de meest bepa-
lende coach is, kan een goede springer het niet
af met enkel een polsstokcoach. Een goede
springer moet namelijk ook technisch goed
kunnen lopen en een acrobatisch vermogen
bezitten. Gedurende de afgelopen vier jaar heb
ik naast een directe coach, ook nog twee andere
coaches gehad. Beiden hebben, ieder op hun
eigen manier, mij de afgelopen jaren voorzien
van prikkelend commentaar. Daarnaast hebben
ze, op voor mij zeer belangrijke momenten,
deuren geopend die anders niet zo snel open
waren gegaan. Bedankt! 
Naast coaches die voornamelijk op het tech-
nische vlak de springer ondersteunen, is het
prettig om ook een soort mentale coach te
hebben. Aangezien in mijn geval deze mentale
coach direct gekoppeld was aan de inclusie van
de deelnemers voor mijn studie en deze
inclusie ver achterliep bij wat we gehoopt
hadden, was ik niet altijd vrolijk en positief
gestemd als ik hem zag. Toch wist hij altijd wel
een glimlach op mijn gezicht te toveren en was
hij er een kei in om mij alles van een zonnigere
kant te laten zien. Ik wil hem dan ook graag
bedanken voor zijn nooit aflatende goede
humeur, maar ook voor zijn inzet voor mijn
studie.
Een goede medische begeleiding is voor een
springer zeker ook een vereiste. Als sporter heb
ik altijd de luxe gehad om door gedreven en
capabele fysiotherapeuten begeleid en opgelapt
te worden. Om als promovenda niet in bles-
sures te verstranden heb je ook een goed
‘medisch’ team nodig dat je onderzoek op de
rails houdt. In mijn geval was er een enorm
‘medisch’ team dat mijn onderzoek draaiende
heeft gehouden. Datamanagers, verpleegkun-
digen, research assistentes, medewerkers van de
planning, fietslaboranten, medewerkers van de
ECG dienst, analisten, cardiologen, revalidatie-
artsen, fysiotherapeuten, trainers, secretaresses,
teammanagers, en medewerkers van de compu-
terondersteuning, een ieder heeft zo zijn eigen
aandeel in het onderzoek gehad en zonder
jullie was dit proefschrift zeker in onoverko-
melijke blessures vastgelopen. Ik wil jullie dan
ook hartelijk bedanken voor jullie inzet en
enthousiasme.
Met goede coaches en een medisch team
ben je er echter nog niet, trainingsmaatjes zijn
ook erg belangrijk. Trainingsmaatjes werken
immers motiverend, je kunt veel van ze leren,
er enorm veel lol mee hebben en als je geluk
hebt houd je er een mooie vriendschap aan
over. De afgelopen 4 jaar heb ik mijn trainings-
maatjes gevonden in mijn ‘tuin’ collega’s!
Nu zou je denken we zijn er bijna, we
hebben immers een aantal coaches, een
medisch begeleidingsteam en trainingsmaatjes.
Niets is echter minder waar. Voor de ultieme
sprong heeft een polsstokhoogspringer immers
een polsstok nodig. Je moet dus goed materiaal
hebben! Dit is bij het doen van onderzoek niet
anders. Zonder de inzet van vele patiënten die
het mij mogelijk gemaakt hebben om gebruik
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